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My heart leaps up when I behold
A rainbow in the sky
So was it when my life began 
So is it now I am a man
So be it when I shall grow old, 
Or let me die!
The Child is father of the Man
William Wordsworth (1770-1850)
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         hroughout the past 50 years, cardiovascular disease (CVD) has been
         the leading cause of morbidity and mortality in most modern 
societies. In 2002, almost 50,000 persons died of CVD in the Netherlands, 
accounting for 33.7% of all deaths.1 Aging of the population and improved 
survival after CVD events bear heavily on medical costs. In order to delay 
the development of atherosclerosis and hence decrease the incidence of 
CVD, it is essential to improve primary prevention of CVD. About four or 
fi ve decades ago, the concept of risk factors was introduced, largely as 
a result of the work done in the Framingham Heart Study.2, 3 Since then, 
extensive research has been done to examine the role of risk factors in the 
development of atherosclerosis and CVD. It has been established that one 
can successfully reduce the incidence of CVD by reducing or even eliminating 
risk factors for this disease. In addition, the decrease in the age-adjusted 
cardiovascular mortality rate, that is seen from the 1970s onwards, can 
be attributed to improved treatment, but also to secondary prevention 
and primary prevention, each accounting for a 25% decrease in CVD 
mortality.4 Many successful preventive campaigns have aimed at creating 
more awareness among adults and drawing attention to people’s own 
responsibility concerning their body and health. In the current view, the best 
way to reduce one’s risk for CVD is to live as healthy as possible by exerting 
regular physical activity, refraining from smoking, consuming alcohol only 
moderately and by a healthy diet.5 Furthermore, much research has been 
devoted to gaining insight into less traditional factors that contribute to the 
initiation and progression of CVD. For example, in recent years, infl ammation 
is recognized as a putative cause of atherosclerosis.6 
Yet, despite these important successes and new insights into the 
pathogenesis of CVD in the past years, unfavourable trends in some coronary 
risk factors, including increasing rates of smoking, obesity7 and decreasing 
levels of physical activity,8 have contributed to a slowing of the rate of 
decline in age-adjusted mortality from CVD. Recently, it has been suggested 
that a proper preventive strategy requires interventions targeting children 
and young adults.9 Already from conception, genetic factors, environmental 
factors and cultural factors emerge that infl uence eventual heart health (see 
fi gure 1-1). For example, parents play an important role in the development 
of the risk factor profi le of their children, not only genetically but also 
environmentally. Children share their parents’ behaviour e.g. eating habits, 
exercising, smoking and drinking habits. 
T
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Figure 1-1: Lifetime factors infl uencing heart and vascular health.
*: conception; CHD: coronary heart disease; CVA: cerebro vascular accident; 
PAD: peripheral artery disease.
DEVELOPMENT OF ATHEROSCLEROSIS
The complex chronic ‘disease’ of the arteries, which eventually may lead to 
clinical CVD, is called atherosclerosis. Atherosclerosis includes thickening 
and hardening of the arterial walls and may be initiated early in life.10 At the 
start, healthy tissue is injured due to exposition to a variety of damaging 
factors. Endothelial dysfunction results in fatty streaks, which are formed 
by an increase of intracellular lipids, smooth muscle cells and multiplying 
macrophages. This initiation of potentially reversible fatty streaks already 
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occurs in childhood and adolescence (fi gure 1-2).11, 12 
When the process of damaging persists, fatty streaks increase in size and 
extent, resulting in so-called atherosclerotic plaques. Initially, these plaques 
are fi brous, covering macrophages, lipids and debris. Longstanding damage 
can lead to rupture of vulnerable plaques, resulting in sudden thrombus 
formation that further occludes the vessel lumen and leads to ischaemia 
of the organ involved.13 Thus, atherosclerosis has a long preclinical phase 
before ischaemic symptoms appear. The Pathobiological Determinants of 
Atherosclerosis in Youth (PDAY) study investigators fi rst reported on the 
occurrence of early atherosclerotic lesions in adolescents in association with 
cigarette smoking and high cholesterol levels.14 
PRIMARY PREVENTION IN EARLY LIFE
Primary prevention programs in younger individuals might help to overcome 
the cardiovascular epidemic by postponing atherosclerotic development, 
and by that retarding the clinical manifestation of CVD.15 The association 
of reduced growth rates in fetal life and infancy with increased death rates 
from CVD poses the question of what processes link the two. Raised blood 
pressure increases the risk of coronary heart disease and stroke, and is one 
obvious link because there is already good evidence that it originates in 
childhood.16-19 The persistence of rank order in the distribution of blood 
pressure among subjects examined at time intervals – so called ‘tracking’ 
– has been repeatedly observed in longitudinal studies of children as well 
as adults.20-24 Besides fetal and infant growth, genetic factors may infl uence 
the development of CVD and its risk factors from early life onwards. Gene-
environment interaction may play an important role in ultimate development 
of CVD. Regarding early environmental factors, it is important to gain insight 
into how parental cardiovascular risk factors infl uence the cardiovascular risk 
profi le of their offspring.  
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Figure 1-2: Natural history of atherosclerosis, showing progressive arterial
occlusion and resultant health effects. Reproduced from McGill et al.(1963).
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DEVELOPMENT OF OVERWEIGHT
In adults and children, the consequences of a decrease in physical activity 
and an increase in the intake of calories are more and more visible over 
the past years. At this time, 36% of the Dutch population is overweight 
and 12% is obese.25 The United States of America still show the highest 
percentages of overweight and obese subjects, 56 % and 22% respectively. 
Data from the US Centers for Disease Control and Prevention (CDC) (see 
fi gure 1-3) show the dramatic increase in overweight children during the 
past 25 years: the proportion of overweight 6-11 year olds doubled and the 
proportion of obese 6-11 year olds rose eightfold.26 
Overweight appears to infl uence the cardiovascular risk profi le already at 
young ages. Over 60% of overweight children have at least one 
additional risk factor for CVD, such as hypertension, hyperlipidemia or 
hypercholesterolemia.27 Enduring overweight is thought to be related to the 
development of an unfavorable cardiovascular risk profi le in adulthood.  
Figure 1-3: Prevalence of overweight in children and adolescents aged 6-19 years 
in the United States.
Overweight is defi ned as body mass index at or above age- and gender-specifi c 95th 
percentile body mass index cut-off points from the 2000 CDC Growth Charts, United 
States. Reproduced from CDC.26
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OUTLINE OF THIS THESIS
Identifi cation of determinants of cardiovascular risk factors in childhood 
and adolescence might create a basis for targeted early preventive action. 
Only few long-term prospective population-based studies are conducted 
among children.28-32 The Epidemiological Preventive Study of Zoetermeer 
(the EPOZ study) is a unique prospective study on cardiovascular risk factors 
for its many repeated measurements of body mass index, blood pressure 
and cholesterol from childhood into adulthood during a follow-up of 27 
years. The study aims at gaining more insight into the determinants of 
early atherosclerosis, cardiovascular risk factors and the development of 
overweight in young adulthood. In chapter 2 of this thesis, the rationale 
and the design of the EPOZ study are described in detail. Chapter 3 covers 
the impact of parental blood pressure and body mass index on offspring 
cardiovascular risk and vascular damage. Chapter 4 focuses on childhood 
determinants of eventual vascular damage in young adulthood. Chapter 
5 discusses the consequences of an insulin-like growth factor (IGF)-1 gene 
polymorphism on birth size, body mass index and atherosclerosis and 
describes the role of birth size in the development of levels of cholesterol 
from childhood into adulthood. Finally, in the general discussion (chapter 
6), the main fi ndings of this thesis are considered in the context of current 
scientifi c knowledge. Furthermore, relevant methodological aspects are 
discussed, and suggestions are made for future research in this fi eld.
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INTRODUCTION
Few prospective population-based studies have been conducted among 
children.1-4 Knowledge on the role of risk factors measured already 
during childhood in the development of adult disease could be important 
concerning early primary prevention. Especially cardiovascular morbidity and 
mortality remains a huge health problem in the industrialized countries and 
is rapidly increasing in the rest of the world. Intervention at the level of the 
known cardiovascular risk factors, especially at young ages, might be the 
only solution to the cardiovascular disease epidemic. For this purpose, the 
predictive value of risk indicators needs to be established at young ages.  The 
Epidemiological Preventive Study of Zoetermeer (EPOZ study) was started in 
1975. All persons aged 5 years or over and living at the same address in 2 
districts of the town of Zoetermeer, the Netherlands constituted the heart of 
this study. Subsequently, this study was continued prospectively in 5-19 year 
olds. In 2002, measurements of vascular damage were added to the usual 
measurements of cardiovascular risk factors (EPOZ 2002 study) (fi gure 2-1).
The objective of the EPOZ 2002 study was to evaluate the early determinants 
of cardiovascular risk factors, subclinical vascular damage, and overweight in 
healthy young adults.
METHODS
STUDY POPULATION AND SELECTION PROCEDURE
Between April 15th 1975 and June 15th 1978, all families with children aged 
between 5-19 years who were living in two districts in the Dutch town of 
Zoetermeer (one urban district, Palenstein and one rural district, Dorp), 
were invited to participate in a cross-sectional population-based study on 
risk-indicators for chronic diseases (EPOZ study). Zoetermeer is a suburban 
residential community of at that time about 55,000 inhabitants which is 
situated near The Hague in the Netherlands. Ultimately, of the potential 
13,461 persons drafted, 10,533 persons participated at baseline (response 
78,2%). Non-response (21,8%) was mainly caused by primary refusal (15%), 
migration (2%) en objections on religious grounds (1.5%). Non-response 
was highest among the 15-19 year olds and among elderly (aged 65+). 
Women were somewhat more willing to participate than men and primary 
attendance was 5% higher in the urban district compared to the 
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rural district. Of all persons aged 5-19 years, 4,649 (82%) took part in the 
EPOZ-study. From this group, a random sample of 596 children was selected 
for annual follow-up in a study on the natural history of cardiovascular risk 
factors and their determinants. After inclusion, participants were invited 
annually to visit the research center in Zoetermeer in the same month of 
the year, at the same time of the day between 17.00-21.00 hours. Between 
1975 and 1993, participants visited the research center annually. In 2002, 
all subjects were invited for an examination that included measurements of 
atherosclerosis. In total, 362 persons participated in this examination. The 
median number of visits is 15 (range 2-19). Median follow-up time for the 
EPOZ 2002 study is 23 years. Response for the majority of visits gradually 
declined to 83% in 1993. For the atherosclerosis measurements in 2002, 
the response was 61%. The EPOZ study was approved by the Medical Ethics 
Committee of the Erasmus MC Rotterdam. All participants gave written 
informed consent at baseline and in 2002.
CARDIOVASCULAR RISK FACTORS
Blood pressure was measured using a Hawksley random-zero 
sphygmomanometer (Lancing, Sussex) according to a standardized protocol5 
on the left brachial artery of the participant sitting after a resting period 
of 15 minutes. A cuff of 23 cm by 10 or 14 cm was used, depending on 
the arm circumference. The largest cuff was usually used in a child over 10 
years of age. Diastolic blood pressure was taken at the 5th Korotkoff phase. 
The mean of two consecutive measurements was used in the analyses. 
Between 1975 and 1993 the same research assistant performed all blood 
pressure measurements. In 2002 three research assistants performed the 
measurements. 
Body height was measured to the nearest 0.1 centimetres using a Seco 
stadiometer. The measurements were taken without shoes in upright 
position, with the heels touching and with the head in Frankfurt plane.6 
Body weight was measured to the nearest 0.1 kg using a Seco digital 
balance. These measurements were taken with the participants standing 
in wearing only light underwear and no shoes. BMI was calculated as body 
weight(kg)/body height(m)2.
Information on smoking and alcohol consumption, medical history 
and medication use was obtained through questionnaires. In addition, 
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women were asked about use of oral contraceptives, menstrual cycle and 
pregnancies.
LABORATORY ANALYSIS 
Blood samples were drawn by antecubital venipuncture, applying minimal 
stasis, using a 21 gauge Butterfl y needle with tube (Surfl o winged infusion 
set, Terumo).
CHOLESTEROL
Serum total cholesterol at baseline was measured with an automated 
enzymatic method7 and from 1983, with a modifi ed reagent (Syswell, 
CHOD/PAP High Performance, Boehringer Mannheim, Germany). In the 
transition period both reagents have been used simultaneously, obtaining 
an excellent correlation (r>0.99). The overall coeffi cient of variation was 
2.5% at baseline and 2.3% during follow-up. Cholesterol determinations 
at follow-up were performed on serum samples stored at -20ºC for up to 4 
years. Repeated measurements performed by our laboratory in frozen serum 
showed no signifi cant changes up to 4 years after sampling compared to 
frozen samples measured within one week after venipuncture. The standard 
deviation of these duplicate serum cholesterol measurements did not exceed 
3.0% in all instances and did not show a signifi cant drift. In 2002, serum 
total cholesterol was determined by an automated enzymatic procedure 
using Hitachi 911 Roche CHOD-PAP reagent kit. A correlation study in 201 
samples between both methods (Syswell versus Hitachi) showed a mean 
decrease of 1.2% (y=0.996x-0.0519).
Measurements of high-density lipoprotein (HDL)-cholesterol were started 
in 1979 and low-density lipoprotein (LDL)-cholesterol in 1984. HDL- and 
LDL-cholesterol were measured by the same method after precipitation. 
For HDL-cholesterol we used the phosphotungstate method according to 
Burstein8 with a minor modifi cation as described by Grove.9 LDL-cholesterol 
measurement was carried out with polyvinylsulphate (Boehringer Mannheim, 
FRG). In 2002, HDL-cholesterol was measured with the Hitachi 911 Roche 
direct HDL-cholesterol assay using PEG-modifi ed enzymes and dextran 
sulphate. For HDL-cholesterol measurements, a correlation study between 
the manual Syswell method and the automated Hitachi 911 was carried out 
in 96 persons. Compared to the old method, HDL-cholesterol levels increased 
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with approximately 7% measured with the Hitachi 911 (y=1.0684x+0.0082). 
In 1994, shortly after the Hitachi 911 method was introduced, Roche 
introduced the fi rst generation homogenous liquid HDL-cholesterol en by 
this mean HDL-cholesterol level decreased by 3% (y=0.9451x+0.0356). 
Summarizing, HDL-cholesterol values measured in 2002 are on average 
5-6% higher compared to HDL-cholesterol levels in 1975.
All measurements were carried out in the laboratory of the Department of 
Epidemiology & Biostatistics at the Erasmus MC, Rotterdam, the Netherlands, 
which from 1978 participated in the lipid standardization program of the 
World Health Organization (WHO) Regional Lipid Reference Centre in 
Prague, Czechoslovakia (Dr. D. Grafnetter), and from 1979 in the Dutch 
National Cholesterol standardization program (KCA foundation), initiated 
in analogy to the program of the CDC Lipid Standardization Laboratory in 
Atlanta. In addition, during the baseline period quality control was indirectly 
checked on the CDC protocol by monthly comparison with cholesterol 
determination using the Abell-Kendall method (Gaubius Institute, TNO, 
Leiden).10 Both accuracy and precision of total cholesterol and HDL-
cholesterol measurements were within acceptable limits (CDC/WHO) over 
the entire period. All automated analyses were initially carried out on a 
Technicon Auto Analyzer-II system (Technicon Instruments, Tarrytown, New 
York, USA) and from 1989 on a Kone Specifi c Analyzer (Kone Instruments, 
Espoo, Finland) using frozen (-20°C) serum samples. From 1987, HDL2-
cholesterol and HDL3-cholesterol subfractions in serum were assayed as 
described by Gidez et al11 with slight modifi cations and separated using 
stepwise precipitation of apolipoprotein B con taining lipoproteins with 
heparin/Mn2+ in two steps and HDL2 with dextran-sulphate. 
INSULIN-LIKE GROWTH FACTOR-1 POLYMORPHISM 
DNA was isolated for insulin-like growth factor (IGF)-1 genotyping at 
the last visit in 2002. Polymerase chain reaction was performed using 
oligonucleotide primers designed to amplify the polymorphic cytosine-
adenine (CA) repeat 1 kb upstream of the human IGF-1 gene.12 The 
reaction was carried out in a fi nal volume of 10 µl containing 50 ng of 
genomic DNA obtained from peripheral blood cells, 0.5 nmol/l forward 
primer (5’ACCACTCTGGGAGAAGGGTA-3’), 0.5 nmol/l reverse primer 
(5’-GCTAGCCAGCTGGTGTTATT-3’), 0.25 mmol/l 2’-dNTP, 2.2 mmol/l 
MgCl2, 0.01% W1 (Gibco BRL), and 0.4 Taq DNA polymerase (Gibco BRL). 
Polymerase chain reaction was performed in 384 well plates (94°C 10 min; 
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35 polymerase chain reaction cycles of 30 s at 94°C, 30 s on 55°C, and 30 s 
on 72°C; 72°C 10 min; 4°C hold). Forward primers were labelled with FAM, 
HEX or NED to determine the size of polymerase chain reaction products by 
autosequencer (ABI 3100, POP 4, fi lter set D, collecting time array 36 cm 7 
s, peak-height between 100 and 2000, each lane containing three samples). 
The size of the polymerase chain reaction products was determined in 
comparison with internal ROX 500-size standard (Perkin Elmer).
PARENTS
Parental data of the participants was obtained at baseline (1975-1978). 
Body weight and height, systolic blood pressure, total cholesterol and HDL 
cholesterol were measured using the same protocols as in the offspring. 
Parental information on alcohol consumption, smoking, medication use and 
medical history was obtained through questionnaires fi lled in by the parents.
COLLECTING BIRTH DATA
To obtain birth data, a questionnaire was sent to the parents of the children 
at baseline between 1975 and 1978. Questions were asked about birth 
weight (gram), birth length (cm), placental weight (gram), gestational 
age, complications during pregnancy and whether or not the mother had 
smoked during pregnancy. In 2002, birth weight was asked again from the 
participants themselves via a questionnaire. In total, birth weight was known 
in 371 subjects (62%).
PARAMETERS OF ATHEROSCLEROSIS
Common carotid intima-media thickness (IMT)
ULTRASOUND PRINCIPLE AND IMAGE
A transducer sends ultrasonic waves into human tissue in a pulsed manner. 
Part of the waves is absorbed by the various components of the tissue and 
part of them is refl ected. From the characteristics of the refl ected waves, a 
two dimensional (2-D) image of various structures of the tissue underlying 
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the transducer is constructed. When differences in acoustic impedance exist 
between various anatomic tissues, refl ection occurs and the structures may 
be seen separately on the image. The acoustic impedance is determined 
by the density and the fl exibility of the tissue. Since calcifi ed tissue has 
high density and low fl exibility it will refl ect most incoming ultrasound 
waves and looks ‘white’ on the scan while blood seems ‘black’ on the scan 
because it hardly refl ects any wave due to low density and high fl exibility. 
When ultrasound waves travel through the human body, reduction of their 
intensity occurs due to absorption, scattering and refl ection. Hence, echoes 
coming from deep structures will tend to be smaller in amplitude than 
those coming from surfaces close to the transducer. To compensate for this 
effect, most ultrasonic instruments use a time gain compensator to amplify 
distant echoes more than close echoes. Whether different structures can 
be identifi ed on the ultrasound image depends on the resolution of the 
equipment used. To be able to distinguish between two structures that are 
both parallel to the sound beam, the axial resolution is most important. 
When the frequency of the transducer increases, the axial resolution will 
also increase. However, high frequencies limit the ability to visualize deeper 
structures. A transducer of 7.5 MHz appears to be a good compromise 
between the resolution and depth for the assessment of carotid IMT, 
resulting in an axial resolution of about 0.3-0.4 mm.13 
On a longitudinal 2-D image of the carotid artery, the near wall and far 
wall are displayed as two bright white lines separated by a hypo-echogenic 
space, representing the lumen fi lled with blood (fi gure 2-2). The three layers 
(tunica intima, tunica media and tunica adventitia) refl ect ultrawave sounds 
separately, as they differ in composition (see this chapter: Parameters of 
arterial stiffness - the vascular wall). The distance of the leading edge of the 
fi rst bright line (lumen-intima interface) and the leading edge of the second 
bright line (media-adventitia interface) indicated the IMT of the far wall. 
Correspondingly, IMT of the near wall was measured.
IMT AS SURROGATE MARKER OF ATHEROSCLEROSIS AND CVD 
Pathology studies have demonstrated that levels of traditional risk factors are 
associated with the extent and severity of atherosclerosis. However, at every 
level of risk factor exposure, there is substantial variation in the amount of 
atherosclerosis, presumably related to genetic susceptibility and the infl uence 
of other risk factors. Therefore, there has been interest in a technique that 
can both measure and monitor atherosclerosis and refl ect the pathological
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Figure 2-2: Longitudinal 2-D ultrasound image of the distal common carotid artery
endpoint of CHD risk factors. As the carotid arteries can be well 
visualized by ultrasonography, several population-based studies have used
ultrasonographic measurements of the thickness of the carotid wall as a
technique to identify and monitor subclinical atherosclerosis and to assess
the predictive value for coronary artery disease. Chambless and colleagues 
in the Atherosclerosis Risk in Communities (ARIC) Study, related IMT
measurements at baseline in 7,289 normal, healthy adults (aged 45 to 64 
years) free from clinical coronary artery disease, to future coronary events 
during a four to seven year follow-up.14 There was a positive association 
between mean carotid IMT and coronary artery heart disease. The strength 
of the relationship was reduced when controlled for major risk factors, but 
remained high in those whose baseline carotid IMT was highest. O’Leary 
Near wall
Far wall
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and colleagues studied an older population (age 65 and older) which 
addressed the association between IMT and the incidence of new myocardial 
infarction or stroke in 4,476 persons without clinical cardiovascular disease 
during a median follow-up period of 6.2 years.15 For patients in the highest 
quintile of IMT at baseline, the accumulative risk for an event was 25% 
and 5% for patients in the lowest quintile of IMT. The yearly incidence of 
myocardial infarction or stroke increased with increasing quintiles for each 
of the measures of IMT. After adjusting for other risk factors the association 
between IMT and risk of a major event was 3.9 times higher for patients 
in the highest quintile. Hodis and colleagues followed 146 men aged 40 to 
59 who had previous coronary artery bypass surgery.16 IMT was measured 
every 6 months throughout a two-year study period and angiograms were 
performed at baseline and at two years. Average follow-up was 8.8 years. 
For each 0.03-mm increase per year in carotid IMT, the relative risk for 
myocardial infarction was 2.2 and the relative risk for any coronary event was 
3.1. This study also showed that LDL cholesterol lowering drugs signifi cantly 
reduce the common carotid artery IMT.
A limitation of carotid artery IMT as a surrogate for coronary artery disease 
is that it does not accurately assess the total atherosclerotic burden and 
therefore cannot predict the severity of coronary artery disease or distinguish 
patients with one-vessel, two-vessel, or more coronary artery disease. Given 
these limitations, more recent research has used the combined carotid artery 
IMT and femoral artery IMT measurements to more accurately determine 
atherosclerotic burden of the coronary arteries. A recent non-randomized 
study of 366 adults with known coronary artery disease was conducted to 
determine whether the addition of femoral artery IMT to carotid artery IMT 
would permit distinctions between subgroups, divided according to the 
severity of their underlying coronary atherosclerosis.17 This study shows that 
the combined assessment of both carotid and femoral arteries may add to 
the ability to accurately estimate the total atherosclerotic burden and thus 
predict coronary artery disease severity. Further study is required before 
conclusions can be drawn concerning whether combined carotid/femoral 
artery assessment improves the health outcomes of patients with known or 
suspected coronary artery disease.
Thus, fi ndings in the recent literature support the current policy on 
ultrasonographic measurement of the carotid IMT for assessing subclinical 
atherosclerosis. 
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IMT MEASURMENT IN THE EPOZ STUDY
The reading protocol that was used for the ultrasound measurements 
in the EPOZ study was developed within the Rotterdam Study.13 B-mode 
ultrasonography of both the left and right carotid artery was performed with 
a 7.5 MHz linear array transducer using a Duplex scanner (ATL Ultramark IV, 
Advanced Technology Laboratories, Bethel, Washington, USA). The subject 
is in supine position with the head turned approximately 45 degrees in 
opposite direction. The ultrasound examination starts at the right carotid 
artery. An initial ultrasound scan is made showing a longitudinal view of 
the common carotid artery, the carotid bifurcation and the internal carotid 
artery. Then, a careful search is performed for the intima-lumen interface 
and the media-adventitia interface of the far wall of the distal common 
carotid artery. When an optimal longitudinal image is obtained, it is frozen 
on the R wave of the electrocardiogram. This procedure is repeated three 
times for three optimal 2-D images of the distal common carotid artery. 
For the bifurcation and the internal carotid artery one image showing the 
site with the largest distance between lumen-intima interface and media-
adventitia interface, is frozen on the R wave of the electrocardiogram. The 
initial ultrasound scan and the frozen images are recorded on VHS videotape.
The actual measurements of lumen diameter and IMT are performed offl ine 
using a procedure and additional dedicated software, that has been closely 
adapted from the Wallenberg Laboratory for Cardiovascular Research, 
Gothenburg, Sweden.18 A frozen image that was stored on videotape is 
digitised and displayed on the screen of a Laser 286/2 personal computer 
using a frame grabber (VP 1400-KIT-512-E-AT, Imaging Technology). After 
calibration, two vertical lines are drawn on the digitised image, using a 
graphic XY tablet and a mouse (Summagraphics M II 1201). The distance 
between the two lines is set on 10 mm. The fi rst vertical line is placed at the 
beginning of the dilatation of the distal common carotid artery, which serves 
as a reference point for the start of the measurement. With a cursor, the 
intima-lumen interface at the near wall and the lumen-intima interface and 
the media-adventitia interface at the far wall of the distal common carotid 
artery are marked over a length of 10 mm. Computer software calculates 
the mean values as well as maximal values for lumen diameter and the IMT. 
The average of the lumen diameter and the IMT of each of the 3 frozen 
images are calculated. For each subject a mean lumen diameter and a mean 
maximal IMT ((left + right)/2) are taken as a measure for current lumen 
diameter and wall thickness of the distal common carotid artery, respectively. 
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A similar procedure is followed for the measurement of the IMT of the 
carotid bifurcation and the internal carotid artery. As in these segments clear 
interfaces of 10 mm are not often seen, IMT is measured from the frozen 
images showing the site of the maximal distance between lumen-intima 
interface and media-adventitia interface.
Carotid Plaques
The presence of plaques in the carotid artery was assessed by evaluating 
the ultrasonographic images of the common, internal and bifurcation site 
of the carotid artery for the presence (yes/no) of atherosclerotic lesions. 
Plaques were defi ned as focal thickenings of the vessel wall of more 
than 50% relative to adjacent segments with protrusion into the lumen 
composed of either only calcifi ed deposits or a combination of calcifi cation 
and noncalcifi ed material. Subsequently, the focal lesions were scored for 
presence of calcifi cation and acoustic shadowing, homogeneity and size.
PARAMETERS OF ARTERIAL STIFFNESS
THE VASCULAR WALL
The arterial wall consists of 3 layers, from the lumen site to the outer site 
tunica intima, tunica media and tunica adventitia respectively (fi gure 2-
3). Demarcation between the tunica intima and media is provided by te 
lamina elastica interna, a structure that consists of a fenestrated membrane 
of elastin lined on te intimal side by a coarse fi brous network. The lamina 
elastica externa demarks the tunica adventitia.
The inner layer of an arterial wall, the tunica intima, consists of vascular 
endothelium. The outer layer of an arterial wall, the tunica adventitia, is a 
region of collagen and some elastin tissue that merges with the surrounding 
connective tissue. The mid layer, the tunica media, consists of elastin and 
collagen fi bers and smooth-muscle cells and forms the largest part of the 
arterial wall. The tunica media is the principal determinant of the mechanical 
properties of the arterial wall. The composition of the tunica media 
changes along the arterial tree. In the proximal aorta elastin is the principal 
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component while in the peripheral arteries collagen dominates. Because 
elastin is much more elastic than collagen, the arteries become stiffer with 
increasing distance from the heart.19 
Figure 2-3: Schematic view of an arterial wall in cross-section. 
With increasing age, arteries stiffen as in the tunica intima, the endothelial 
cells become more irregular in size and shape, the subendothelial layer 
thickens and in the tunica media elastic fi bers degenerate with an increase 
in collagenous fi bers and calcium deposition. Thus, an artery is a viscoelastic 
tube, whose diameter varies with pulsating pressures due to contraction 
of the heart (fi gure 2-4). In addition to their conduit function, arteries also 
perform a cushioning function that transforms the pulsatile fl ow generated 
1 tunica intima    4 lamina elastica externa 
2 lamina elastica interna    5 tunica adventitia 
3 tunica media
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by contraction of the left ventricle into steady fl ow at the periphery, enabled 
by the viscoelastic properties. These viscoelastic properties are frequently 
described in terms of compliance, distensibility or stiffness, which is the 
inverse of distensibility. The propagation velocity is determined by the elastic 
and geometric properties of the arterial wall and the characteristics of the 
fl uid (blood density).20 When the elastic vessel wall properties of the arterial 
system decrease and the artery becomes stiffer, the high pressure generated 
by the heart is no longer cushioned. This results in a higher proportion of the 
stroke volume that is forwarded directly to the peripheral circulation and by 
that to increased systolic blood pressure. The higher the stiffness, the lower 
the distensibility and the higher the velocity. 
Figure 2-4:  The effect of the pulse wave of the blood on the arterial wall.
Reproduced from www.complior.com.
In conclusion, arterial stiffness plays a potential etiologic role in 
cardiovascular disease and may help to recognize arterial changes. Arterial 
stiffness may constitute an early risk marker.
The past decade, accurate methods to non-invasively measure arterial stiffness 
have become available. Two of the most frequently used methods are the 
measurement of pulse wave velocity over a certain part of the arterial tree and 
the measurement of changes in arterial diameter due to changes in arterial 
pressure over the cardiac cycle at one specifi c point in the arterial tree.
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Aortic pulse wave velocity (PWV)
PWV is a simple noninvasive, accurate and highly reproducible method to 
assess arterial stiffness21,22 that has been used for a long time.23 It can be 
performed quickly (within 10 minutes) with relatively inexpensive equipment. 
In comparison to other methods for measuring arterial stiffness, using 
ultrasound or even magnetic resonance imaging (MRI), PWV requires a 
relatively simple computer with a software application and two connected 
tonometers. The measurement is easy to perform and does not require 
extensively trained personnel. Another advantage of carotid-femoral PWV 
is that it measures arterial stiffness over a large part of the arterial tree, 
thereby providing a measure of general stiffness of that part of the arterial 
tree. Other methods, which measure arterial stiffness at one specifi c point in 
the arterial tree, could have the disadvantage of that specifi c point not being 
representative of a larger arterial area. 
One limitation of carotid-femoral PWV is that it combines measurement of 
elastic arteries (proximal aorta) with more muscular arteries (distal aorta, 
iliac artery and femoral artery), making it impossible to evaluate differences 
in elastic properties or differences in determinants of the process of arterial 
stiffening between elastic arteries and more muscular arteries.
PWV MEASUREMENT IN THE EPOZ STUDY 
Participants were instructed to refrain from smoking, from drinking coffee, 
tea, alcohol and taking pain-medication on the day of measurement, and 
from drinking alcohol on the day before measurement. Carotid-femoral 
PWV was measured with subjects in supine position. Before measurement 
of PWV, blood pressure was measured twice with a sphygmomanometer 
after fi ve minutes of rest and the mean was taken as the subject’s reading. 
Mean arterial pressure (MAP) was calculated by the following formula: 
diastolic blood pressure + ⅓*(systolic blood pressure – diastolic blood 
pressure). Carotid-femoral PWV was assessed using an automatic device 
(Complior, Colson, Garges-lès-Gonesse Cx, France)21 that assessed the time 
delay between the rapid upstroke of the feet of simultaneously recorded 
pulse waves in the carotid artery and the femoral artery (fi gure 2-5). The 
distance travelled by the pulse wave between the carotid artery and the 
femoral artery was measured in a straight line using a compass to reduce 
the infl uence of body contours: (a) from the sternal notch to the proximal 
sampling site on the carotid artery and (b) from the sternal notch to the 
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distal sampling site on the femoral artery. The carotid to femoral path length 
was estimated by subtracting distance (a) from (b).24 PWV was calculated 
as the ratio between the distance travelled by the pulse wave and the foot-
to-foot time delay and expressed in meters per second. The average of 10 
successive measurements, to cover a complete respiratory cycle, was used in 
the analyses. One limitation of the method used is a possible higher short-
term variability as the PWV measurements are not performed on the same 
pressure waves.
Figure 2-5: Measurement of aortic pulse wave velocity.
Reproduced from: Popele, NM van; Causes and consequences of arterial stiffness. An 
epidemiological approach (Thesis).24
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Carotid distensibility
Common carotid distensibility was assessed with the subjects in supine 
position. The vessel wall motion of the right CCA was measured by means of 
a Duplex scanner (Ultramark IV, ATL, Bethel, Washington, USA) connected 
to a vessel wall movement detector system.25,26 After fi ve minutes of rest, a 
region at 1.5 cm proximal to the origin of the bulb of the carotid artery was 
identifi ed using B-mode ultrasonography. The displacement of the arterial 
walls was obtained by processing the radio frequency signals originating 
from two-selected sample volumes positioned over the anterior and 
posterior walls. The end-diastolic diameter (D), the absolute stroke change 
in diameter during systole (∆D), and the relative stroke change in diameter 
(∆D/D) were computed as the mean of four cardiac cycles of three successive 
recordings (fi gure 2-6).
Figure 2-6: Measurement of carotid distensibility.
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Blood pressure was measured twice with a Dinamap automatic blood 
pressure recorder (Critikon, Tampa, Florida, USA) and the mean was taken 
as the subjects reading. Pulse pressure (∆P) was calculated as the difference 
between systolic and diastolic blood pressure. The cross-sectional arterial 
wall distensibility coeffi cient (DC) was calculated according to the following 
equation: DC = (2∆D/D)/∆P (10-3 / kPa).27
DATA ANALYSIS
In most analyses, repeatedly measured blood pressure, cholesterol or body 
weight in the offspring were studied as outcome. As repeated measurements 
within children are non-independent observations, we used unbalanced 
repeated measurement analysis to take this correlation into account. With 
this method, we investigated the pattern of the outcome in the offspring 
over time and the effect of covariates on these patterns. Intercept and age 
were mostly used as random effects. In the analyses with parameters of 
vascular damage as outcome, univariate and multivariate linear regression 
models were used. The relationships between cardiovascular risk factors in 
offspring or parents and the dichotomous variable for presence of plaques 
were evaluated by univariate and multivariate logistic regression analysis.
Subgroup analysis was performed only when the added interaction term was 
signifi cant in the multivariate model and if a biologically plausible mechanism 
was present.
In the analysis with PWV as the outcome variable and cardiovascular risk 
factors as independent variables, failure to correct for blood pressure 
could result in residual confounding: on the one hand PWV is related to 
wall elasticity and by that to distending pressure,28 while on the other 
hand blood pressure is related to several cardiovascular risk factors such as 
body mass index, waist circumference, HDL-cholesterol and insulin. Mean 
arterial pressure (MAP) is preferred to use for this correction because it 
remains constant between central and peripheral arteries while all other 
blood pressure parameters show pressure amplifi cation along the arterial 
tree.29 Besides blood pressure, also heart rate is an important factor in the 
intraindividual variation of PWV.30
All statistical analyses were performed by using the Statistical Analysis 
System (SAS), with the Proc Mixed module for unbalanced repeated 
measurement analysis,31 the Proc GLM module for linear regression analysis 
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and the Proc Logistic module for logistic regression analysis.
CONCLUSION
The EPOZ-study is a cohort study in children, followed from childhood into 
adulthood, which aimed to provide data on early determinants of vascular 
damage. Together with knowledge from other cohort studies in children, 
in particular the Pathobiological Determinants of Atherosclerosis in Youth 
(PDAY) study,32 the Muscatine Study33 and the Bogalusa Heart Study,34 
the EPOZ study aimed to enhance our understanding of the underlying 
mechanism of atherosclerosis and CVD. Such knowledge is needed for the 
possible new paradigm of the 21st century, namely shifting the diagnosis and 
treatment of atherosclerosis to children and young adults. 
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ABSTRACT
BACKGROUND
Previous studies on familial aggregation of blood pressure have reported 
data on family history of hypertension. Data on actual parental blood 
pressure levels and the subsequent natural history of blood pressure in their 
offspring are scarce. 
METHODS
In a population based study with 596 children aged 5-19 years, 
cardiovascular risk factors were measured annually from 1975 until 
2002. Parental data were obtained at baseline. Repeated blood pressure 
measurements were studied as a function of tertiles of age-adjusted blood 
pressures measured in their parents at baseline. 
RESULTS
Systolic blood pressure during follow-up was higher in offspring whose 
parents were both in the highest tertile compared to children whose parents 
were not in the highest tertile (difference 2.7 mmHg, 95% confi dence 
interval: 0.2,5.2). Having both parents in the highest tertile of diastolic blood 
pressure resulted in a substantially higher diastolic blood pressure ranging 
from 1.9 mmHg at age 15 to 8.5 mmHg at age 45. These differences were 
adjusted for age, gender, body mass index, total serum cholesterol, smoking 
habits and alcohol consumption.
CONCLUSION
Actual parental blood pressure shows to be an important predictor of 
blood pressure development from childhood into young adulthood. This 
is important when constituting cardiovascular risk profi les for children and 
young adults.
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INTRODUCTION
Prospective studies have shown that cardiovascular disease aggregates in 
families.1,2 This is probably partly due to familial aggregation of important 
cardiovascular risk factors such as blood pressure and plasma cholesterol.3,4 
It is long recognized that primary hypertension has its roots in early life.5,6 
Familial aggregation of blood pressure levels is well established in cross-
sectional studies in various societies7-10 and was shown to be detectable in 
children at a very young age.11 
In longitudinal studies, children with a family history of hypertension were 
shown to have persistently higher blood pressure levels than children 
without such a history over follow-up periods of up to 10 years.12-14 Still, 
the usefulness of recording a positive family history in the prediction of 
hypertension in the individual is considered to be limited.15,16 No data is 
available on young parents’ actual blood pressure levels in relation to 
the subsequent natural history of blood pressure in their children. It is of 
particular interest to know whether parental blood pressure levels are 
predictors of their offspring’s subsequent blood pressure development 
into young adulthood and whether this holds for the whole distribution of 
parental blood pressure. In young adulthood, environments are shared less 
than in childhood and the more stable blood pressure levels are claimed 
to be predictive of future hypertension and its cardiovascular sequelae.17 
In our 27-year follow-up study, we assessed the relation between blood 
pressure levels measured in young parents and the subsequent course of 
blood pressure levels in their offspring, measured annually from childhood to 
young adulthood.
 
METHODS
STUDY POPULATION
Families with children aged 5-19 years old who were living in 2 districts 
in the Dutch town of Zoetermeer were invited to participate in a cross-
sectional population-based study on risk-indicators for chronic disease 
(Epidemiological Preventive Study Zoetermeer (EPOZ)). All participants were 
included between 1975 and 1978.18 Zoetermeer is a suburban residential 
community of at that time about 55,000 inhabitants which is situated near 
The Hague in the Netherlands. Of all persons, 4,649 (82 %) took part in 
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the study. From this group, a random sample of 596 children was selected 
for annual follow-up in a study on the natural history of cardiovascular risk 
factors and their determinants. Between 1975 and 1993, subjects visited the 
research center annually in the same month of the year, preferably at the 
same time of the day. In 2002, all subjects were invited for an examination 
that included measurements of both blood pressure and measurements 
of atherosclerosis. The median number of visits is 15 (range 2-19). Median 
follow-up time for the present analyses is 23 years. The present study is 
based on 452 subjects with data available on blood pressures of both 
mother and father. Response gradually declined to 83% in 1993. In 2002 
response was 61%. The Medical Ethics Committee of the Erasmus MC 
approved the study and all participants gave informed consent.
MEASUREMENTS
Blood pressure was measured using a Hawksley random-zero 
sphygmomanometer (Lancing, Sussex) according to a standardized protocol19 
on the left brachial artery of a sitting subject after a resting period of 15 
minutes. A cuff of 23 cm by 10 or 14 was used, depending on the arm 
circumference. The largest cuff was usually used in a child over 10 years 
of age. Diastolic blood pressure was taken at the 5th Korotkoff phase. 
The mean of two consecutive measurements was used in the analyses. 
Between 1975 and 1993 the same research assistant performed all blood 
pressure measurements. In 2002 three research assistants performed 
the measurements. Body height and weight were measured and body 
mass index (BMI) was calculated (weight(kg)/height²(m²)). At each visit 
non-fasting blood samples were taken. In the period 1975-1993 serum 
total cholesterol was determined by an enzymatic procedure using 
Boehringer Mannheim CHOD/PAP High Performance. The latest serum total 
cholesterol measurements were determined by an automated enzymatic 
procedure using Roche CHOD-PAP reagent kit. Information on smoking 
habits and alcohol use, medical history and medication use was obtained 
through questionnaires. In addition, women were asked about use of 
oral contraceptives, menstrual cycle and pregnancies. Parental data of the 
subjects were obtained at baseline. In parents, blood pressure was measured 
similarly using a Hawksley random-zero sphygmomanometer (Lancing, 
Sussex) according to a standardized protocol.19 Total cholesterol was 
determined by an enzymatic procedure using Boehringer Mannheim CHOD/
PAP High Performance. Parental information on smoking habits, alcohol 
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consumption, medical history and use of antihypertensive medication was 
obtained through questionnaires.
DATA ANALYSIS
Parental blood pressure level was examined as a determinant of offspring 
blood pressure levels over time. Tertiles of age-adjusted blood pressure 
distributions were made separately for fathers and mothers using linear 
regression. The highest tertile included parents using anti-hypertensive 
medication. A categorical variable indicating for each child the number of 
parents (none, one or both) in the highest tertile of blood pressure was used 
as the determinant in the subsequent analysis. Repeatedly measured blood 
pressure levels in offspring were studied as outcome. As repeated blood 
pressure measurements within children are non-independent observations 
we used unbalanced repeated measurement analysis. The relation between 
blood pressure and age was modelled using fractional polynomials.20 
Intercept and age were used as random effects. The same modelling was 
used to obtain mean blood pressure in offspring by parental blood pressure 
adjusted for offspring gender, age, height, BMI, total cholesterol, smoking 
habits and alcohol consumption. An interaction term age offspring*parental 
blood pressure was added to evaluate if the relation between parental blood 
pressure and offspring blood pressure changed with increasing offspring 
age. The model included repeated blood pressure measurements in offspring 
as the dependent variable and an indicator for parental blood pressure 
tertile as well as the above-mentioned factors as independent variables. To 
evaluate the impact of paternal and maternal blood pressure separately, 
offspring blood pressure level was analysed according to continuous blood 
pressure levels in respectively fathers and mothers. The interaction terms 
gender*paternal systolic blood pressure, gender*maternal systolic blood 
pressure, gender*paternal diastolic blood pressure and gender*maternal 
diastolic blood pressure were added to assess the paternal and maternal 
effects on sons and daughters separately. All statistical analyses were 
performed by using the Statistical Analysis System (SAS), with the Proc Mixed 
module for unbalanced repeated measurement analysis.21
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RESULTS
The mean age, median years of follow-up and the levels of risk factors at 
baseline of both parents and offspring are shown in table 3-1. Mean baseline 
systolic blood pressure of 362 subjects seen in 2002 and of 183 subjects not 
seen in 2002 was 113.3 mmHg respectively 114.8 mmHg (p=0.26). The fi nal 
model included age and age-½. 
Figure 3-1 refl ects the association between parental systolic blood pressure 
and systolic blood pressure of the offspring. Offspring with both parents in 
the highest blood pressure tertile at baseline had persistently higher systolic 
blood pressure levels throughout the 27-year follow-up as compared to 
those with only one or no parents in the highest tertile. Differences between 
the highest and the lowest parental tertiles were statistically signifi cant. The 
Table 3-1 Characteristics of parents and offspring at fi rst visit.
Variable
Mother
n=452
Father
n=452
Female 
offspring
n=219
Male 
offspring 
n=233
Age (years) 41.9 (7.4) 44.8 (7.9) 12.9 (4.1) 13.3 (4.2)
Height (cm) 164.5 (6.0) 176.1 (6.8) 152.1 (17.6) 157.9 (22.2)
Weight (kg) 65.9 (10.2) 76.4 (10.1) 44.4 (15.3) 47.3 (18.0)
Total cholesterol (mmol/l) 5.7 (1.1) 5.9 (1.1) 4.8 (0.7) 4.6 (0.8)
Systolic blood pressure 
(mmHg)
125.7 (16.6) 128.6 (15.3) 112.9 (13.2) 115.5 (16.5)
Diastolic blood pressure 
(mmHg)
79.3 (11.7) 79.4 (11.3) 67.2 (10.4) 67.7 (10.1)
Body mass index (kg/m²) 24.3 (3.6) 24.6 (2.8) 18.5 (3.2) 18.1 (2.7)
% hypertensive* 22.8 26.8
Anti-hypertensive drugs 
(%)
2.6 2.0  
Median follow-up (years) 23.2 23.3
Values are means (standard deviations) unless otherwise indicated.
* using antihypertensive medication or having systolic blood pressure >140 mmHg 
and/or diastolic blood pressure >90 mmHg.
FAMILIAL CARDIOVASCULAR DISEASE RISK: BLOOD PRESSURE
51
difference for systolic blood pressure was estimated at 2.72 mmHg (95% 
confi dence interval 0.21,5.24). The coeffi cient for the interaction term age 
offspring*parental systolic blood pressure was not statistically signifi cant 
(p=0.67), indicating that parentally determined systolic blood pressure 
differences in offspring did not vary with increasing offspring age. 
Figure 3-2 shows the positive association between parental diastolic blood 
pressure and diastolic blood pressure of offspring. The coeffi cient of the 
interaction term age offspring *parental diastolic blood pressure was highly 
statistically signifi cant (p=0.006). Having both parents in the highest tertile 
of diastolic blood pressure resulted in a substantially higher diastolic blood 
pressure in the offspring, from 1.94 mmHg at age 15 to 8.47 mmHg at age 
45 and 11.74 mmHg at age 60.
Figure 3-1 Systolic blood pressure development of children according to parental 
systolic blood pressure.
Values based on a repeated measurement regression model adjusted for offspring 
age, gender, standardized height, body mass index, total cholesterol, smoking habits 
and alcohol consumption. SBP = systolic blood pressure.
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Figure 3-2 Diastolic blood pressure development of children according to parental 
diastolic blood pressure.
Values based on a repeated measurement regression model adjusted for offspring 
age, gender, standardized height, body mass index, total cholesterol, smoking habits, 
alcohol consumption and the interaction term age*parental DBP.
DBP = diastolic blood pressure.
The systolic blood pressure of the offspring raises 0.09 mmHg (0.04,0.13) 
per mmHg increase of maternal systolic blood pressure and diastolic 
blood pressure raises 0.04 mmHg (-0.01,0.08) per mmHg increase of 
maternal diastolic blood pressure. No difference in effect of maternal blood 
pressure was seen in sons and daughters (p-values of interaction terms 
gender*maternal systolic blood pressure and gender*maternal diastolic 
blood pressure 0.38 respectively 0.50). For paternal systolic blood pressure 
the interaction term with gender was borderline signifi cant (p=0.07), being a 
0.14 mmHg per mmHg increase in systolic blood pressure in sons (0.07,0.22) 
and a 0.02 mmHg increase per mmHg in daughters (–0.05,0.09). The effect 
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of paternal diastolic blood pressure was signifi cantly different for sons and 
daughters (p-value interaction term gender*paternal diastolic blood pressure 
0.02), being a 0.16 mmHg increase per mmHg for sons (0.10,0.23) and a 
0.08 mmHg per mmHg increase for daughters (0.01,0.14). 
DISCUSSION
In this longitudinal study, we found that actual parental blood pressure is a 
strong determinant of the natural history of blood pressure in their offspring 
from childhood into young adulthood. The association was found for the 
highest tertile of blood pressure levels of the parents and not only for 
parental hypertension.
Before we discuss our fi ndings, some methodological issues need to be 
considered. The group selected for follow-up was a random sample from 
the youngsters who participated in the baseline study. Blood pressure values 
among those lost to follow-up and those not lost to follow-up were similar. 
Therefore, we do not think that loss-to-follow-up has affected our results. 
Moreover, only small numbers of children were lost in a strict sense; most 
only had some missing values. Measurements of blood pressure include 
within-subject variability and measurement error. The large number of 
measurements of blood pressure that were performed in each individual 
enhances more accurate estimation of subject’s true underlying blood 
pressure levels at every age.
Cardiovascular risk factors including high blood pressure are known to 
aggregate in families,9,11-14 with studies showing the variation in blood 
pressure determined by both genetic and environmental infl uences.14,22-26 A 
relation between a positive family history of hypertension and blood pressure 
in offspring from childhood to young adulthood has been shown,12,13 
including in previous reports of the EPOZ study in children.19,27 A genetic 
basis for the differences found in our study is supported by the fact that 
familial differences are not only present at a young age when environments 
are shared, but persist into young adulthood when environments become 
more different. Familial aggregation is also found for other important 
cardiovascular risk factors such as total serum cholesterol and low-density 
lipoprotein cholesterol,28 smoking habits,29 diabetes mellitus30 and obesity.31 
Our association remained after control for these factors, suggesting that the 
fi ndings of this study are independent of the familial aggregation of those 
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other factors.
It is well established that there is a positive relation between initial level 
of blood pressure and subsequent rise of blood pressure in adulthood,32 
a phenomenon called horse-racing.33 This would indicate that the familial 
differences found in our study might be expected, if anything, to further 
increase in later life. Furthermore, is has been shown in adulthood (> 25 
years of age) that prolonged differences in blood pressure have a substantial 
impact on heart disease risk.34 For example, differences in systolic blood 
pressure of 9, 14 and 19 mmHg were reported to be associated with 
subsequent 34%, 46% and 56% differences in 10-year stroke risk and 
21%, 29% and 37% differences in 10 year coronary heart disease risk, 
respectively. The longitudinal association between high blood pressure in 
childhood and cardiovascular disease much later in life has been shown in  
cross-sectional and short-term longitudinal studies only. However, recent 
long-term follow-up studies showed a signifi cant relationship between blood 
pressure in childhood and levels of atherosclerosis in young adulthood.39,40 
The familial differences in youngsters found in our study, amounting to 
2.72 mmHg systolic and 8.47 mmHg diastolic blood pressure at 45 years of 
age, may lead to material differences in risk of getting stroke and coronary 
heart disease in the far future. It should be added that blood pressure is 
not the only cardiovascular risk factor that shows familial aggregation over 
time. We have shown previously in this cohort that increased parental lipid 
levels are associated with persistently and substantially higher lipid levels in 
their offspring.28 Familial aggregation of multiple cardiovascular risk factors 
already present at an early age seems to persist over time in the offspring, as 
described here. Moreover, it has been reported that clusters of cardiovascular 
risk factor levels show tracking in unselected young populations.41 Our 
fi ndings add to the current knowledge in several ways. The impact of 
parental blood pressure was present over the whole distribution of parental 
blood pressure levels, meaning the lower the parental blood pressure the 
lower the blood pressure levels of the offspring. Furthermore, our data 
suggest that the impact of parental blood pressure starts at an early age 
and is strong and long lasting. Cardiovascular high-risk profi les in the young 
may be better predictors of elevated risk profi les in adulthood and eventually 
of cardiovascular endpoints than single risk factors. Because our data show 
that on a group level parental blood pressure characterizes offspring blood 
pressure throughout youth into young adulthood, actual parental blood 
pressure levels may play an important role in assessing cardiovascular risk in 
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childhood. 
CONCLUSION
Actual parental blood pressure shows to be an important predictor of 
blood pressure development from childhood into young adulthood. This 
is important when constituting cardiovascular risk profi les for children and 
young adults.
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ABSTRACT 
BACKGROUND
The dramatic increase in the prevalence of childhood obesity may have 
implications for children’s current and future cardiovascular health. Family 
dynamics may play an important role in the development of childhood 
obesity and subsequent vascular changes in adulthood. Objective of this 
study is to determine the association between parental body mass index 
(BMI) and the subsequent development of BMI, cardiovascular risk profi le 
and vascular changes in their children.
METHODS
During a follow-up of 27 years, cardiovascular risk factors were 
measured annually in 596 children aged 5-19 years at baseline. In 2002, 
measurements of carotid intima-media thickness were added. In their 
parents, cardiovascular risk factors were measured at baseline. Repeated 
measurements of BMI, cholesterol and systolic blood pressure and a single 
measurement of atherosclerosis in children were studied as a function of 
parental BMI. Overweight was defi ned as age, sex and height adjusted 
weight ≥ 1 standard deviation.
RESULTS
Offspring with both parents in the highest tertile of BMI had a 3.0 kg/m² 
(2.0-3.9) higher BMI and a 14 times higher risk of becoming overweight 
(odds ratio 14.4 (9.1-22.8)) compared to offspring with both parents in 
the lowest tertile. High parental BMI was associated with clustering of 
cardiovascular risk factors and increased carotid intima-media thickness in 
offspring, independent of childhood BMI. 
CONCLUSION
Parental BMI has a strong and lasting impact on the BMI and cardiovascular 
risk profi le of the offspring, already at young ages. Parental BMI predicts 
vascular changes in young adulthood. The results underline the importance 
of early prevention of excessive weight gain and the necessity of involving 
the parents in fi ghting the obesity epidemic.
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INTRODUCTION
The prevalence of overweight and obesity has strongly increased in adults 
as well as in children.1-5 Obesity, once established, is diffi cult to treat. It has 
been proposed that early life prevention is the only effective solution to 
the problem of adult obesity.6 Already at young ages family dynamics may 
play an important role in the development of obesity.7 The importance of 
parental obesity in predicting children’s risk of obesity in adulthood has been 
shown in a retrospective cohort study.8 In this study, Whitacker et al showed 
that parental obesity more than doubles the risk of adult obesity among 
both obese and nonobese children less than 10 years of age. The impact 
of parental body mass index (BMI) on the manifestation of overweight has 
been shown in cross-sectional studies as well.4,9,10 Few studies however, used 
actual measurements of parental BMI and only few studies used repeated 
measurements of BMI in offspring from childhood into adulthood. Most 
studies looked at familial aggregation of obesity using cut-offs for BMI. 
Furthermore, little is known about the impact of parental body weight and 
body weight in childhood on vascular risk in early life. 
The present study was designed to examine the association between 
measurements of parental BMI and BMI and cardiovascular risk factors in 
offspring during a 27-year follow-up period. We also evaluated the relation 
between parental BMI and the presence of atherosclerosis in adult offspring. 
 
 
METHODS
STUDY POPULATION
Families with children aged 5-19 years who were living in two districts 
in the Dutch town of Zoetermeer were invited to participate in a cross-
sectional population-based study on risk-indicators for chronic diseases 
(Epidemiological Preventive Study Zoetermeer (EPOZ)). Zoetermeer is a 
suburban residential community of at that time about 55,000 inhabitants 
which is situated near The Hague in the Netherlands. All families were 
included between 1975 and 1978.11 Of all persons aged 5-19 years, 4,649 
(82 %) took part in the study. From this group, a random sample of 596 
children was selected for annual follow-up in a study on the natural history 
of cardiovascular risk factors and their determinants. After inclusion, 
participants were invited annually to visit the research center in Zoetermeer 
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in the same month of the year, at the same time of the day between 17.00-
21.00 hours. Between 1975 and 1993, participants visited the research 
center annually. In 2002, all subjects were invited for an examination that 
included measurements of atherosclerosis. In total, 362 persons participated 
in this examination. The median number of visits is 15 (range 2-19). Median 
follow-up time for the present analyses is 23 years. Response for the 
majority of visits gradually declined to 83% in 1993. For the atherosclerosis 
measurements in 2002, the response was 61%. The EPOZ study was 
approved by the Medical Ethics Committee of the Erasmus MC Rotterdam. 
All participants gave written informed consent at baseline and in 2002.
MEASUREMENTS
Body height was measured to the nearest 0.1 centimetres using a Seco 
stadiometer. The measurements were taken without shoes in upright 
position, with the heels touching and with the head in Frankfurt plane.12 
Body weight was measured to the nearest 0.1 kg using a Seco digital 
balance. These measurements were taken with the participants standing 
in wearing only light underwear and no shoes. BMI was calculated as body 
weight(kg)/body height(m)2. Blood pressure was measured using a Hawksley 
random-zero sphygmomanometer according to a standardized protocol 
on the left brachial artery of the sitting participant after a resting period 
of 15 minutes.13 The mean of two consecutive measurements was used in 
the analyses. At each visit non-fasting blood samples were taken. In the 
period 1975-1993, serum total cholesterol was determined by an enzymatic 
procedure using Boehringer Mannheim CHOD/PAP High Performance, 
high-density lipoprotein (HDL) cholesterol was measured similarly after 
precipitation of the non-HDL-cholesterol fraction.14 In 2002, serum total 
cholesterol was determined by an automated enzymatic procedure using 
Roche CHOD-PAP reagent kit. HDL cholesterol was measured with the Roche 
direct HDL cholesterol assay using PEG-modifi ed enzymes and dextran 
sulphate. Information on smoking and alcohol consumption, medical history 
and medication use was obtained through questionnaires. Parental data of 
the participants were obtained at baseline. Body weight and height, systolic 
blood pressure, total cholesterol and HDL cholesterol were measured using 
the same protocols as in the offspring. Parental information on alcohol 
consumption, smoking, medication use and medical history was obtained 
through questionnaires fi lled in by the parents. 
In 2002, IMT was measured by recording of ultrasonographic images of both 
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the left and right carotid artery, using a 7.5 MHz linear array transducer (ATL 
Ultramark IV, Advanced Technology Laboratories, Bethel, Washington, USA). 
The lumen-intima interface and the media-adventitia interface of the near 
and far wall of the distal common carotid artery were measured off-line. The 
protocol has been described in detail elsewhere.15 The common carotid IMT 
was determined as the average of near and far wall measurements of both 
left and right side. 
STATISTICAL ANALYSIS
The fi rst aim was to analyse parental BMI as a determinant of offspring 
BMI over time. To that end, an unbalanced repeated measures model was 
used with repeated measurements of offspring BMI as dependent variable 
and an independent variable indicating both parents being in the highest, 
the middle, or the lowest tertile of BMI. Each offspring BMI response was 
assumed to have a linear relation with age and to have its own random 
intercept and slope. The independent variable was constructed using 
tertiles of age-adjusted BMI distributions that were made separately for 
fathers and mothers. An interaction term parental BMI*age offspring was 
used to evaluate a possible change in the relation between parental BMI 
and offspring BMI with increasing offspring age. Using logistic regression 
we evaluated the relation between parental BMI and overweight in the 
offspring. Overweight was defi ned as age, sex and height adjusted weight 
≥ 1 standard deviation (SD). The same model was used for evaluating the 
effect of maternal and paternal BMI separately. In all models we adjusted 
for offspring gender, age, total cholesterol, smoking habits and alcohol 
consumption. A repeated measures linear regression model was used to 
evaluate the relation between parental BMI and cardiovascular risk factors 
in the offspring. At each visit, a cardiovascular risk score was calculated for 
each person based on systolic blood pressure, total cholesterol and BMI 
level, ranging from 0 (none of the variables in the highest tertile) and 3 (all 
variables in the highest tertile). The models included repeated risk scores in 
offspring as the dependent variable and the categorical variable indicating 
parental BMI status as the independent variable. Adjustments were made 
for age, gender, smoking habits and alcohol consumption of the offspring. 
The impact of parental BMI on carotid IMT in the offspring was studied 
using multiple linear regression analysis. The model included offspring IMT 
as the dependent variable and parental BMI as the independent variable and 
adjustments were made for age, gender, total cholesterol, smoking habits 
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and alcohol consumption. All statistical analyses were performed using the 
Statistical Analysis System (SAS), with the Proc Mixed module for unbalanced 
repeated measurement analysis.16
 
RESULTS
The mean age, median years of follow-up and the levels of risk factors of 
both parents and offspring are shown in Table 3-2. Mean baseline levels of 
BMI of the offspring seen at baseline, in 1992 and in 2002 were 18.4 kg/m², 
18.3 kg/m² and 18.6 kg/m², respectively. Offspring with both parents in the 
highest BMI tertile at baseline had persistently higher BMI throughout the 
27-year follow-up as compared to those with both parents in the middle 
or lowest tertile (Figure 3-3). Having both parents in the highest tertile of 
BMI was associated with an average 2.97 kg/m² (95% confi dence interval 
2.04-3.89) higher BMI in offspring in comparison with having both parents 
in the lowest tertile. Having both parents in the middle tertile resulted in 
a 1.38 kg/m² (0.32-2.43) higher BMI compared to having both parents in 
the lowest tertile. There was no interaction between the effects of parental 
BMI and age of the offspring (p=0.30). Thus, the relation between parental 
and offspring BMI did not depend on offspring age. Adjustment for total 
cholesterol, smoking and alcohol use of offspring did not substantially 
change the estimates. Male offspring with both parents in the highest 
tertile had a 2.22 kg/m² (1.07-3.37) higher BMI than male offspring with 
both parents in the lowest tertile. The difference between male offspring 
with both parents in the middle tertile of BMI and those with both parents 
in the lowest tertile was 0.84 kg/m² (–0.48-2.15). In female offspring, 
corresponding differences in BMI amounted to 3.72 kg/m² (2.27-5.18) and 
1.94 kg/m² (0.28-3.61) respectively. The difference in effect of parental BMI 
between boys and girls was not statistically signifi cant (p=0.10). Offspring 
with a father in the highest tertile had a 1.66 kg/m² (1.11-2.21) higher BMI 
than offspring with a father in the lowest tertile. Offspring with a mother in 
the highest tertile had a 1.19 kg/m² (0.64-1.73) higher BMI than offspring 
with a mother in the lowest tertile. The relation between parental BMI and 
risk of becoming overweight in the offspring is shown in table 3-3. 
Figure 3-4 shows the relation between parental BMI and cardiovascular risk 
in the offspring. Children with both parents in the highest tertile of BMI had 
a 0.65 (0.45-0.86) higher cardiovascular risk score compared to children with  
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both parents in the middle or lowest tertile. Neither age nor gender effects 
were present (interaction terms respectively p=0.81 and p=0.94). The 
effects of father’s BMI and mother’s BMI on cardiovascular risk were similar.
Offspring with paternal BMI in the highest tertile had a 0.036 mm (0.015-
0.057) higher IMT compared to offspring of fathers with a BMI in the lowest 
tertile (fi gure 3-5). Offspring’s IMT increased with 0.005 (0.002-0.008) 
mm per 1 kg/m² increase in their father’s BMI (p=0.001). This association 
was independent of offspring BMI as the IMT still increased when adding 
offspring BMI to the latter model (0.004 (0.001-0.008) mm per 1 kg/m² 
increase in paternal BMI (p=0.004)). Offspring with maternal BMI in the 
highest or middle tertile did not differ in IMT with offspring of mothers with 
a BMI in the lowest tertile (differences were –0.002 mm (-0.023-0.019) and 
–0.012 mm (-0.033-0.009), respectively).
DISCUSSION
In the present 27-year follow-up study, we found that the BMI of parents 
is strongly related to the BMI and cardiovascular risk of their offspring from 
childhood well into adulthood. Notably, we found an association between 
parental BMI and vascular changes in adult offspring. 
Before interpreting our results, some methodological issues need to be 
discussed. During the follow-up period of 27 years, a single research 
assistant performed the vast majority of the average of 15 measurements 
per participant, reducing measurement variation. The large number of 
measurements of BMI that was performed in each individual further 
enhanced more accurate estimation of person’s true underlying levels at 
every age. The population selected for follow-up was a random sample from 
the youngsters who participated in the baseline study. As BMI values at 
baseline were similar among those who were and those who were not lost 
to follow-up, we do not think that selective loss-to-follow-up has affected 
our results. We used measurement of IMT which is a recognized measure of 
atherosclerosis.15,17-20 Ultrasonographic measurement of carotid IMT correlates 
well with pathological measurements21 and is an established risk indicator of 
cardiovascular disease.
The importance of family dynamics for the development of childhood obesity 
is suggested by several fi ndings. From previous studies it is known that 
parental obesity is associated with body mass index in the offspring. 
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Figure 3-3 Offspring body mass index according to parental body mass index at 
different ages.
Values (standard error) based on a repeated measurement regression model adjusted 
for age, gender, total cholesterol, smoking and alcohol consumption of offspring and 
interaction of age with parental body mass index; BMI=body mass index.
*p-value < 0.05, compared to offspring with both parents in the lowest tertile of BMI 
(reference).
Table 3-3 Parental body mass index and risk of overweight in offspring.
  
Category of offspring OR * 95% CI
both parents in highest tertile of BMI * 14.4 9.1 – 22.8
both parents in middle tertile of BMI * 3.1 2.2 – 4.1
father in highest tertile of BMI * 3.0 2.5 – 3.6
mother in highest tertile of BMI * 1.8 1.5 – 2.2
Overweight: age, sex and height adjusted weight ≥ 1 standard deviation; OR: 
odds ratio; CI: confi dence interval; BMI: body mass index. Values are from logistic 
regression models adjusted for offspring gender, age, total cholesterol, smoking 
habits and alcohol consumption. *Reference category is offspring with a father and/
or a mother in the lowest tertile of BMI.
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Whitacker et al showed that parental obesity more than doubles the risk of 
adult obesity among both obese and nonobese children under 10 years of 
age.8 The impact of parental BMI on the manifestation of overweight in the 
offspring has also been shown in cross-sectional studies.4,9,10,22 Furthermore, 
it is known that obese children tend to become obese adults. Of children 
who were overweight at around 12 years of age some 80% were still obese 
at around 30 years.23 Our fi ndings add to the current knowledge in several 
ways. The impact of parental BMI was present over the whole range of 
Figure 3-4 Clustering of cardiovascular risk factors in offspring according to 
parental body mass index.
Values (standard error) based on a repeated measurement regression model adjusted 
for age, gender, smoking and alcohol consumption of offspring and with the 
interaction age offspring*parental body mass index; BMI=body mass index.
*p-value < 0.05, compared to offspring with both parents in the lowest tertile of BMI 
(reference).
† Cardiovascular risk score is based on systolic blood pressure, total cholesterol and 
BMI and ranges from 0 (none of the variables in the highest tertile) to 3 (all variables 
in the highest tertile).
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parental BMI levels, meaning the lower the parental BMI the lower the child’s 
BMI. Furthermore, our data suggest that the impact of parental BMI starts at 
an early age, is strong and long lasting, and is also associated with increased 
cardiovascular risk. Finally, our data showed a relation between parental BMI 
and vascular changes in young adulthood, independent of childhood BMI. 
Data on the cardiovascular consequences of high parental BMI are scarce. 
In previous studies we showed BMI development in adolescence to be 
related to young adult arterial wall thickness.24 Two longitudinal studies have 
recently shown that BMI measured in childhood and adolescence predict 
carotid IMT in young adulthood.25,26 However, this association was not found 
in the Thousand Families cohort Study.27 In the present study we found that 
paternal BMI was related to offspring IMT and the association between 
parental BMI and childhood BMI could only partly explain this 
effect. We have no explanation for the restriction of the latter association to
BMI of the fathers.
Figure 3-5 Carotid intima-media thickness in adult offspring according to parental 
body mass index.
Values (standard error) based on a linear regression model adjusted for offspring 
age, gender, total cholesterol, smoking habits and alcohol consumption.
*p-value < 0.05, compared to offspring with a father in the lowest tertile of BMI.
BMI = body mass index; IMT = intima-media thickness.
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There is growing agreement that the environment, rather than biology, 
is driving the current obesity epidemic.28,29 Biology clearly contributes to 
individual differences in weight and height as more than 430 genes, markers, 
and chromosomal regions have been associated or linked with human 
obesity phenotypes.30 Twin studies and earlier observational studies also 
revealed an inherited susceptibility to obesity.30-32 However, the rapid excess 
weight gain and dramatic increase in the prevalence of overweight and 
obesity that has occurred over the past decades in both children and 
adults1-5 is more likely the result of at least a strong interaction with the 
changing environment. In our study, adjustment for the life style factors 
smoking and alcohol consumption did not substantially change the 
estimates. As we lack information on physical activity and nutrition, it is not 
possible to discriminate between effects of environment and biology. 
Once there is manifest obesity it is very diffi cult to treat, also in youngsters,33 
and there is growing consensus that intervention at early ages may be the 
only effective preventive approach.6,7 Knowledge about familial clustering 
of body weight is of crucial importance for primary prevention at an early 
age. First, our study shows that familial weight clustering has a strong and 
long-lasting impact on the BMI in children. Second, the impact of parental 
BMI was present over the whole range of parental BMI levels, meaning the 
lower the parental BMI the lower the child’s BMI. Finally, parental BMI does 
not only affect the current health or social status but is also a predictor of 
future vascular damage in adult offspring and thereby the risk of manifest 
cardiovascular disease in later life. Therefore, the family drive of BMI may 
have strong implications for children’s current and future cardiovascular 
health. 
 
CONCLUSION
Parental body mass index has a strong and lasting impact on the body 
mass index and cardiovascular risk of the offspring, already at young ages. 
Furthermore, parental body mass index is associated with vascular changes 
in young adulthood. The results from our study underline the importance of 
early prevention of excessive weight gain and the necessity of involving the 
parents in fi ghting the obesity epidemic.
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ABSTRACT
BACKGROUND
It has been suggested that the proper strategy for cardiovascular disease 
prevention should target children and young adults. Accurate identifi cation 
of those at highest risk at a younger age can only be based on knowledge 
of the predictive ability of childhood cardiovascular risk factors for vascular 
damage at later age. Objective is to determine the associations of repeated 
childhood measurements of body mass index, systolic blood pressure and 
serum total cholesterol with atherosclerosis and arterial stiffness in young 
adulthood.
METHODS
During a follow-up of 27 years, cardiovascular risk factors were measured 
repeatedly in 596 children aged 5-19 years at baseline. In 2002, 
measurements of atherosclerosis (carotid intima-media thickness (IMT) 
and plaques) and arterial stiffness (femoral-carotid pulse wave velocity 
(PWV) and carotid distensibility) were added and the vascular measures 
were studied as functions of repeated measurements of body mass index, 
systolic blood pressure and total cholesterol. Adjustments were made for 
age, gender, social economic status, smoking habits, alcohol consumption 
and alternately mean arterial pressure, heart rate, body mass index and total 
cholesterol.
RESULTS
Body mass index, systolic blood pressure and total cholesterol levels 
measured both in adulthood and childhood predicted carotid intima-media 
thickness and carotid plaques in adulthood. Relative risks of plaques were 
largest for cardiovascular risk factors measured 20 years earlier in childhood 
(odds ratio’s per 1 SD increase in body mass index, systolic blood pressure 
and total cholesterol, respectively 1.5 (1.1-1.9), 1.4 (1.3-1.5) and 1.6 (1.2-2.2). 
Carotid-femoral pulse-wave velocity was only predicted by systolic blood 
pressure and total cholesterol, measured concurrently. Carotid distensibility 
was solely predicted by systolic blood pressure, measured both in childhood 
and in adulthood. 
CONCLUSION
We found that repeated childhood measurements of body mass index, 
systolic blood pressure and serum total cholesterol were strongly related 
to atherosclerosis in young adulthood. Childhood systolic blood pressure 
was associated with future arterial stiffness. These fi ndings underline the 
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importance of targeting children in delaying atherogenesis and lowering the 
risk of its cardiovascular sequelae with aging. 
 
INTRODUCTION
It has been suggested that the proper strategy for tackling cardiovascular 
disease should target children and young adults.1 Information about risk 
factors for the development of early atherosclerosis has been derived 
mainly from autopsy studies.2,3 In the Bogalusa autopsy study, the number 
of plaques in the aorta and coronary artery wall increased signifi cantly 
with age among children and young adults and was associated with 
traditional coronary risk factors. Furthermore, a higher number of risk 
factors predicted more extensive lesions.3 These observations have been 
extended by ultrasound studies relating childhood risk factors to carotid 
intima-media thickness (IMT) in young adults.4-7 Data on the association 
between childhood cardiovascular risk factors and arterial stiffness in young 
adulthood are scant.8 Knowledge of the predictive value of cardiovascular 
risk factors for premature atherosclerosis and arterial stiffness in adulthood, 
may lead to identifi cation of those at highest risk of cardiovascular disease at 
a young age. 
The aim of our 27-year follow-up study was to determine the relationship 
of body mass index (BMI), systolic blood pressure and total cholesterol 
measured from childhood into adulthood with measures of atherosclerosis 
and arterial stiffness in adulthood. 
METHODS
STUDY POPULATION
Families with children aged 5-19 years who were living in two districts in the 
Dutch town of Zoetermeer were invited to participate in a population-based 
study on risk-indicators for chronic diseases (Epidemiological Preventive 
Study Zoetermeer (EPOZ)). Zoetermeer is a suburban residential community 
of at that time about 55,000 inhabitants which is situated near The Hague 
in the Netherlands. All families were included between 1975 and 1978.9 Of 
all persons aged 5-19 years, 4,649 (82 %) took part in the study. From this 
group, a random sample of 596 children was selected for annual follow-
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up in a study on the natural history of cardiovascular risk factors and their 
determinants. Between 1975 and 1992, participants were invited annually 
to visit the research center in Zoetermeer in the same month of the year, 
preferably at the same time of the day. In 2002, all subjects were invited 
again for an examination that included measurements of atherosclerosis and 
arterial stiffness. In total, 362 subjects participated in this examination. The 
median number of visits is 15 (range 2-19). Median follow-up time for the 
present analyses is 23 years. Response for the annual visits gradually declined 
to 83% in 1992. For the atherosclerosis measurements in 2002, the response 
was 61%.
RISK FACTOR ASSESSMENT
Body height was measured to the nearest 0.1 centimetres using a Seco 
stadiometer. The measurements were taken without shoes in upright 
position, with the heels touching and with the head in Frankfurt plane.10 
Body weight was measured to the nearest 0.1 kg using a Seco digital 
balance. These measurements were taken with the participants standing 
and wearing only light underwear and no shoes. BMI was calculated as 
body weight(kg)/body height(m)2. Information on smoking and alcohol 
consumption, medical history and medication use was obtained through 
annual questionnaires. At all visits, blood pressure was measured using a 
Hawksley random-zero sphygmomanometer (Lancing, Sussex) according to 
a standardized protocol11 on the left brachial artery of a sitting subject after 
a resting period of 15 minutes. The mean of two consecutive measurements 
was used in the analyses. Between 1975 and 1992 the same research 
assistant performed all blood pressure measurements. At each visit non-
fasting blood samples were taken. In the period 1975-1992, serum total 
cholesterol was determined by an enzymatic procedure using Boehringer 
Mannheim CHOD/PAP High Performance.12 In 2002, serum total cholesterol 
was determined by an automated enzymatic procedure using Roche CHOD-
PAP reagent kit. Finally, at the last visit, additional measurements of vascular 
status were performed. 
INDICATORS OF ATHEROSCLEROSIS AND ARTERIAL STIFFNESS
All measurements were taken with the subjects in supine position. First, IMT 
was measured by recording of ultrasonographic images of both the left and 
right carotid artery, using a 7.5 MHz linear array transducer (ATL Ultramark 
IV, Advanced Technology Laboratories, Bethel, Washington, USA).  Three 
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optimal longitudinal images of the intima-lumen inter interface and the 
media-adventitia interface of the far wall and the near wall of the distal 
common carotid artery were frozen on the R wave of the electrocardiogram 
and stored on videotape. The actual measurements of lumen diameter and 
IMT were performed off-line using a procedure and additional dedicated 
software, that has been closely adapted from the Wallenberg Laboratory for 
Cardiovascular Research, Gothenburg, Sweden.13 A frozen image that was 
stored on videotape is digitised and displayed on the screen of a Laser 286/2 
personal computer using a frame grabber (VP 1400-KIT-512-E-AT, Imaging 
Technology). The protocol has been described in more detail elsewhere.14 
The common carotid intima-media thickness was determined as the average 
of the maximal near and far wall measurements of both left and right side. 
The amount of plaques in the carotid artery was assessed by evaluating the 
ultrasonographic images of the common, internal and bifurcation site of 
the carotid artery for the presence of atherosclerotic lesions. Plaques were 
defi ned as a focal thickening relative to adjacent segments with protrusion 
into the lumen composed of either only calcifi ed deposits or a combination 
of calcifi cation and noncalcifi ed material. 
Carotid-femoral pulse-wave-velocity (PWV) was assessed using an automatic 
device (Complior, Colson, Garges-lès-Gonesse Cx, France)15 that computed 
the time delay between the rapid upstroke of the feet of simultaneously 
recorded pulse waves in the carotid artery and the femoral artery. Distances 
from the carotid sampling site to the suprasternal notch and from the 
suprasteranal notch to the femoral artery were measured using a pair of 
compasses.16 PWV was calculated as the ratio between the distance travelled 
by the pulse wave and the foot-to-foot time delay and expressed in meters 
per second. The average of 10 successive measurements, to cover a complete 
respiratory cycle, was used in the analyses. Before measurement of PWV, 
blood pressure was measured twice with a sphygmomanometer after fi ve 
minutes of rest and the mean was taken as the subjects reading. Mean 
arterial pressure was calculated by the following formula: diastolic blood 
pressure + ⅓*(systolic blood pressure – diastolic blood pressure).
Finally, the vessel wall motion of the right common carotid artery was 
measured by means of a Duplex scanner (Ultramark IV, ATL, Bethel, 
Washington, USA) connected to a vessel wall movement detector system.17,18 
After fi ve minutes rest, a region at 1.5 cm proximal to the origin of the 
bulb of the carotid artery was identifi ed using B-mode ultrasonography. 
The displacement of the arterial walls was obtained by processing the radio 
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frequency signals originating from two-selected sample volumes positioned 
over the anterior and posterior walls. The end-diastolic diameter (D), the 
absolute stroke change in diameter during systole (∆D), and the relative 
stroke change in diameter (∆D/D) were computed as the mean of four 
cardiac cycles of three successive recordings. During the common carotid 
distensibility measurement, blood pressure was measured twice with a 
Dinamap automatic blood pressure recorder (Critikon, Tampa, Florida, USA) 
and the mean was taken as the subjects reading. Pulse pressure (∆P) was 
calculated as the difference between systolic and diastolic blood pressure. 
The cross-sectional arterial wall distensibility coeffi cient (DC) was calculated 
according to the following equation: DC = (2∆D/D)/∆P (10-3 / kPa).19
DATA ANALYSIS
All measurements of atherosclerosis and arterial stiffness were studied as 
functions of repeated measurements of BMI, systolic blood pressure and 
total cholesterol. BMI was fi rst standardized by age and gender.20 Systolic 
blood pressure and total cholesterol were standardized by age. Next, the 
means of standardized levels of BMI, systolic blood pressure and total 
cholesterol were calculated separately for four time-periods (16-20 years, 
11-15 years and 6-10 years before and concurrent to the measurement 
of vascular status). These means were used to compute tertiles of the 
risk factor variables for each of the four time-periods. Carotid IMT was 
studied as a function of the tertiles of BMI, systolic blood pressure and total 
cholesterol in each period, adjusted for age, gender, social economic status, 
smoking habits and alcohol consumption. With logistic regression analysis, 
we examined the relation of standardized mean levels of BMI, systolic 
blood pressure and total cholesterol at the different points in time and the 
presence of plaques in the carotid arteries, adjusted for the variables as 
described for the analysis of carotid IMT. The relations of mean standardized 
BMI, mean standardized systolic blood pressure and mean standardized total 
cholesterol in each period with carotid-femoral PWV and carotid distensibility 
were examined using multiple linear regression analysis. The analyses with 
BMI as independent variable were additionally adjusted for blood pressure 
and total cholesterol. In the analyses with systolic blood pressure and total 
cholesterol as independent variables additional adjustments were made 
for BMI. As both blood pressure and heart rate are important factors in 
the intraindividual variation of PWV,21,22 we additionally adjusted for mean 
arterial pressure and heart rate in all analyses with PWV as outcome. 
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A possible age-effect in the relations of BMI, systolic blood pressure and 
total cholesterol with vascular damage was evaluated by adding interaction 
terms with age. All statistical analyses were performed using the Statistical 
Analysis System (SAS), with the Proc Mixed module for unbalanced repeated 
measurement analysis.23
RESULTS
General characteristics of the study population at baseline and at the latest 
visit are presented in table 4-1. 
Figure 4-1 shows the associations of BMI, standardized for age and sex 
and measured at four different time periods with IMT in 2002. There 
was a steady positive relationship between BMI and IMT. Persons with a 
concurrently measured BMI in the highest tertile had a 0.043 mm (0.024-
0.062) higher IMT compared to persons with a BMI in the lowest tertile. 
Being in the highest tertile of BMI 6-10 years before, 11-15 years before and 
16-20 years before the IMT measurement predicted respectively a 0.032 mm 
(0.013-0.051), 0.028 mm (0.010-0.047) and 0.025 mm (0.007-0.043) higher 
IMT compared to persons in the lowest tertile of BMI at these points in time. 
Also, those with a concurrently measured BMI in the middle tertile had a 
signifi cantly higher IMT (0.024 mm (0.006-0.043)) than persons with a BMI 
in the lowest tertile. This association was not seen for BMI measurements 
in earlier time periods. Figure 4-2 shows the association between systolic 
blood pressure and carotid IMT. At all time periods, carotid IMT increased 
signifi cantly with increasing of systolic blood pressure. Being in the highest 
tertile of systolic blood pressure measured concurrently, 6-10 years before, 
11-15 years before and 16-20 years before the IMT measurement, predicted 
respectively a 0.024 (0.005-0.044) mm, 0.041 (0.021-0.061) mm, 0.036 
(0.016-0.057) mm and 0.030 (0.010-0.049) mm higher IMT compared to 
persons in the lowest tertile of systolic blood pressure at these points in 
time. Figure 4-3 shows the association between total cholesterol levels and 
carotid IMT. The differences in carotid IMT between subjects in the highest 
tertile of total cholesterol compared to subjects in the lowest tertile of total 
cholesterol, amounted to 0.020 (0.001-0.038), 0.024 (0.005-0.042), 
0.027 (0.009-0.045) and 0.027 (0.009-0.045) mm for the time-periods 
concurrently, 6-10 years earlier, 11-15 years earlier and 16-20 years earlier, 
respectively. Table 4-2 shows the relationship between BMI, systolic blood 
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Table 4-1 General characteristics of the study population at baseline and at last 
visit.
Values are expressed as mean (standard deviation) in case of continuous variables, 
and as percentages in case of categorical variables.
Characteristic Men Women
 (n=193)  (n=166)
Baseline (1975-1978)
Age (years) 14.4 (5.9) 13.5 (5.8)
Height (cm) 160.4 (21.8) 151.8 (17.5)
Weight (kg) 49.7 (18.5) 44.7 (16.3)
Body mass index (kg/m2) 18.5 (2.9) 18.7 (3.6)
Total cholesterol (mmol/l) 4.6 (0.9) 4.8 (0.8)
Systolic blood pressure (mmHg) 116.4 (16.3) 113.0 (13.2)
Diastolic blood pressure (mmHg) 68.8 (10.6) 67.9 (9.7)
Last visit (2001-2002)
Age (years) 38.0 (4.4) 36.9 (4.5)
Height (cm) 182.2 (6.8) 169.0 (7.4)
Weight (kg) 85.1 (13.6) 73.0 (15.1)
Body mass index (kg/m2) 25.6 (3.6) 25.5 (4.7)
Waist-to-hip ratio 0.90 (0.06) 0.80 (0.08)
Alcohol (n/week) 15.0 (21.0) 5.5 (8.9)
Highest education (%): elementary school 0 0.6
                                        secondary school                  23.5 31.2
                                        lower/intermediate vocational training 50.8 49.4
                                        higher vocational training/university 25.7 18.8
Smoking (%):   current 39.9 28.9
                          past 23.8 33.1
Total cholesterol (mmol/l) 5.2 (1.1) 4.9 (0.9)
HDL-cholesterol (mmol/l) 1.12 (0.29) 1.37 (0.32)
Systolic blood pressure (mmHg) 124.2 (13.9) 115.5 (11.7)
Diastolic blood pressure (mmHg) 82.5 (9.2) 76.4 (8.9)
Use of antihypertensive drugs (%) 2.6 1.2
Mean arterial pressure (mmHg) 96.3 (9.8) 89.4 (9.2)
Pulse pressure (mmHg) 41.6 (10.1) 39.1 (7.9)
Heart rate (beats per minute) 65.6 (11.2) 69.2 (10.9)
Maximal carotid intima-media thickness (mm) 0.72 (0.08) 0.69 (0.07)
Carotid plaques present (%) 34.9 30.1
Carotid-femoral pulse wave velocity (m/s) 9.98 (1.50) 8.63 (1.15)
Median follow-up (years) 23.3 23.2
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pressure and total cholesterol measured at four different time periods and 
the presence of carotid plaques. The earlier the risk factor is measured, the 
higher the risk of carotid plaques.
Table 4-3 shows the associations of BMI, systolic blood pressure and total 
cholesterol on both carotid-femoral PWV and common carotid distensibility. 
BMI was inversely associated with both PWV and carotid distensibility. With 
increasing systolic blood pressure, PWV increased and carotid distensibility 
decreased. No association was found between total cholesterol and arterial 
stiffness except for a positive relation between PWV and total cholesterol 
measured concurrently.
Figure 4-1 Carotid intima-media thickness in adulthood according to body mass 
index measured at different point in time.
Values (standard error) based on a linear regression model adjusted for age, gender, 
social economic status, smoking habits and alcohol consumption.
*p-value < 0.05, compared to the lowest tertile of BMI.
BMI = body mass index standardized for age and gender; IMT = intima-media 
thickness.
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Figure 4-2 Carotid intima-media thickness in adulthood according to systolic 
blood pressure level measured at different point in time.
 
Values (standard error) based on a linear regression model adjusted for age, gender, 
social economic status, smoking habits and alcohol consumption.
*p-value < 0.05, compared to the lowest tertile of systolic blood pressure.
SBP=systolic blood pressure standardized for age; IMT = intima-media thickness.
 
DISCUSSION
In the present 27-year follow-up study, we found that BMI, systolic blood 
pressure and total cholesterol measured during childhood and young 
adulthood were strongly related to carotid IMT and plaques in adulthood. 
The association of these risk factors with carotid plaques was stronger when 
these risk factors were measured at a young age. Arterial stiffness was 
associated with BMI and total cholesterol measured concurrently, but with 
blood pressure measurements in both childhood and adulthood.
Before interpreting our results, some methodological issues need to be 
discussed. During the follow-up period of 27 years, a single research 
assistant performed the vast majority of the average of 15 measurements 
per participant, reducing measurement variation. The large numbers of 
measurements of BMI, systolic blood pressure and total cholesterol that were 
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Figure 4-3 Carotid intima-media thickness in adulthood according to total 
cholesterol level measured at different point in time.
 
Values (standard error) based on a linear regression model adjusted for age, gender, 
social economic status, smoking habits and alcohol consumption.
*p-value < 0.05, compared to the lowest tertile of total cholesterol.
Cholesterol=total cholesterol standardized for age; IMT = intima-media thickness.
performed in each individual further enhanced more accurate estimation of 
person’s true underlying levels. The population selected for follow-up was a 
random sample from the youngsters who participated in the baseline study. 
Furthermore, as values of BMI, systolic blood pressure and total cholesterol 
at baseline were similar among those who were and those who were not lost 
to follow-up, we do not think that selective loss-to-follow-up has affected 
our results. 
We used the measurement of carotid IMT and plaques as measures of 
atherosclerosis.24 Ultrasonographic measurement of carotid IMT correlates 
well with pathological measurements of atherosclerosis.25, 26 Prospective 
epidemiological studies have shown that carotid IMT is associated with the 
risk for myocardial infarction and stroke, and that a decrease in IMT due to
drug treatment is associated with a decrease in the risk of vascular events. 
14,27-30 The presence of carotid plaques is associated with cardiovascular 
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Table 4-3 Relation of body mass index, systolic blood pressure and total 
cholesterol at different points in time and arterial stiffness in adulthood.
Risk factor (SD)
Carotid-femo-
ral PWV 
(m/s)
Carotid 
distensibility 
(10-3 /kPa)
BMI (kg/m²) measured concurrently -0.08 (-0.20, 0.05) -1.09 (-1.66, -0.52)
BMI (kg/m²) measured 10 yrs earlier -0.21 (-0.38, 0.04) -0.74 (-1.51, 0.04)
BMI (kg/m²) measured 11-15 yrs earlier -0.24 (-0.40, -0.08) -0.59 (-1.32, 0.14)
BMI (kg/m²) measured 16-20 yrs earlier -0.16 (-0.31, -0.00) -0.44 (-1.13, 0.25)
SBP (mmHg) measured concurrently 0.016 (0.004, 0.028) -0.15 (-0.20, -0.09)
SBP (mmHg) measured 10 yrs earlier 0.015 (-0.002, 0.032) -0.08 (-0.16, -0.00)
SBP (mmHg) measured 11-15 yrs earlier 0.015 (-0.001, 0.030) -0.04 (-0.11, 0.04)
SBP (mmHg) measured 16-20 yrs earlier 0.013 (-0.002, 0.029) -0.09 (-0.17, -0.02)
Total cholesterol (mmol/l) measured concurrently 0.21 (0.06, 0.35) 0.15 (-0.51, 0.80)
Total cholesterol (mmol/l) measured 10 yrs earlier -0.002 (-0.17, 0.17) 0.24 (-0.52, 0.99)
Total cholesterol (mmol/l) measured 11-15 yrs earlier 0.04 (-0.15, 0.22) -0.41 (-1.23, 0.42)
Total cholesterol (mmol/l) measured 16-20 yrs earlier 0.10(-0.09, 0.28) -0.57 (-1.37, 0.23)
Values are β-coeffi cients and 95% confi dence intervals from multivariable linear 
regression models adjusted for age, gender, social economic status, smoking habits 
and alcohol consumption. The analysis with BMI are additionally adjusted for 
total cholesterol and mean arterial pressure. The analysis with total cholesterol  
is additionally adjusted for BMI and mean arterial pressure. The analysis with SBP 
are additionally adjusted for BMI and total cholesterol. The analysis with PWV 
as dependent variable are additionally adjusted for heart rate and mean arterial 
pressure. 
Bold: p-value<0.05; SD=standard deviation; BMI=body mass index; SBP =systolic 
blood pressure; PWV=pulse wave velocity. 
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and cerebrovascular disease as well, irrespective of the side and location 
of the plaque.29,31,32 We used the measurements of carotid-femoral 
PWV and carotid distensibility as measures of arterial stiffness. Aortic 
stiffness, measured through PWV is increased in the presence of a 
myocardial infarction with a strength of association comparable to that of 
atherosclerosis.33-35 The measurement of aortic PWV allows only an estimate 
of the actual distance travelled by the pulse wave between the carotid 
artery and the femoral artery. The distances were measured in a straight 
line using a pair of compasses to reduce the infl uence of body contours. We 
tried to approach the true distance by subtracting the distance between 
the suprasternal notch and the carotid location from the distance between 
the suprasternal notch and the femoral site, because the pulse travels in 
the opposite direction.36 This might underestimate PWV, because arteries 
become longer and more tortuous with age. However, as the participants 
were relatively young, the error will be relatively small. Common carotid 
artery distensibility is strongly associated with previous stroke and also, 
but less strongly with previous myocardial infarction.37 By calculating the 
distensibility coeffi cient, distension of the common carotid artery is adjusted 
for pulse pressure measured in the brachial artery. We thereby assume that 
pulse pressure measured in the brachial artery is representative of pulse 
pressure in the carotid artery. In dogs, it has been demonstrated that pulse 
pressure in the brachial artery is linearly related to blood pressure in the 
carotid artery over a wide range of blood pressures.38 However, it is known 
that the arterial pressure waves undergo transformation in the arterial tree 
and therefore the pulse pressure is higher in the brachial artery than in the 
more central vessels like the carotid artery.39 On the other hand, non-invasive 
cuff-based measurement of blood pressure underestimates pulse pressure.40 
Therefore, we do not think that this difference in pulse pressure had a large 
effect on our measurements.
Longitudinal data on the vascular consequences of cardiovascular risk 
factors in childhood are scarce. In the ARYA study, it was shown that 
BMI development in adolescence was related to young adult arterial wall 
thickness.41 Four other longitudinal studies showed that BMI, systolic blood 
pressure and low-density-lipoprotein cholesterol measured both in childhood 
and in adolescence predicted carotid IMT in adulthood.4-7 However, these 
associations were not found in the Thousand Families cohort Study.42 In the 
present study, we found strong relationships between BMI, systolic blood 
pressure and total cholesterol during childhood and young adulthood and 
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carotid IMT in adulthood, irrespective of the moment of measurement of the 
cardiovascular risk factors. The risk of carotid plaques in young adulthood 
was also associated with childhood and young adulthood measurements 
of BMI, systolic blood pressure and total cholesterol. The associations were 
strongest with the earliest measurements of risk factors.
As a high arterial distensibility indicates a high elasticity of the vessel, an 
inverse relationship was expected between the risk factors studied and 
carotid distensibility. We indeed observed an inverse association between 
carotid distensibility and BMI. Hyperglycaemic conditions can lead to 
increased arterial stiffness by increased collagen cross linking due to 
non-enzymatic glycation.43-45 As BMI is known to be strongly related to 
insulin46 this may be the mechanism underlying the association. However, 
no relation was found of PWV with BMI, measured concurrently, while 
unexpected inverse associations were found with childhood BMI. We have 
no explanation for the difference in fi ndings of BMI with carotid distensibility 
and PWV. A possible explanation for the confl icting result is that in obese 
persons PWV is structurally underestimated as a proper recording of the 
pulse wave at the femoral artery is more diffi cult in obese persons. Two 
cross-sectional studies have reported a signifi cant positive association 
between BMI and PWV in postmenopausal women.47,48 
High systolic blood pressure measured both in childhood and in young 
adulthood was associated with lower carotid distensibility and higher PWV, 
although the latter relation was only present with systolic blood pressure 
measured concurrently. Thus, those who had higher blood pressure levels 
in childhood had stiffer arteries 20 years later, which suggests that blood 
pressure already in early childhood plays a role in the process of arterial 
stiffening. This is consistent with a recent study, showing that childhood 
blood pressure is predictive of arterial elasticity later in life.8 The relation 
between childhood systolic blood pressure and arterial stiffness may be 
explained by the link between the mechanism of vascular stiffening and 
blood pressure. Arterial stiffening is due to degeneration of the arterial wall, 
probably as a consequence of repetitive cyclic stress. This repetitive strain 
activates vascular smooth muscle cell growth and consequently synthesis 
of matrix components.49 Collagen and elastin are linked by smooth muscle 
whose activity modulates the contribution of each to arterial stiffness and 
may further increase blood pressure. 
Results of studies on the associations between serum cholesterol and 
arterial stiffness have been controversial. In children (mean age 15 years) 
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with familial hypercholesterolaemia, a reduced thoraco-abdominal aortic 
stiffness has been observed, whereas both in adult subjects with familial 
hypercholesterolemia (mean age 37 years) and in adult healthy subjects 
(mean age 27 years), a positive association was observed between and low-
density lipoprotein cholesterol and aortic stiffness. A possible explanation 
for these contradicting results is that the initial increase in distensibility 
could be due to a mechanistical effect of the presence of relatively small 
amounts of lipid in the wall while the later stiffening is due to sclerosis and 
the laying down of connective tissue in the vessel wall.50 Therefore, a positive 
association between atherogenic lipoproteins and aortic stiffness can be 
expected after the third decade of life, when sclerotic changes appear.51 In 
agreement with this view, we found a positive relation between PWV and 
total cholesterol, measured concurrently, but no signifi cant association was 
found of PWV or carotid distensibility with total cholesterol, measured in 
childhood.
The current study underscores the importance of childhood cardiovascular 
risk factors in the development of cardiovascular disease risk. Already at very 
young ages BMI, systolic blood pressure and total cholesterol are related to 
partly irreversible vascular damage. These fi ndings underline the importance 
of targeting children in delaying atherogenesis and lowering the risk of its 
cardiovascular sequelae with aging. At present, attention to early prevention 
of overweight is important. 
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ABSTRACT 
BACKGROUND
Moderate alcohol consumption has been shown to protect against 
cardiovascular disease. Aortic stiffness can be regarded as a marker of 
cardiovascular disease risk. Previously we have shown an inverse to J-shaped 
association between alcohol intake and aortic stiffness in middle-aged and 
elderly men and postmenopausal women. In the present study we examined 
whether such a relation is already present at a younger age. 
METHODS
Cross-sectional data of a cohort study in men and women aged 28 years 
were analysed stratifi ed by gender (240 men and 283 women). Alcohol 
intake was derived from a questionnaire and aortic stiffness was assessed by 
pulse-wave velocity measurement. 
RESULTS
In women an alcoholic beverage intake of ≥1 glass per day was associated 
with a 0.36 m/s (95%CI: -0.58 to -0.14) lower pulse-wave velocity compared 
with non-drinkers. This effect was independent of changes in blood pressure 
and heart rate. In men alcohol intake was also inversely related to pulse-
wave velocity but this was not signifi cant. 
CONCLUSION
These fi ndings provide evidence for the view that moderate intake of alcohol 
may affect vascular elasticity at an early age, notably in women. These 
fi ndings are compatible with a vascular protective effect of alcohol that 
expresses well before the occurrence of symptomatic cardiovascular disease.
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INTRODUCTION
The relation between alcohol intake and the cardiovascular system seems 
to be U-shaped, suggesting a higher risk of cardiovascular disease in non-
drinkers and heavy alcohol consumers compared to those with moderate 
alcohol intake.1 Mechanisms proposed to explain a positive health effect 
of moderate alcohol consumption include benefi cial effects of lipoprotein 
metabolism,2 hemostasis3 and infl ammatory processes4 with regard to 
atherogenesis. In addition, cross-sectional and large prospective studies 
have shown that moderate alcohol consumption reduces the risk of diabetes 
mellitus type 25 and increase insulin sensitivity.6
While cardiovascular protection has been demonstrated in older subjects, it 
is less clear whether benefi cial effects of alcohol intake on the cardiovascular 
system express already at a younger age when subjects are still free of 
overt vascular disease. Early vascular evidence of cardiovascular risk may be 
provided by measurement of arterial characteristics, such as aortic stiffness. 
Aortic pulse-wave velocity (PWV) is a non-invasive measurement of the 
distensibility of the aorta, which is reported to be a reliable index of aortic 
stiffness.7 An increased aortic stiffness at young adulthood may refl ect life-
long exposure to risk factors. Increased aortic stiffness has been related 
to unfavourable levels of risk factors, prevalent cardiovascular disease and 
atherosclerosis elsewhere in the arterial system. Also, increased arterial 
stiffness has been shown to predict cardiovascular events.8
Previously, we reported an inverse to J-shaped association between alcohol 
intake and aortic stiffness in postmenopausal women9 and in men aged 40 
to 80 years.10 In the present study we examined whether such a relation is 
already present at younger age.
METHODS
SUBJECTS
The Atherosclerosis Risk in Young Adults (ARYA) Study comprises two 
cohorts of young adults, one performed in the city of The Hague and one 
in the city of Utrecht. Since vascular measurements were not performed in 
the Hague-cohort, this paper is restricted to the Utrecht-participants of the 
ARYA-study. The Utrecht cohort includes 750 young adults born between 
January 1, 1970 and December 31, 1973, who attended secondary school 
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in the city of Utrecht in the Netherlands and of whom the original medical 
records from the Municipal Health Care were available.11 From October 1, 
1999 to December 31, 2000, all participants visited our outdoor clinic twice 
within a 3-week period. PWV measurements were performed in 524 subjects 
(46% male). The ARYA study was approved by the Medical Ethics Committee 
of the UMC Utrecht. All participants gave written informed consent.  
CARDIOVASCULAR RISK FACTORS
During the fi rst visit, anthropometric measurements were performed. Height, 
weight, and waist-hip circumference were measured with indoor clothes 
without shoes. A written standardized questionnaire was completed on 
alcohol intake, smoking, highest education, and contraceptive pill use in 
women. In the questionnaire, subjects had to select 1 out of 5 options to 
categorize their alcohol intake (0; <1; 1-2; 3-5 and ≥6 glasses/day). Because 
there were only few subjects in the highest alcohol intake levels (see table 
4-4), the two highest categories in men and the three highest categories in 
women were combined. Statistical analyses were performed with 4 alcohol 
intake levels for men (0, <1, 1 to 2, and ≥3 glasses/day) and 3 alcohol intake 
levels for women (0, <1, and ≥1 glasses/day). 
During the second visit, fasting venous blood samples were drawn. The 
samples were stored at -20°C until all participants were enrolled into the 
study. Total cholesterol and high-density lipoprotein (HDL) cholesterol 
were determined using an automatic enzymatic procedure (Vitros950 dry-
chemistry analyser (Johnson & Johnson, Rochester, New York, USA)). 
At each visit, blood pressure was measured twice, after 5 minutes of rest, 
and at an interval of 5 to 15 minutes, in the left brachial artery in sitting 
position with an automated device (Dinamap, Critikon, Tampa California, 
USA) without replacing the cuff between the measurements. The mean of 
2 consecutive measurements was used in the analyses. Pulse pressure was 
defi ned as systolic blood pressure minus diastolic blood pressure. Mean 
arterial pressure was calculated as diastolic blood pressure + (1/3 * pulse 
pressure). 
ARTERIAL STIFFNESS
Arterial stiffness was noninvasively assessed by measuring carotid-femoral 
(aortic) PWV, using an automated device (SphygmoCor device (AtCor 
Medical, West Ryde, Australia)). Aortic PWV was determined by sequential 
acquisition of pressure waves from the carotid and femoral arteries by 
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applanation tonometry (Millar Instruments, Houston, TX, USA). Wave transit 
time (t) was calculated by the system software, using the R-wave on the 
simultaneously recorded ECG as reference frame. The distance travelled 
by the pulse wave was measured in a straight line to reduce the infl uence 
of body contours. The carotid to femoral path length (D) was defi ned 
as the distance between the recording sites at the femoral artery to the 
suprasternal notch minus the distance from the recording site at the carotid 
artery to the suprasternal notch. PWV was calculated as D/t. The average 
of 10 successive waveforms was used in the analyses to cover a complete 
respiratory cycle. The whole procedure was repeated 3 times per subject and 
the average PWV value was used for the analysis.12 
In order to evaluate the reproducibility of the technique in our research 
center, a subset of 25 participants had their PWV re-measured several weeks 
after their fi rst visit. Absolute mean difference (standard error) in PWV of the 
repeated measurements between visits was 0.12 m/s (0.45). The intraclass 
correlation coeffi cient (ICC) for repeated measurements was 0.67. Since 
the repeated measurements were performed on 2 different occasions, the 
moderate ICC could partially be explained by the variability in blood pressure 
over time.
STATISTICAL ANALYSIS
Data on alcohol consumption was missing in one participant, leaving 523 
subjects for analysis. The alcohol intake levels (categorical) were put into 
a linear regression model as dummy variables with the lowest category as 
reference.
The association between alcohol consumption and PWV was examined, 
using multivariate linear regression analysis, adjusted for major determinants 
of PWV, namely age, mean arterial pressure and heart rate (Model A).13, 14
In addition, Model A was extended with factors which were at least 
signifi cantly (P<0.05) or which are biologically plausibly related to either 
PWV or alcohol intake (Model B). This model included waist-to-hip ratio, 
total cholesterol, HDL-cholesterol, highest education and current smoking. 
To validate the self-reported information on alcohol intake, we evaluated the 
relation of HDL-cholesterol to alcohol intake using multiple linear regression 
analysis, adjusted for age, mean arterial pressure and heart rate.
Data were analysed using the SAS statistical software package (SAS/STAT 
Version 8.02, SAS Institute, Cary, NC).15
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RESULTS
General characteristics of the study are presented in table 4-4. Table 4-5 
shows the relation of alcohol intake to PWV and HDL-cholesterol separately 
for men and women because the association between alcohol and PWV 
differed by gender (p=0.03). In both men and women HDL-cholesterol 
increased with increasing alcohol intake. There was an inverse association 
between alcohol intake and aortic stiffness in women. An alcoholic beverage 
intake of ≥1 glass per day decreased the PWV by 0.36 m/s (95%CI: -0.58 
to -0.14) compared with non-drinkers. In men, alcohol consumption of 
≥3 glasses per day lowered the PWV by 0.15 m/s (95%CI: -0.51 to 0.20). 
Additional adjustment for factors which were at least signifi cantly (P<0.05) 
or which are biologically plausibly related to either PWV or alcohol intake 
(Table 4-5, Model B) did not change the magnitude of the relations. 
DISCUSSION
These fi ndings provide evidence of an inverse association between alcohol 
consumption and aortic stiffness in young women. To appreciate the 
fi ndings, certain aspects of the study need to be addressed. The use of self-
reported information on alcohol intake may have introduced misclassifi cation 
of exposure, specifi cally those in the heavier drinking groups.16 However, 
selective misclassifi cation of heavy drinkers as non-drinkers seems unlikely, 
because we observed a positive association between alcohol consumption 
and HDL-cholesterol, a fi nding that supports the rank-order validity of 
self-reported alcohol intake. No information was available on alcoholic 
beverage type consumed, changes in drinking behaviour and drinking 
pattern. However, type of beverage consumed is not likely to have infl uenced 
our fi ndings, since much of the benefi t is from alcohol rather than other 
components of each type of drink.17, 18 In addition, changes in drinking 
behaviour are probably not relevant at a young age. Drinking pattern might 
be a factor that has infl uenced the results. Yet, Mukamal et al.18 recently 
observed within categories of frequency of alcohol consumption similar 
inversely related risks of myocardial infarction, regardless of the amount of 
alcohol consumed per drinking day. 
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Table 4-4 Characteristics of the study population.
Characteristic Men (n=240) Women (n=283)
Age (years) 28.2 (0.9) 28.2 (0.9)
Body mass index (kg/m2) 24.6 (3.7) 24.4 (4.5)
Waist-to-hip ratio 0.88 (0.06) 0.81 (0.06)
Alcohol (n (%)):
0 glasses/day 31 (12.9) 70 (24.7)
                              <1 glasses/day 111 (46.2) 161 (56.9)
                             1-2 glasses/day 59 (24.6) 46 (16.3)
                             3-5 glasses/day 34 (14.2) 6 (2.1)
                             ≥6 glasses/day 5 (2.1) 0 (0)
Highest education (%):
elementary school 3.3 1.8
secondary school 19.2 21.5
lower/intermediate vocational training 41.7 38.5
higher vocational training/university 35.8 38.2
Current smokers (%) 33.3 26.5
Contraceptive pill use (%) NA 65.4
Total cholesterol (mmol/L) 4.86 (0.94) 4.84 (0.82)
HDL-cholesterol (mmol/L) 1.30 (0.30) 1.58 (0.36)
Systolic blood pressure (mmHg) 130.4 (12.1) 120.2 (12.1)
Diastolic blood pressure (mmHg) 72.5 (7.2) 70.8 (8.4)
Mean arterial pressure (mmHg) 91.8 (8.0) 87.3 (9.0)
Pulse pressure (mmHg) 57.8 (9.3) 49.4 (7.9)
Heart rate (bpm) 63.4 (9.5) 66.4 (8.8)
Values are expressed as mean (standard deviation) in case of continuous variables, 
and as percentages in case of categorical variables.
HDL-cholesterol=high density lipoprotein cholesterol; bpm=beats per minute; 
PWV=pulse wave velocity; NA: not applicable.
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To our knowledge, there are only 5 studies presenting the relation of 
alcohol consumption on aortic PWV. A cross-sectional study in Japanese-
American middle-aged and older men and women reported that the risk 
for high aortic PWV was lower among current drinkers and ex-drinkers than 
among non-drinkers.19 In a follow-up study in middle-aged Japanese men 
the incidence of aortic stiffness was not related to alcohol intake,20 whereas 
another longitudinal study in Japanese men suggested that alcohol is an 
important risk factor for development of aortic stiffness at an intake of more 
than 16 glasses of alcoholic beverage per week.21 We recently reported an 
inverse to J-shaped association between alcohol consumption and aortic 
PWV in cross-sectional studies among postmenopausal women9 and among 
men aged 40 to 80 years of age.10
In young women an alcoholic beverage intake of about 1 to 2 glasses per 
day decreased the PWV approximately 7% compared to non-drinkers. This is 
comparable with the decrease in PWV observed in postmenopausal women 
with an intake of 10 to 14 glasses alcoholic beverage per week (8% decrease 
compared to non-drinkers).9
In young men, the inverse relation between alcohol and PWV was less 
pronounced. There are several possible explanations for the sex difference in 
strength of association. Firstly, the smaller increase in HDL-cholesterol with 
increasing alcohol intake in men compared with women might suggest that 
men were less precise in their recall of alcohol intake. Secondly, the drinking 
pattern in men might be unfavourable, namely binge drinking instead of 
regular daily consumption. Thirdly, an alternative explanation could be 
that the effect of atherogenic factors, like smoking and lipids, are more 
pronounced in young men, in such a way that the infl uence of alcohol on 
PWV cannot be observed. Finally, it may be that the association truly does 
not exist in men, or that the numbers of men in our study, particularly in the 
non-drinking group, were too small and the variation in PWV too large for 
statistical detection of an inverse trend.
The mechanism by which moderate alcohol intake may reduce aortic 
stiffness is unknown. Alcohol consumption increases HDL-cholesterol,2 with 
associated increases in paraoxonase activity2 and cholesterol effl ux.22 These 
changes might decrease the amount of cholesterol within peripheral cells, 
and thus increase the fl exibility of the vascular wall. However, the relation 
between alcohol intake and PWV remained when HDL-cholesterol was 
taken into account, suggesting that our fi nding could not be fully explained 
by an increase in HDL-cholesterol. With increasing age the arteries become 
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stiffer due to a decrease in elastin and an increase in collagen and connective 
tissues in the arterial wall.23 Alcohol intake might delay or change this process, 
possibly by an effect on gene expression. Damaging of the vascular wall due 
to infl ammation might also cause arterial stiffness. The observed decrease in 
the infl ammation factor C-reactive protein4 with moderate alcohol intake could 
decrease the risk of lesions of the vascular wall and explain the increase in 
vascular elasticity. Finally, epidemiological studies have shown that moderate 
alcohol consumption reduces the risk of diabetes mellitus type 25 and increase 
insulin sensitivity.6 This effect of alcohol might decrease the formation and 
cross-linking of glycated collagen in the vascular wall, which is accelerated in 
hyperglycaemic milieu.24
PERSPECTIVES
Moderate intake of alcohol may affect vascular elasticity already at an early 
age, notably in women. These fi ndings are compatible with a vascular 
protective effect of alcohol that expresses well before the fi rst occurrence of 
symptomatic cardiovascular disease.
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ABSTRACT
BACKGROUND
Current evidence on the relation between body size at birth and lipid levels 
in adulthood is contradictory. Our objective was to study the natural history 
of blood lipids from childhood to young adulthood according to birth size. 
METHODS
Lipid levels were annually measured from 1975 to 1993 and in 2002 in a 
cohort of 330 subjects from the Dutch town of Zoetermeer, initially aged 
5 - 19 years. Birth data were obtained through questionnaires sent to the 
parents. We studied birth weight and length in relation to total cholesterol 
and low-density lipoprotein-, high-density lipoprotein (HDL)-, HDL2- and 
HDL3-cholesterol levels in 5-year age periods and to change of levels with 
increasing age. 
RESULTS
Particularly males born with low birth weight had lower adverse lipid 
levels before and around puberty, but had substantially higher low-
density lipoprotein cholesterol when they reached young adulthood (linear 
regression coeffi cient in 30 to 37 year old males: -0.51 (-0.93 to -0.09) 
mmol/l /kg birth weight). Particularly females who were shorter at birth 
had higher adverse lipid levels from childhood to young adulthood (linear 
regression coeffi cient in 20 to 24 year old females: total cholesterol: -0.08 
(-0.14 to -0.02) mmol/l /cm higher birth length). 
CONCLUSION
Size at birth is related to the natural history of lipids from childhood to young 
adulthood. Children born with low birth weight or length get higher adverse 
lipid levels particularly when they reach young adulthood.
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INTRODUCTION
There is evidence that cardiovascular disease has its origins in the fetal phase 
and early childhood.1,2 Size at birth, an indicator for intra-uterine growth has 
an effect on atheroclerosis3,4  and coronary artery disease,5 but the effect 
is modifi ed by adult body size. Further, birth size has been found to be 
inversely associated with cardiovascular risk factors such as blood pressure, 
insulin resistance, and obesity in adult life.6-8 Less is known about relations 
between birth size and blood lipids in later life. During the fi rst year of life 
babies with higher birth weight were shown to have higher apolipoprotein B 
and lower apolipoprotein A-I levels in the blood.9 Studies in children showed 
relations between lower birth length and higher total cholesterol levels,10 and 
lower birth weight with higher triglyceride levels.11 Another study reported 
no relation between birth weight and lipids in early adulthood.12 Thinness at 
birth as indicated by a small abdominal circumference was related to higher 
total and LDL-cholesterol and apolipoprotein B levels in adults.13 Men with 
lower birth weight or lower weight at 1 year had higher apolipoprotein B 
levels in the blood in adulthood.14 Women with lower birth weight were 
shown to have higher serum triglycerides and lower HDL-cholesterol levels in 
adulthood.15 A recent study in adolescents and a systematic review showed a 
weak relation of fetal nutrition to total cholesterol.16
Thus, the current evidence may be indicative of a relation between birth size 
and blood lipid levels in later life, but particularly in the young longitudinal 
data on this relation is limited and to some extent inconsistent. We have 
therefore studied the relation between body size at birth and the natural 
history of total and lipoprotein cholesterol levels in a cohort of children 
followed up into young adulthood.
 
METHODS
SUBJECTS
Between 1975 and 1978 the total population aged 5 years and over of 
two districts of Zoetermeer, a suburban town in the western part of the 
Netherlands, was invited to participate in a study of chronic disease risk 
indicators.17 Of 5670 eligible children aged 5-19 years, 4,649 (response 82%) 
took part in the study. From this group a random sample of 596 children 
was selected for annual follow up in a study of cardiovascular risk factors 
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and its determinants. The present study was based on 483 (response 81%) 
subjects who took part in the yearly follow-up (252 males and 231 females) 
until 1993. Data on parents of these 483 subjects were obtained at the 
baseline study (1975 - 1978). Complete data were available for 425 fathers 
and 454 mothers. In 2002, all subjects were invited for an examination that 
included measurements of atherosclerosis. In total, 362 subjects participated 
in this examination. The median number of visits is 15 (range 2-19). Median 
follow-up time for the present analyses is 23 years. Response for the 
majority of visits gradually declined to 83% in 1993. For the atherosclerosis 
measurements in 2002, the response was 61%.
MEASUREMENTS
The annual measurements for each individual were performed in the same 
month of the year. A Hawksley random-zero sphygmomanometer was 
used at each examination to measure systolic and diastolic blood pressure 
(5th Korotkoff phase) according to a standardised protocol.17 Body height 
and weight were measured without shoes and heavy clothing. At each 
examination a questionnaire about use of medication, alcohol intake, 
coffee consumption, smoking habits and use of oral contraceptives was 
administered. Serum blood samples were drawn by antecubital venipuncture 
for measurement of total cholesterol, low-density lipoprotein (LDL) 
cholesterol, high-density lipoprotein (HDL) cholesterol, and its subfractions, 
HDL2 cholesterol and HDL3 cholesterol. In all children who were 5 - 14 
years of age initially, skeletal age was determined at each follow-up 
examination, when they had not yet reached skeletal maturity. Skeletal age 
was determined using a radiograph of the hand and wrist according to the 
procedures and the rating system of Tanner et al.18
LABORATORY ANALYSIS
The laboratory analysis of lipoprotein-cholesterol concentrations for this 
cohort study is described in detail elsewhere.19 Briefl y, serum total cholesterol 
at baseline was measured with an automated enzymatic method20 and from 
1983, with a modifi ed reagent (CHOD/PAP High Performance, Boehringer 
Mannheim, FRG). The standard deviation of duplicate serum cholesterol 
measurements stored at -20ºC for up to 4 years did not exceed 3.0% and 
did not show a signifi cant drift. Measurements of HDL-cholesterol (from 
1979) and LDL-cholesterol (from 1984) were performed by the same method 
after precipitation. For HDL-cholesterol we used a phosphotungstate 
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method21 with a minor modifi cation22 and polyvinylsulphate (Boehringer 
Mannheim, FRG) for LDL-cholesterol. All measurements were carried out 
at the Department of Epidemiology & Biostatistics at Erasmus University 
Rotterdam, the Netherlands, which from 1978 participated in the lipid 
standardization program of the World Health Organization (WHO) Regional 
Lipid Reference Centre in Prague, Czechoslovakia, and from 1977 in the 
Dutch National Cholesterol standardization program (KCA foundation). 
During the baseline period quality control was indirectly checked on the 
CDC protocol by monthly comparison with cholesterol determination using 
the Abell-Kendall method.23 Accuracy and precision of total cholesterol and 
HDL-cholesterol measurements were within acceptable limits (CDC/WHO) 
over the entire period.  Automated analyses were initially carried out on 
a Technicon Auto Analyzer-II system (Technicon Instruments, Tarrytown, 
New York) and from 1989 on a Kone Specifi c Analyzer (Kone Instruments, 
Espoo, Finland) using frozen (-20°C) serum samples. From 1987, HDL2-
cholesterol and HDL3-cholesterol subfractions in serum were assayed as 
described by Gidez et al24  with slight modifi cations and separated using 
stepwise precipitation of apolipoprotein B containing lipoproteins with 
heparin/Mn2+ in two steps and HDL2 with dextran-sulphate. In 2002, serum 
total cholesterol was determined by an automated enzymatic procedure 
using Roche CHOD-PAP reagent kit. HDL-cholesterol was measured with the 
Roche direct HDL-cholesterol assay using PEG-modifi ed enzymes and dextran 
sulphate.
COLLECTING BIRTH DATA
To obtain birth data, a questionnaire was sent to the parents of the children 
at baseline. Questions were asked about birth weight (gram), birth length 
(cm), placental weight (gram), gestational age, complications during 
pregnancy and whether or not the mother had smoked during pregnancy. 
The addresses of 33 parents could not be found and 2 children had died 
during follow-up. Of the 448 questionnaires sent, 353 (response 78.8%) 
were completed and returned to the investigators. Of the 353 returned 
questionnaires, 330 had usable data on birth weight. All 330 subjects 
had suffi cient follow-up data on lipoprotein-cholesterol and possible 
confounders. In 59% of the returned questionnaires, the parents reported 
the birth weight as they remembered it (59% of these reported birth 
weights to the nearest 100g). In 19% parents obtained the birth weight 
from a maternity center (55% reported to the nearest 100g). In 22%, 
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parents took the birth weight from birth announcements (43% reported 
to the nearest 100 grams). In 2002, birth weight was asked again from the 
participants themselves via a questionnaire. Forty-one subjects without 
information on birth size at baseline reported their birth weight. In total, 
birth weight was known in 371 subjects.
DATA ANALYSIS
Aim was to analyse body size at birth as a determinant of offspring 
(lipoprotein) cholesterol over time. To that end, an unbalanced repeated 
measures model was used with repeated measurements of offspring 
(lipoprotein) cholesterol as dependent variable and birth weight respectively 
birth length as independent variables. As the infl uence of birth weight on 
total cholesterol changed with increasing age (highly signifi cant interaction 
term between birth weight and age (p=0.002)), this was fi rst done within 5-
year age-categories starting 5 to 9 to 25 to 29 and then 30 to 37 years. The 
same model was used to adjust for offspring current body weight, height, 
use of cigarettes, alcohol consumption and gestational age. Furthermore, 
both a variable indicating the change in skeletal age per calendar year and an 
interaction term between birth weight and the repeated measurements of 
the BMI were added to the regression models. The infl uence of gestational 
age was also evaluated by both restricting the analyses to children born at 
term and by adding the variable gestational age to the model. In each model 
a random intercept and slope were used.
The relation between change of lipoprotein cholesterol with age and birth 
weight and length was studied using a linear regression model with repeated 
measures of lipoprotein cholesterol as the dependent variable and age, birth 
weight, birth length and the interaction terms birth weight*age or 
birth length*age as independent variables. In analyses of change the 
covariance structure was assumed to be random. Each subject’s responses 
(lipids) were assumed to have a linear relation with age and to have its own 
random intercept and slope. 
The basic model for the infl uence of birth weight can be written as: 
Cholesterol = β0 + β1*age + β2*birth weight*age + β3*birth weight. 
Written as a function of age this makes: 
Cholesterol = (β0 + β3*birth weight) + (β1 + β2*birth weight)*age, 
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whereby (β0 + β3*birth weight) is the intercept and  (β1 + β2*birth weight) is 
the slope of cholesterol change with age.
All statistical analyses were performed using the Statistical Analysis System 
(SAS), with the Proc Mixed module for unbalanced repeated measurement 
analysis.25
RESULTS
Table 5-1 shows characteristics of the subjects on entry into the cohort and 
birth data. Subjects were on average 13 years old, with 72% under 16 years 
of age. Males had slightly higher birth weights and lengths than females. 
Males who dropped out of the study before 1992 (21%) had on average 
a 213 grams lower birth weight and 0.1 mmol/l lower baseline cholesterol 
levels than those who were completely followed up. In those subjects of 
whom we did not obtain birth data, the baseline mean lipid levels in males 
(n=76); total cholesterol: 4.7 mmol/l, LDL-cholesterol: 3.4 mmol/l  and 
HDL-cholesterol: 1.4 mmol/l, and in females (n=77); total cholesterol: 4.8 
mmol/l, LDL-cholesterol: 3.2 mmol/l and HDL-cholesterol: 1.4 mmol/l, were 
comparable to levels in the studied group (table 5-1).
BIRTH WEIGHT AND LIPIDS
Males showed a tendency towards a negative association for total 
cholesterol levels with birth weight in childhood. For both total cholesterol 
and LDL-cholesterol levels progressively inverse associations were found at 
young adulthood (table 5-2). Among females, total cholesterol and LDL-
cholesterol levels were positively associated with birth weight in childhood. 
In adulthood, females also showed inverse associations. In young adult males 
a positive association was found of birth weight with HDL-cholesterol and 
particularly with HDL2-cholesterol, but not with HDL3-cholesterol. In females, 
associations with HDL-cholesterol and subfractions were not statistically 
signifi cant except for the positive association between birth weight and 
HDL3-cholesterol at the ages 20-24 years. Adjustment for current weight and 
height, use of cigarettes and alcohol consumption did not materially change 
the results, nor did adjustment for total cholesterol level, systolic 
blood pressure and body mass index in both fathers and mothers. Inclusion 
in the model of a variable indicating whether subjects were breast-fed as 
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Table 5-1 Baseline characteristics at entry into the study cohort and birth data.
Variable Males (n = 178) Females (n = 152)
Age (years) 13.1 (5.5-21.1) 12.7 (5.6-21.1)
Body height (cm) 157.0 (109-195) 157.0 (114-181)
Body weight (kg) 44.5 (18-92) 45.0 (17-81)
Body Mass Index (kg/m2) 17.8 (13.2-28.4) 18.5 (12.0-28.5)
Systolic blood pressure (mmHg) 116.0 (77-156) 112.0 (71-156)
Diastolic blood pressure (mmHg) 69.0 (34-89) 67.0 (38-96)
Total serum cholesterol (mmol/l) 4.5 (2.7-6.7) 4.7 (3.1-6.3)
LDL-cholesterol (mmol/l) 3.0 (0.8-8.0) 3.1 (0.8-6.8)
HDL-cholesterol (mmol/l) 1.3 (0.6-2.2) 1.4 (0.7-2.2)
HDL2-cholesterol (mmol/l) 0.3 (0.05-1.1) 0.4 (0.05-1.2)
HDL3-cholesterol (mmol/l) 0.9 (0.5-1.5) 0.9 (0.5-1.4)
Birth weight (kg) 3.5 (0.6) 3.3 (0.5)
Birth length (cm) 51.6 (2.8) 50.4 (2.1)
Gestational age (weeks) 39.1 (1.6) 39.1 (1.5)
Complications during pregnancy* (%) 28.2 29.6
Mother smoked during pregnancy (%) 19.1 19.7
Values are median (range), birth data are mean (SD). LDL = low density lipoprotein, 
HDL = high density lipoprotein.* including hypertension and diabetes mellitus.
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babies still yielded an inverse relation in males for LDL-cholesterol in young 
adulthood (-0.24 mmol/l/kg, -0.45 to -0.04) and no changes compared to 
unadjusted analyses in females. Further, to examine the mediating role of 
maturation, we added a variable indicating the change in skeletal age per 
calendar year to the regression models. For both males and females this 
yielded decreased and non-signifi cant relations for total cholesterol and LDL-
cholesterol.
BIRTH LENGTH AND LIPIDS
In males and females, total cholesterol and LDL-cholesterol levels were 
persistently inversely associated with birth length (table 5-3). An inverse 
association was found in males with HDL-cholesterol and subfractions. In 
females, mostly a positive relation with HDL-cholesterol and subfractions 
was found. Adjustment for current weight and height, use of cigarettes 
and alcohol, for total cholesterol level, systolic blood pressure and BMI 
of both fathers and mothers, and for breast-feeding did not change the 
results. Adjustment for change in skeletal age per calendar year still showed 
associations in young adult males (LDL-cholesterol (n=87): -0.05 mmol/l/cm, 
-0.10 to -0.003) and in young adult females (LDL-cholesterol (n=59): -0.09 
mmol/l/cm, -0.16 to -0.008). In males, there was a negative interaction 
between birth length and the repeated measurements of the BMI with total 
cholesterol (p=0.052) and LDL-cholesterol (p=0.03). In females, a positive 
interaction was found for HDL-cholesterol (p=0.03). 
The effects of birth weight and birth length, particularly on total cholesterol 
and LDL-cholesterol, were similar in direction in males and females, but 
differed somewhat in magnitude. In fi gure 5-1, the mean values of total 
cholesterol by birth weight are given for males. The mean values of LDL-
cholesterol by birth length are given for females (fi gure 5-2).
Based on the data in table 5-2 and in fi gure 5-1 the analysis of the relation 
between birth weight and lipid change was performed from the age of 20 
years as from this age lipid change was linear and indicative of differences 
in change by birth weight. Statistically signifi cant associations were found 
between birth weight and age in males for models with total cholesterol 
and LDL-cholesterol as dependent variable and similarly in females for LDL-
cholesterol. Table 5-4 shows intercepts and slopes that were calculated 
for subjects with a birth weight of 2 kg and of 4 kg. Both in males and in 
females with a birth weight of 2 kg the intercepts of total cholesterol and 
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Table 5-2 Age specifi c regression coeffi cients for total and lipoprotein-cholesterol
levels depending on birth weight.
 Values based on repeated measurement regression models, stratifi ed by age and 
gender, with birth weight as independent variable.
n = number of subjects; b = linear regression coeffi cients (repeated measurement 
analysis) (mmol/l/kg); 95% CI = 95 percent confi dence interval; Bold =p-value < 0.05.
 
 
 
 
 
Males Females
 
 
 
Age (yrs) 
 
n b (95% CI) n 
 
b (95% CI) 
 
5-9 
 
51 0.03  (-0.23 to 0.29) 62 
 
-0.08 (-0.49 to 0.32) 
 
10-14 
 
126 -0.06  (-0.25 to 0.13) 125 
 
0.002  (-0.18 to 0.19) 
 
15-19 
 
199 -0.02  (-0.21 to 0.18) 172 
 
-0.02  (-0.19 to 0.15) 
 
20-24 
 
190 -0.08  (-0.28 to 0.13) 149 
 
0.01  (-0.19 to 0.22) 
 
25-29 
 
146 -0.16  (-0.42 to 0.10) 110 
 
-0.17  (-0.43 to 0.08) 
 
Total 
cholesterol 
 
30-37 
 
151 -0.26  (-0.55 to -0.03) 141 
 
-0.02  (-0.30 to 0.25) 
    
 
15-19 
 
56 0.04  (-0.25 to 0.33) 47 
 
0.61  (0.09 to 1.13) 
 
20-24 
 
103 -0.08  (-0.37 to 0.21) 85 
 
0.08  (-0.20 to 0.36) 
 
25-29 
 
115 -0.26  (-0.57 to 0.05) 90 
 
-0.12  (-0.40 to 0.15) 
 
LDL-
cholesterol 
 
30-37 
 
65 -0.51  (-0.93 to -0.09) 46 
 
-0.08  (-0.51 to 0.35) 
  
 
7-14 
 
127 0.02  (-0.05 to 0.08) 132 
 
0.02  (-0.09 to 0.014) 
 
15-19 
 
199 -0.01  (-0.07 to 0.04) 172 
 
0.05  (-0.02 to 0.12) 
 
20-24 
 
190 0.02  (-0.03 to 0.07) 149 
 
0.04  (-0.04 to 0.12) 
 
25-29 
 
146 0.02  (-0.04 to 0.08) 110 
 
0.07  (-0.02 to 0.17) 
 
HDL-
cholesterol 
 
 
 
30-37 
 
151 0.03  (-0.05 to 0.10) 141 
 
0.02  (-0.09 to 0.13) 
    
 
15-19 
 
56 -0.04  (-0.08 to 0.01) 47 
 
-0.09  (-0.21 to 0.04) 
 
20-24 
 
102 -0.01  (-0.06 to 0.03) 83 
 
-0.0001  (-0.07 to 0.07) 
 
25-29 
 
113 0.04  (-0.02 to 0.09) 89 
 
0.03  (-0.04 to 0.10) 
 
HDL2-
cholesterol 
 
30-37 
 
65 0.08  (0.01 to 0.15) 46 
 
0.07  (-0.06 to 0.21) 
    
 
15-19 
 
56 0.0008  (-0.06 to 0.06) 47 
 
0.04  (-0.05 to 0.13) 
 
20-24 
 
102 -0.002  (-0.04 to 0.04) 83 
 
0.06  (0.01 to 0.12) 
 
25-29 
 
113 -0.02  (-0.05 to 0.02) 89 
 
0.03  (-0.03 to 0.08) 
 
HDL3-
cholesterol 
 
  
30-37 
 
65 0.02  (-0.04 to 0.08) 46 
 
0.006  (-0.09 to 0.10) 
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LDL-cholesterol are consistently lower, but there is a more marked rise in 
lipid levels than in those with a birth weight of 4 kg. For HDL-cholesterol the 
opposite is found in males.
In males, there was a negative interaction between birth weight and 
the repeated measurements of the BMI in models with total cholesterol 
(p<0.0001) and LDL-cholesterol (p<0.0001), indicating that particularly 
low birth weight subjects with currently higher relative body weight had 
increased levels of total cholesterol and LDL-cholesterol. In females, positive 
interactions were found for HDL-cholesterol (p<0.0001), HDL2-cholesterol 
(p=0.06) and HDL3-cholesterol (p=0.02). 
GESTATIONAL AGE
Analyses restricted to subjects born at term ( ≥ 37 weeks of gestation) still 
showed inverse associations in males for birth weight with LDL-cholesterol 
and in females for birth length with total cholesterol and LDL-cholesterol. 
Inclusion of gestational age in models with either birth weight or birth 
length did not materially change the results. 
DISCUSSION
In this study we found that low birth weight or low birth length are related 
to higher lipid levels in the blood of children and adolescents particularly 
when they reach young adulthood.
Associations of birth weight with total cholesterol changed from positive in 
childhood to inverse at young adulthood. Both in males and females, birth 
length was inversely associated with lipoprotein-cholesterol levels from 
childhood to adulthood. These fi ndings were consistent with analyses of 
birth size in relation to individual change of lipids over time.
Before we can interpret these fi ndings some methodological aspects of the 
study should be discussed. Birth data were obtained through the parents 
and without reference to the annual lipid measurements. At the time of 
birth of the subjects in the present study, there was no national registry of 
birth data, nor are these available from vital statistics. Furthermore, a large 
proportion of children in the Netherlands, was, and still is, born at home. 
Accurate birth weight data may be obtained from maternity center cards and 
from personal birth announcements. Although the recall from  memory of 
particularly, birth weights by mothers, as opposed to other prenatal and 
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Table 5-3 Age specifi c regression coeffi cients for total and lipoprotein-cholesterol  
levels depending on birth length.
Values based on repeated measurement regression models, stratifi ed by age and 
gender, with birth length as independent variable
n = number of subjects; b = linear regression coeffi cients (repeated measurement
analysis) (mmol/l/cm); 95% CI = 95 percent confi dence interval; Bold = p-value < 0.05.
 
 
 
 
 
Males 
 
Females 
 
 
 
Age (yrs) 
 
n 
 
b (95% CI) 
 
n 
 
b (95% CI) 
 
5-9 
 
39 -0.03  (-0.10 to 0.04) 39
 
-0.02  (-0.12 to 0.07)
 
10-14
 
89 -0.007  (-0.05 to 0.04) 82
 
-0.07  (-0.13 to -0.01)
 
15-19
 
129 -0.003  (-0.05 to 0.04) 113
 
-0.07  (-0.12 to -0.03)
 
20-24
 
124 -0.02  (-0.07 to 0.03) 102
 
-0.08  (-0.14 to -0.02)
 
25-29
 
86 -0.007  (-0.07 to 0.06) 76
 
-0.08  (-0.16 to -0.001)
 
Total 
cholesterol 
 
30-37
 
90 -0.04  (-0.12 to 0.03) 82
 
-0.08  (-0.16 to 0.005)
 
15-19
 
50 -0.05  (-0.12 to -0.02) 38
 
-0.06  (-0.18 to 0.05)
 
20-24
 
85 -0.02  (-0.08 to 0.05) 71
 
-0.08  (-0.16 to 0.007)
 
25-29
 
76 -0.04  (-0.12 to 0.03) 68
 
-0.08  (-0.16 to -0.003)
 
LDL-
cholesterol 
 
30-37
 
36 -0.08  (-0.20 to 0.05) 31
 
-0.02  (-0.14 to 0.09)
 
7-14
 
89 -0.010  (-0.03 to 0.009) 82
 
-0.002  (-0.04 to 0.03)
 
15-19
 
129 -0.002  (-0.02 to 0.01) 113
 
0.007  (-0.01 to 0.03)
 
20-24
 
124 -0.003  (-0.02 to 0.01) 102
 
0.01  (-0.01 to 0.03)
 
25-29
 
86 -0.0001  (-0.02 to 0.02) 76
 
0.02  (-0.008 to 0.05)
 
HDL-
cholesterol 
 
30-37
 
90 0.008  (-0.01 to 0.03) 82
 
0.02  (-0.01 to 0.05)
 
15-19
 
49 -0.007  (-0.02 to 0.006) 38
 
-0.008  (-0.04 to 0.02)
 
20-24
 
85 -0.002  (-0.01 to 0.009) 70
 
0.005  (-0.02 to 0.03)
 
25-29
 
75 -0.0001  (-0.01 to 0.01) 68
 
0.02  (-0.003 to 0.04)
 
HDL2-
cholesterol 
 
30-37 
 
36 0.006  (-0.01 to 0.03) 31 
 
0.006  (-0.03 to 0.04) 
 
15-19
 
49 -0.006  (-0.02 to 0.01) 38
 
-0.001  (-0.02 to 0.02)
 
20-24
 
85 -0.006  (-0.02 to 0.004) 70
 
0.006  (-0.01 to 0.02)
 
25-29
 
75 -0.004  (-0.01 to 0.005) 68
 
-0.0008  (-0.02 to 0.02)
 
HDL3-
cholesterol 
 
  
30-37
 
36 -0.006  (-0.02 to 0.01) 31
 
0.002  (-0.02 to 0.02)
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Figure 5-1 Mean levels of low density lipoprotein (LDL)-cholesterol by birth weight 
in males.
 below median
Birth weight 
 
 above median
 
Figure 5-2 Mean levels of total cholesterol by birth length in females.
 below median
Birth length 
 
 above median
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postnatal characteristics, has been shown to be reliable26 it may be expected 
to affect precision. Some imprecision in the self-reported birth weights 
occurred as there were many rounded-off numbers, in particular when birth 
weight was reported from memory. A sex adjusted analysis of the pooled 
data of males and females restricted to subjects whose parents reported 
birth weights (41% of total group) from maternity center cards of birth 
announcements showed associations similar to those reported, although 
a gender specifi c analysis included too small numbers of subjects to be 
meaningful. Therefore, misclassifi cation with respect to birth data is most 
likely to be random and, if anything, may have underestimated the real 
association for birth weight and lipids. Baseline values of lipids in responders 
and non-responders to the birth data questionnaire were similar for both 
males and females. Differences in birth weight and cholesterol levels in those 
who dropped out of the study before 1992 may have affected the relation. 
These differences, however, were small as compared to the mean birth 
weight and baseline total cholesterol levels of the total group. Furthermore, 
all data provided by the dropouts are included in the analysis. In a previous 
report, we have shown that secular trends in lipid levels in this study group, 
if any, are small19 and not likely to explain the results with respect to birth 
data. 
One study showed an association between low birth weight and increased 
triglyceride levels in white male and female children born at term, but 
not with variables examined in the present study such as total-, LDL- and 
HDL-cholesterol.11 It was further shown that differences in cardiovascular 
risk factors across groups of British children from areas with high and 
low cardiovascular mortality were unaffected by standardisation for birth 
weight.27 Another study showed that in prepubertal children total cholesterol 
was inversely related only to birth length.10 Thus, in these studies an 
association between birth weight and lipids could, except for triglycerides, 
not be shown. Recently, a systematic review of the effect of birth weight on 
total cholesterol showed a signifi cant decrease in total cholesterol of 0.05 
mmol/l per kg higher birth weight.16 We found an inverse relation with birth 
weight in adulthood, particularly in males, which is in line with previous 
reports.13 The inverse relation between lipids and birth length in our study 
was somewhat stronger in females than in males, which is to the authors’ 
knowledge not described earlier for these age groups.
Like in other studies,13 the relations found in the present study were 
independent of gestational age and of life-style factors including use of 
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oral contraceptives, although we did not measure current dietary habits. 
Walker et al. reported that the relation between birth weight and adult 
blood pressure level attenuated when adjusted for parental blood pressure 
level.28 Adjustment for parental cardiovascular risk by total cholesterol 
and blood pressure levels and BMI in our analysis did not change the 
fi ndings. Therefore, the relations found seem to be independent of familial 
aggregation of cardiovascular risk factors at least as measured in parents 
and offspring at baseline. It has been postulated that lower social class in 
early life is associated with risk of ischaemic heart disease,29 while socio-
economic status is also associated with fetal growth.30 It was shown that 
for the inverse relation between birth weight and blood pressure in 50 year 
olds, confounding by social-economic status is not a very likely explanation.31 
There is evidence to suggest that prolonged breast feeding is associated with 
increased low density lipoprotein cholesterol levels and higher death rates in 
adulthood.12,27 Adjustment for breast-feeding, however, did not change our 
results.
The mechanism by which birth size could be related to cholesterol levels 
is largely unknown. It is postulated that intra-uterine growth retardation, 
particularly during late gestation, results in a disproportionate effect on liver 
growth, which may lead to altered lipoprotein cholesterol metabolism.13 
Earlier fi ndings indicated a relation between an adverse intra-uterine 
environment during the fi rst two trimesters of pregnancy and adult 
obesity.32 The fact that obesity has been repeatedly reported to modify 
relations between birth size and cardiovascular risk factors, diabetes mellitus 
and incident coronary heart disease points at the importance of later life 
exposures as well,2,6,7 although others reported such modifi cation to be 
absent.8 Previously, we have shown in this study group that the inverse 
relation between birth weight and blood pressure is mediated by the BMI 
later in life.33 The interaction between BMI and birth size in males suggests 
that total cholesterol and LDL-cholesterol are particularly raised in those with 
low birth weight or length and with high current body mass. Data in females 
suggests that HDL-cholesterol is lower in those with low birth weight and 
high current body mass. A mediating effect of current body size in the 
relation between infant body mass and adult cholesterol levels was also 
found in one other study.12
Relations in children between birth weight and blood pressure have been 
reported to amplify with increasing age.34 This could in principle be due to 
tracking of blood pressure together with dispersion of the distribution with 
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increasing age, or to detracking of blood pressure such that children with 
low birth weight change to higher ranks in the blood pressure distribution 
with increasing age. Our fi ndings with regard to lipid levels, but particularly 
lipid change with age, indicate detracking (excessive change) of lipids by 
birth weight to the extent that the relation even reverses. This reversal 
appears to express after puberty. In another study, restriction of analyses 
to prepubertal children yielded no relation between birth weight and 
lipids.11 Our data suggest that the rate of maturation is involved and may 
be a confounding factor in the birth weight and lipid relation. Birth length 
showed a consistent inverse relation with lipids. Like with birth weight the 
associations between birth length and lipids appeared to get slightly stronger 
in adulthood. Adjustment for rate of maturation left the relation between 
birth length and lipids unchanged. This supports our observation that low 
birth length is related to less favourable lipid levels early in life, remaining 
throughout adulthood regardless of growth related factors. 
Our data support the view that differences in levels of lipids may have their 
origins in early life. Differences amount to almost 0.5 mmol/l per kilogram 
difference in birth weight for LDL-cholesterol in adulthood and are as such 
important. These differences are graded and particularly pertain to children 
born at term. Further, as the relations between birth size and lipids in this 
study were obtained without any adjustment, unlike relations with blood 
pressure in these age groups,33 these fi ndings may have implications from a 
public health point of view.
We conclude that size at birth is related to the natural history of lipids from 
childhood to young adulthood. Children born with low birth weight or 
length have higher adverse lipid levels particularly when they reach young 
adulthood.
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ABSTRACT
BACKGROUND
The potential role of insulin-like growth factor (IGF)-1 in cardiovascular 
pathophysiology has raised considerable interest over the past years. A 
common functional polymorphism in the promoter region of IGF-1 may play 
an important role in the development of type 2 diabetes and myocardial 
infarction. Our aim was to study the relation of this polymorphism with 
birthsize and cardiovascular disease risk in young adulthood. 
METHODS
Data of 2 prospective population based studies in men and women aged 
at baseline between 5 and 21 years were pooled. Birth characteristics 
were collected using school health records and questionnaires. Repeated 
measurements of cardiovascular risk factors were extended with carotid 
intima-media thickness and aortic pulse-wave velocity measurements during 
the last visit. A functional polymorphism in the promoter region of the IGF-1 
gene was determined in 1079 subjects.
RESULTS
70% were homozygous carriers of either the 192 base pairs (bp) or the 194-
bp allele or heterozygous carriers of both the 192-bp allele and the 194-bp 
allele (wild type group), 30% was non-carrier or heterozygous carrier of 
either the 192-bp allele or the 194-bp allele (variant carriers). At the age 
of 30 years, the wild type group was on average 1.7 cm taller compared to 
variant carriers (p=0.006), while they were born with a 0.3 cm larger birth 
length (p=0.13). No associations were observed between IGF-1 genotype 
and body mass index, blood pressure, serum cholesterol and carotid intima-
media thickness, aortic pulse-wave velocity. 
CONCLUSION
Birth length and subsequent height growth from childhood into young 
adulthood are affected by IGF-1 genotype. In our age group of young adults, 
no relation could be found between the IGF-1 genotype and cardiovascular 
risk factors and measures of vascular damage.
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INTRODUCTION
Insulin-like growth factor (IGF-1) is an essential regulator of developmental 
growth as IGF-1 levels are strongly associated with both fetal and postnatal 
growth.1-4 Over the last years, IGF-1 has been suggested to be involved 
in the pathophysiology of type 2 diabetes and cardiovascular disease.5-
8 Subjects with low circulating IGF-1 levels have a signifi cantly increased 
risk of myocardial infarction.9, 10 There is also strong evidence that IGF-1 is 
a critical determinant of vascular growth responses in vitro and in vivo.11-
13 A direct interaction between the activity of the growth hormone (GH) 
- IGF-1 axis and the endothelium may play a role. It is possible that the 
modulating effect of IGF-1 on nitric oxide synthesis is a mediating factor,14 
together with an anabolic effect on the myocardiocytes.15 Recently, a 
polymorphism in the promoter region of IGF-1 on chromosome 12q21 has 
been identifi ed, which has been found to be related to IGF-1 levels.16, 17 In 
elderly individuals, Vaessen et al. showed that non-carriers of the wild-type 
allele of this polymorphism had an increased risk of type 2 diabetes mellitus 
and myocardial infarction and also low circulating IGF-1 levels, reduced body 
height and low birth weight.18, 19 However, a second study in young adults 
showed no relation between the IGF-1 promoter polymorphism and either 
type 2 diabetes, birth size and growth and showed an increase in IGF-1 levels 
in non-carriers.20 To expand upon these contradicting results, we examined 
the relation between this functional polymorphism in the promoter region 
of the IGF-1 gene and birth size, childhood growth and cardiovascular risk in 
young adulthood. 
 
METHODS
SUBJECTS
Data of the Atherosclerosis Risk in Young Adults (ARYA) study9 and the 
Epidemiological Preventive Study Zoetermeer (EPOZ)10 were pooled to 
increase statistical power for analysis. The ARYA study was approved by 
the Medical Ethics Committee of the UMC Utrecht and the EPOZ study was 
approved by the Medical Ethics Committee of the Erasmus MC Rotterdam. 
All participants gave written informed consent. 
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ARYA-STUDY
From the Municipal Health Service medical records were obtained from all 
young adults born between 1970-1973 who attended secondary school 
in the city of Utrecht in the Netherlands. The available charts (n=15,592) 
were checked for the presence of adequately registered birth weight and 
at least one blood pressure measurement during adolescence. The median 
number of childhood measurements was 1 (range 1-4). All young adults 
with a complete chart (n=4,208; 27%) were invited by mail to participate. 
Eventually, 750 subjects completed both visits to the research center within a 
3-week period.21
EPOZ-STUDY
Families with children aged 5-19 years old who were living in 2 districts 
in the Dutch town of Zoetermeer were invited to participate in a cross-
sectional population based study on risk-indicators for chronic disease. 
All participants were included between 1975 and 1978.22 Zoetermeer is a 
suburban residential community of in that time about 55,000 inhabitants 
which is situated near The Hague in the Netherlands. Of all persons aged 
5-19 years, 4,649 (82 %) took part in the study. From this group, a random 
sample of 596 children was selected for annual follow-up in a study on the 
natural history of cardiovascular risk factors and their determinants. The 
median number of visits was 15 (range 2-19). The median follow-up time 
for the present analyses was 23 years. The response for the majority of visits 
gradually declined to 83% in 1992. For the atherosclerosis measurements in 
2002, the response was 61%. The present study involved 362 persons that 
participated in the last visit.
IGF-1 GENOTYPE
For both studies, DNA was isolated at the last visit for IGF-1 genotyping in 
the same laboratory using the same techniques. Polymerase chain reaction 
was performed using oligonucleotide primers designed to amplify the 
polymorphic cytosine-adenine (CA) repeat 1 kb upstream of the human IGF-
1 gene.23 The reaction was carried out in a fi nal volume of 10 ml containing 
50 ng of genomic DNA obtained from peripheral blood cells, 0.5 nmol/l 
forward primer (‘5-ACCACTCTGGGAGAAGGGTA-3’), 0.5 nmol/l reverse 
primer (‘5-GCTAGCCAGCTGGTGTTATT-3’), 0.25 mmol/l 2’-dNTP, 2.2 mmol/l 
MgCl2, 0.01% W1 (Gibco BRL), and 0.4 Taq DNA polymerase (Gibco BRL). 
Polymerase chain reaction was performed in 384 well plates (94°C 10 min; 
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35 polymerase chain reaction cycles of 30 s at 94°C, 30 s on 55°C, and 30 s 
on 72°C; 72°C 10 min; 4°C hold). Forward primers were labeled with FAM, 
HEX or NED to determine the size of polymerase chain reaction products by 
autosequencer (ABI 3100, POP 4, fi lter set D, collecting time array 36 cm 7 
s, peak-height between 100 and 2000, each lane containing three samples). 
The size of the polymerase chain reaction products was determined in 
comparison with internal ROX 500-size standard (Perkin Elmer).
MEASUREMENTS
Clinical data were obtained without knowledge of IGF-1 genotype. At each 
visit, anthropometric measurements were performed with indoor clothes 
without shoes and a written questionnaire was completed on alcohol 
intake, smoking and highest education. In ARYA, information on birth 
characteristics was obtained from fi led records of child health facilities. 
In EPOZ, information about birth weight was collected both from the 
mothers at the baseline visit and from the participants themselves at the 
last visit. Total cholesterol and HDL-cholesterol were measured using an 
automatic enzymatic procedure (ARYA: Vitros950 dry-chemistry analyser 
(Johnson & Johnson, Rochester, New York, USA); EPOZ: Roche Diagnostics 
(Mannheim, Germany)). At each visit, blood pressure was measured twice 
in the left brachial artery in sitting position (ARYA: semi automated device 
(Dinamap, Critikon, Tampa California, USA); EPOZ: Hawksley random-zero 
sphygmomanometer (Hawksley and Sons, Ltd)). The mean of 2 consecutive 
measurements was used in the analyses. Mean arterial blood pressure (MAP) 
was calculated as [diastolic blood pressure + (1/3 * (systolic blood pressure 
- diastolic blood pressure))]. Pulse pressure was defi ned as systolic blood 
pressure minus diastolic blood pressure. The indicators of atherosclerosis 
and arterial stiffness used in these analyses were measured once at the 
last examination phase. Intima-media thickness (IMT) was measured by 
recording of ultrasonographic images of both the left and right carotid 
artery, using a 7.5 MHz linear array transducer (ARYA: Acuson Aspen; EPOZ: 
ATL Ultramark IV (Advanced Technology Laboratories, Bethel Washington, 
USA)). The lumen-intima interface and the media-adventitia interface of 
the near and far wall of the distal common carotid artery were measured 
off-line. The protocol has been described in detail elsewhere.24 In short, the 
common carotid intima-media thickness was determined as the average 
of maximal near and far wall measurements of both left and right side. In 
ARYA reproducibility was assessed by repeating the common carotid IMT 
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of 21 participants at the same visit by another sonographer. Absolute mean 
difference of IMT was 0.012 mm (standard error 0.004). The intraclass 
correlation coeffi cient for repeated measurements was 0.84. The PWV was 
determined using an automated device (ARYA: SphygmoCor device (PWV 
Medical, Sydney, Australia); EPOZ: Complior (Colson, Garges-lès-Gonesse 
Cx, France)), which allowed an online pulse wave recording and automatic 
calculation of PWV with 2 transducers, 1 positioned at the base or the neck 
for the common carotid artery and the other over the femoral artery. The 
average of 10 successive waveforms was used in the analyses to cover a 
complete respiratory cycle. The whole procedure was repeated 3 times per 
subject and the average PWV-value was used for the analysis. Reproducibility 
of the PWV measurement was only evaluated in the ARYA study. A subset 
of 25 participants had their PWV re-measured several weeks after their fi rst 
visit. Absolute mean difference (standard error) in PWV of the repeated 
measurements between visits was 0.12 m/s (0.45). The intraclass correlation 
coeffi cient (ICC) for repeated measurements was 0.67. Since the repeated 
measurements were performed on 2 different occasions, the moderate ICC 
could be explained in part by the variability in blood pressure over time.
DATA ANALYSIS
The present analyses are based on 1,079 subjects in whom IGF-1 genotype 
was determined. The wild-type allele in the promoter region of the IGF-1 
gene had a length of 192 base pairs, which is equivalent to 19 cytosine-
adenine (CA) repeats. As the levels of IGF-1 are similar in homozygous 
carriers of the wild-type allele as well as homozygous carriers of the 194-bp 
allele,25 we grouped on one hand all homozygous carriers of either the wild-
type allele or the 194-bp allele and all heterozygous carriers of both a 192-
bp allele and a 194-bp allele (wild type group). The second group comprised 
the non-carriers and all heterozygous carriers of either the 192-bp allele or 
the 194-bp allele (variant carriers).
First, a multivariate linear regression model was used to study the relation 
between genotypes and birth size. Due to differences between men 
and women in birth size, gender was added as a possible confounder. 
Secondly, repeatedly measured cardiovascular risk factors blood pressure, 
weight, height, total- and HDL-cholesterol were studied as outcome. As 
these repeated measurements within children were mutually dependent 
observations we used unbalanced repeated measures analysis (Proc Mixed, 
SAS).26 In the analysis each subject’s response was assumed to have a linear 
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relation with age and to have its own random intercept and slope and 
therefore a random covariance structure was chosen. This model was used to 
obtain mean cardiovascular risk factor by genotype adjusted for gender and 
age. An interaction term genotype*age was added. Finally, a multivariate 
linear regression model was used to study the relation between genotype 
and the measures of vascular damage as continuous variables (Proc GLM, 
SAS). Because of the differences between men and women in the measures 
of vascular damage, gender was always included. As PWV is related to wall 
elasticity and thus depends on blood pressure, analyses using PWV were 
adjusted for mean arterial pressure.27
Because the association between IGF-1 genotype and both cardiovascular 
risk factors and measures of vascular damage did not differ by study 
population, pooled results are presented only. Still, in order to correct for 
possible differences between the studies, all analyses were adjusted for 
study. Data were analyzed using the SAS statistical software package (SAS/
STAT Version 8.02, SAS Institute, Cary, NC).26
RESULTS
Table 5-5 shows the general characteristics of the two cohorts according to 
gender. Men (49.0%) were born signifi cantly heavier and taller. At young 
adulthood, blood pressure, weight, height, levels of total cholesterol and 
measures of vascular damage were higher in men, and HDL-cholesterol was 
lower in women.
IGF-1 GENOTYPE
The IGF-1 genotype was determined in 728 (97.2% of the 750) participants 
of the ARYA study (47% male) and in 351 (96.7% of the 362) participants of 
the EPOZ study (54% male). Table 5-6 shows that 9 alleles were identifi ed. 
Genotype and allele distribution were in Hardy-Weinberg equilibrium (for the 
ARYA study p=0.44 and for the EPOZ-study p=0.56). 
BIRTH SIZE AND GROWTH
The wild type group had a mean birth length of 51.1 cm (50.9-51.4) and 
the variant carriers had a mean birth length of 50.8 cm (50.5-51.2). This 
0.3 cm difference was not statistically signifi cant (p=0.13). The wild type 
group had a mean birth weight of 3.41 kg (95% confi dence interval 3.37-
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3.48), which was not signifi cantly different from the mean birth weight of 
the variant carriers (3.40 kg (3.33-3.46); p=0.68). The associations between 
IGF-1 genotype and birth height and weight were similar in men and women 
(p=0.99 respectively 0.92). 
The increase in height from childhood into adulthood differed per genotype 
group (p=0.006). Thirty year-old men from the wild type group had a mean 
height of 183.3 (182.6-184.0) cm compared to a mean height of 181.6 
cm (180.6-182.6) cm in male variant carriers of either a 192-bp allele or a 
194-bp allele. In women, the differences were similar (170.0 (169.3-170.6) 
respectively 168.4 (167.5-169.3)).
CARDIOVASCULAR RISK FACTORS AND VASCULAR DAMAGE
No differences were seen in cardiovascular risk factors between genotype 
groups (table 5-7). Common carotid intima-media thickness and pulse wave 
velocity did not differ between the genotypes either (table 5-8).
IGF-1 GENE AND CARDIOVASCULAR RISK IN THE YOUNG
139
Table 5-5 General characteristics of the study populations.
Values are expressed as mean (standard deviation) in case of continuous variables, 
and as percentages in case of categorical variables. For defi nitions see text. 
n: number; NA: not applicable; HDL: high-density lipoprotein; IMT: intima-media 
thickness
Characteristic Men Women 
 ARYA 
(n=340) 
EPOZ 
(n=189) 
ARYA+EPOZ 
(n=529) 
ARYA 
(n=388) 
EPOZ 
(n=162) 
ARYA+EPOZ 
(n=550) 
Birth characteristics       
Birth weight (kg) 3.48 (0.5) 3.50 (0.6) 3.49 (0.6) 3.36 (0.5) 3.33 (0.6) 3.35 (0.6) 
Birth length (cm) 51.3 (2.4) 51.7 (3.0) 51.4 (2.6) 50.4 (2.5) 50.5 (2.1) 50.4 (2.4) 
   
Last visit       
Age (years) 28.2 (0.9) 38.1 (4.4) 32.6 (5.7) 28.2 (0.9) 36.9 (4.5) 31.4 (5.1) 
Height (m) 1.84 (0.07) 1.82 (0.07) 1.83 (0.07) 1.70 (0.06) 1.69 (0.08) 1.70 (0.07) 
Weight (kg) 83.5 (13.7) 85.2 (13.6) 84.1 (13.7) 71.1 (14.6) 72.7 (14.9) 71.6 (14.7) 
Body mass index (kg/m2) 24.6 (3.7) 25.6 (3.4) 25.0 (3.6) 24.4 (4.5) 25.4 (4.7) 24.8 (4.6) 
Waist-to-hip ratio  0.88 (0.06) 0.90 (0.06) 0.89 (0.06) 0.81 (0.06) 0.80 (0.08) 0.81 (0.07) 
Alcohol (n (%)):    0 glasses/day 31 (12.9) 27 (14.2) 58 (13.5) 70 (24.7) 47 (28.7) 117 (26.2) 
                             1 111 (46.2) 35 (18.4) 146 (33.9) 161 (56.9) 63 (38.4) 224 (50.1) 
                             1-2 59 (24.6) 86 (45.3) 145 (33.7) 46 (16.3) 44 (26.8) 90 (20.1) 
                             3-5 34 (14.2) 30 (15.8) 64 (14.9) 6 (2.1) 3 (1.8) 9 (2.0) 
                             6 5 (2.1) 12 (6.3) 17 (4.0) 0 (0) 7 (4.3) 7 (1.6) 
Highest education (%):        
     elementary school 3.3 0 1.9 1.8 0.6 1.4 
     secondary school                   19.2 23.5 21.1 21.5 31.2 25.1 
     lower/intermediate  
         vocational training 
41.7 50.8 45.6 38.5 49.4 42.4 
     higher vocational      
         training/university 
35.8 25.7 31.4 38.2 18.8 31.1 
Current smokers (%) 33.3 40.0 36.3 26.5 28.7 27.3 
Contraceptive pill use (%) NA NA NA 65.4 41.9 56.9 
Total cholesterol (mmol/l) 4.86 (0.94) 5.22 (1.05) 5.02 (1.01) 4.84 (0.82) 4.91 (0.87) 4.87 (0.84) 
HDL-cholesterol,  (mmol/l) 1.30 (0.30) 1.12 (0.29) 1.22 (0.31) 1.58 (0.36) 1.37 (0.32) 1.50 (0.36) 
Systolic blood pressure (mmHg) 130.4(12.1) 124.1 (13.7) 127.6 (13.2) 120.2 (12.1) 115.5 (11.7) 118.5 (12.2) 
Diastolic blood pressure (mmHg) 72.5 (7.2) 82.4 (9.2) 76.9 (9.5) 70.8 (8.4) 76.4 (8.9) 72.8 (9.0) 
Mean Arterial Pressure (mmHg) 91.8 (8.0) 96.3 (9.8) 93.8 (9.1) 87.3 (9.0) 89.4 (9.2) 88.1 (9.2) 
Pulse Pressure (mmHg) 57.8 (9.3) 41.6 (10.1) 50.7 (12.6) 49.4 (7.9) 39.1 (7.9) 45.6 (9.3) 
Heart rate (beats per minute) 63.4 (9.5) 65.6 (11.2) 64.4 (10.3) 66.4 (8.8) 69.2 (10.9) 67.4 (9.7) 
Mean common carotid 
maximum IMT(mm) 
0.67 (0.09) 0.72 (0.08) 0.69 (0.09) 0.69 (0.08) 0.69 (0.07) 0.69 (0.08) 
Pulse Wave Velocity (m/s) 6.26 (0.76) 9.98 (1.50) 7.91 (2.18) 5.70 (0.69) 8.63 (1.15) 6.77 (1.67) 
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Table 5-6 IGF-I promoter polymorphism- and 192-bp/ 194-bp genotype frequency 
distributions and of the study populations.
Polymorphism Men Women
Allele
 (bp)
(CA)n ARYA 
(n=340)
EPOZ 
(n=189)
ARYA 
(n=388)
EPOZ 
(n=162)
176 11 0 (0) 1 (0.3) 1 (0.1) 0 (0)
186 16 2 (0.3) 0 (0) 0 (0) 0 (0)
188 17 6 (0.9) 8 (2.1) 12 (1.5) 5 (1.5)
190 18 29 (4.3) 23 (6.1) 46 (5.9) 19 (5.9)
192 (wild-type) 19 439 (64.6) 241 (63.8) 493 (63.5) 206 (63.6)
194 20 142 (20.9) 73 (19.3) 145 (18.7) 63 (19.4)
196 21 49 (7.2) 25 (6.6) 58 (7.5) 28 (8.6)
198 22 13 (1.9) 6 (1.6) 21 (2.7) 3 (0.9)
200 23 0 (0) 1 (0.3) 0 (0) 0 (0)
Genotypes
    Homozygous 194-bp
    Homozygous 192-bp
    Heterozygous 194-bp/192-bp
    Non-carrier
17 (5.0) 6 (3.2) 15 (3.9) 4 (2.5)
145 (42.6) 78 (41.3) 158 (40.7) 62 (38.3)
89 (26.2) 50 (26.5) 90 (23.2) 47 (29.0)
10 (2.9) 9 (4.8) 13 (3.4) 6 (3.7)
Data are n (%). The allele distribution is based on 2 alleles per participant.
bp: length of PCR product in base pairs; (CA) n: number of cytosine-adenine repeats;
wild-type allele: most frequent allele in this population;
IGF-1: insulin-like growth factor-1
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Table 5-7 IGF-1 promoter polymorphism and cardiovascular risk factors in young 
adulthood.
Cardiovascular risk 
factor
                                 Genotype
wild type group variant carriers p-value
Systolic blood pressure (mmHg) 125.1 (124.2-126.1) 124.6 (123.3-125.8) 0.43
Diastolic blood pressure (mmHg) 73.8 (73.3-74.4) 73.8 (73.0-74.6) 0.98
Weight (kg) 79.8 (78.7-80.9) 79.0 (77.6-80.3) 0.22
Body mass index (kg/m²) 25.0 (24.7-25.3) 25.0 (24.6-25.4) 0.91
Total cholesterol (mmol/l) 5.0 (4.9-5.1) 5.0 (4.9-5.1) 0.62
LDL-cholesterol (mmol/l) 3.07 (2.99-3.14) 3.13 (3.02-3.23) 0.31
HDL-cholesterol (mmol/l) 1.35 (1.32-1.37) 1.35 (1.31-1.39) 0.90
Values are means (standard error of the mean) adjusted for age and gender.
wild type group: homozygous 192, homozygous 194, heterozygous 192/194 or 194/192
variant carriers: non-carriers 192 and 194, heterozygous 192 without 194 and 194 without 192
IGF-1: insulin-like growth factor-1; LDL: low-density lipoprotein; HDL: high-density lipoprotein
 
Table 5-8 IGF-1 promoter polymorphism and vascular damage in young adulthood.
Parameter for 
vascular damage
                                 
Genotype
wild type group variant carriers p-value
Maximal common carotid 
intima-media thickness (mm) *
0.669 (0.661-0.678) 0.670 (0.659-0.681) 0.90
Pulse Wave Velocity (m/s) † 6.72 (6.61-6.68) 6.72 (6.61-6.83) 0.52
Values are means for men and women combined at age 30 (standard error of the mean).
* : adjusted for age, gender.
† : adjusted for age, gender, mean arterial pressure, height.
IGF-1: insulin-like growth factor-1.
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DISCUSSION
Our fi ndings show a clear association between a polymorphism in the 
promoter region of the IGF-1 gene and changes in body height growth from 
childhood into adulthood. Already at birth, carriers of this polymorphism 
were taller, although the difference was not statistically signifi cant. However, 
no association was seen between this polymorphism and birth weight. 
Also, no relation was found between this polymorphism and cardiovascular 
risk factors measured from childhood into young adulthood and vascular 
damage at young adulthood. 
Before interpreting our results, some methodological issues need to be 
discussed. Circulating levels of IGF-1 do not necessarily refl ect the local 
production of IGF-1 in pancreatic beta cells, myocardium or bone cells. Over 
90% is bound to specifi c IGF binding proteins. For this reason we examined 
a genetic polymorphism in the promoter region of IGF-1 on chromosome 
12q, that appears to be functional as studies showed that it is related to 
the IGF-1 level and body height.16-18 Two longitudinal studies were pooled 
in order to increase statistical power. Both cohorts consisted of subjects 
who were included in childhood or young adolescence and their last visit 
took place when they were young adults. Although the EPOZ participants 
were older than the ARYA participants, the associations between IGF-1 
genotype and the different outcomes did not differ by study. Nevertheless, 
a dichotomous variable for study was added in all analyses in order to take 
possible measurement and study differences between the studies into 
account. In the ARYA study, measurement error is minimized by using birth- 
and adolescent characteristics obtained from fi led medical health records, 
instead of parental recall and self-report. Although only 750 of the 4,208 
invited subjects ultimately entered the study and 70% of the young adults 
underwent the pulse wave velocity measurement, we have several reasons 
to assume that selection bias regarding relations under study did not occur. 
Data at birth and adolescence did not differ between the responders and 
the non-responders, and the obtained data between the participants with 
and without a pulse wave velocity measurement were similar. Furthermore, 
the invited adults in the ARYA study were unaware of their IGF-1 genotype, 
87% of our participants had a 19-CA repeat in the promoter region of the 
IGF-1 gene similar to the EPOZ study and similar to other population based 
studies.16-18, 20, 28, 29 During the 27-year follow-up period in the EPOZ study, 
a single research assistant performed the vast majority of the average of 15 
IGF-1 GENE AND CARDIOVASCULAR RISK IN THE YOUNG
143
measurements per participant, reducing measurement variation. The large 
numbers of measurements that were performed within the EPOZ study in 
each individual further enhanced more accurate estimation of subject’s true 
underlying levels at every age. The population selected for follow-up was a 
random sample from the youngsters who participated in the baseline study. 
As BMI, blood pressure and total cholesterol values at previous EPOZ visits 
were similar among those who were and those who were not lost to follow-
up, we do not think that selective loss-to-follow-up has affected our results. 
Accuracy of maternally reported birth size has been shown to be higher for 
the eldest child and in younger mothers.30 As most participants in the EPOZ 
study were fi rstborns and mean maternal age at baseline was 41 years, we 
think that this added to the validity of reported birth size.
Similar to our study, the Rotterdam Study18 and a U.K. study20 found that 
homozygous carriers of the 192-bp allele were the tallest subjects. The 
Nurses Health Study described a non signifi cant test for trend for body 
height in women (p=0.47) but did not mention body height per genotype.17 
Our data further showed that already at birth the wild type group was 0.3 
cm taller compared to the variant carriers. However, like Frayling et al.20 we 
could neither confi rm the results of Vaessen et al.19 who found that non-
carriers of the 192-bp allele had a low birth weight nor the results of Arends 
et al. The latter study showed an association between birth length, birth 
weight, head circumference and an intronic repeat in the promoter region of 
the IGF-1 gene in a cohort of 124 short children with a mean age of 7 years 
and born small for gestational age.
Our data showed no relation between the IGF-1 genotype and cardiovascular 
risk factors at a young age. The Rotterdam Study has previously shown that 
homozygous carriers of the 192-bp allele had a lower risk to develop type 2 
diabetes mellitus and myocardial infarction.18 Within our study, we did not 
fi nd an association between genetic variation in the IGF-1 gene and arterial 
wall thickness and arterial stiffness at young adulthood. Ultrasonographically 
measured common carotid intima-media thickness is a recognized 
measure of atherosclerosis24, 31-34 which correlates well with pathological 
measurements of human carotid arteries35 and is an established risk indicator 
of cardiovascular disease. Finally, pulse wave velocity has repetitively been 
related to type 2 diabetes mellitus, myocardial infarction and mortality in 
adults and elderly subjects.36, 37 
Given the results of the Rotterdam Study,18 we would have expected a 
relation between IGF-1 genotype and cardiovascular risk factors and vascular 
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damage. It is possible that another pathogenic mechanism is responsible 
for the association between IGF-1 and CVD than convential cardiovascular 
risk factors. IGF-1 is a potent survival factor preventing apoptosis of vascular 
smooth muscle cells12 as well as stimulating the proliferation38 and migration 
of vascular smooth muscle cells.39 IGF-1 may contribute to the balance 
between apoptosis and survival in atherosclerotic lesions.40 Circulating 
IGF-1 levels stimulate nitric oxide, which is essential for the integrity of the 
vessel wall. Decreased NO production by vascular endothelium, due to low 
IGF-1 levels, might be another pathway linking IGF-1 levels and CVD. In 
addition, IGF-1 can promote vasodilatation through activation of potassium 
channels,41, 42 and aortic angiogenesis through stimulation of tube-forming 
activity and migration of vascular endothelial cells.43 Also, IGF-1 has been 
shown to inhibit the adherence of human peripheral blood monocytes to an 
endothelial cell line.44
In conclusion, our results indicate that a functional polymorphism in the 
promoter region of the IGF-1 gene is associated with childhood growth, 
whereas no signifi cant association is seen with birth size. Our results do 
not support the view that this polymorphism is associated with increased 
cardiovascular risk or vascular damage at young adulthood. 
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         ver the past century, research into the aetiology of cardiovascular   
         diseases (CVD) has focussed on adult risk factors, such as blood 
pressure, cholesterol, diabetes, diet, physical exercise and smoking. Advances 
in the diagnosis and treatment of coronary heart disease have increased 
the lifespan and quality of life for many patients. It is estimated that about 
half of the dramatic decline in CVD between 1980 and 1990 is attributed 
to reductions in risk factors, while the other half has been attributed to 
improved treatment of clinically apparent disease.1 However, CVD is still 
the major cause of mortality in most western societies and an increasing 
health threat in developing countries. CVD still claim large parts of health 
budgets and are responsible for many quality adjusted life years lost.1-3 Since 
the 1980s, there has been a revived interest in the early origins of adult 
disease. It has been shown that atherosclerosis is present and progresses 
for many decades before the onset of clinical manifestations.4 Furthermore, 
the dramatic increase in the prevalence of childhood obesity in the past 
three decades5-9 may have implications for children’s current and future 
cardiovascular health. Finally, family dynamics may play an important role in 
the development of childhood risk factors and subsequent vascular changes 
in adulthood. 
The work presented in this thesis aims at exploring early determinants of 
vascular damage in healthy adults and gaining insight into the aetiology and 
the development of later cardiovascular disease. 
This chapter will focus on the main fi ndings, considered in the light of 
current knowledge and ongoing research in the fi eld of the early origins 
of adult disease. Subsequently, some methodological issues concerning 
the EPOZ-study are discussed. Finally, I will elaborate on the importance of 
cardiovascular risk assessment in the young and consider the implications for 
public health and future research. 
MAIN FINDINGS
Prospective studies have shown that cardiovascular disease aggregates in 
families.10, 11 This is probably partly due to familial aggregation of important 
cardiovascular risk factors such as blood pressure and plasma cholesterol.12, 
13, 14-17 and was shown to be detectable in children at a very young age.18 
In longitudinal studies, children with a family history of hypertension were 
shown to have persistently higher blood pressure levels than children without 
O
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such a history over follow-up periods of up to 10 years.19-21 Still the usefulness 
of recording a positive family history in the prediction of hypertension in the 
individual is considered to be limited.22, 23 It is of particular interest to know 
whether parental blood pressure levels are predictors of their offspring’s 
subsequent blood pressure development into young adulthood and whether 
this holds for the whole distribution of parental blood pressure. In our 
27-year follow-up study, actual parental blood pressure showed to be an 
important predictor of blood pressure development from childhood into 
young adulthood. Our fi ndings add to the current knowledge in several 
ways. The impact of parental blood pressure was present over the whole 
distribution of parental blood pressure levels, meaning the lower the 
parental blood pressure the lower the blood pressure levels of the offspring. 
Furthermore, our data suggest that the impact of parental blood pressure 
starts at an early age and is strong and long lasting. A genetic basis for 
the differences found in our study is supported by the fact that familial 
differences are not only present at a young age when environments are 
shared, but persist into young adulthood when environments become more 
different.
Already at young ages, family dynamics also play an important role in the 
development of obesity.24 In a retrospective cohort study it was shown that 
parental obesity doubles the risk of adult obesity among both obese and 
nonobese children under 10 years of age.25 The impact of parental body 
mass index (BMI) on the manifestation of overweight in offspring has been 
shown in cross-sectional studies as well.6, 26-28 In our study, we used actual 
measurements of parental BMI and repeatedly measured BMI in offspring 
from childhood into adulthood. We showed that the impact of parental BMI 
was present over the whole range of parental BMI levels, meaning that the 
lower the parental BMI the lower the child’s BMI. Furthermore, parental 
BMI was also associated with increased cardiovascular risk in the offspring, 
already at young ages. Parental and children’s BMI did not only affect the 
current health status but were also predictors of future vascular damage and 
thereby the risk of manifest cardiovascular disease in later life. These results 
underline the importance of early prevention of excessive weight gain and 
the necessity of involving the parents in fi ghting the obesity epidemic.
Thus, parental risk status is important for one’s cardiovascular risk profi le. 
But which childhood risk factor determines cardiovascular risk at later age? 
The study of the relation between cardiovascular risk factors in children and 
clinically manifest CVD requires a follow-up of many decades as in most 
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cases manifest CVD occurs after the fi fth decade. As an alternative, we 
can estimate the relation between cardiovascular risk factors in childhood 
and early vascular damage, measured non-invasively. Knowledge about 
the predictive value of childhood cardiovascular risk factors may result 
in identifi cation of young subjects at high risk of CVD. Early detection of 
those at highest risk can subsequently lead to early treatment or preventive 
measures. We found that BMI, systolic blood pressure and total cholesterol 
measured during childhood were strongly related to both carotid intima-
media thickness (IMT) and presence of plaques in the carotid arteries. For 
example, IMT increased with 0.025 mm per kg/m² increase in childhood BMI, 
measured 20 years before assessment of IMT. The risk of having plaques in 
the carotid arteries increased with 60% per mmol/l increase in childhood 
total cholesterol level. Four other longitudinal studies showed that BMI, 
systolic blood pressure and low-density-lipoprotein cholesterol measured 
both in childhood and in adolescence predicted carotid IMT in adulthood.29-
32  However, the associations were not found in the Thousand Families 
cohort Study.33 In our study, we also found relations between childhood 
risk factor levels and arterial stiffness, measured by carotid-femoral pulse-
wave velocity (PWV) and carotid distensibility. Those who had higher blood 
pressure levels in childhood had stiffer arteries 20 years later, suggesting 
that blood pressure even in early childhood plays a role in the process of 
arterial stiffening. This is consistent with recent fi ndings of the Bogalusa 
Heart Study.34 Notably, we found an association between childhood systolic 
blood pressure and both PWV and distensibility in adult offspring indicating 
an increase in arterial stiffness with increasing blood pressure. Similar 
results were found in our study for BMI and common carotid distensibility as 
marker for arterial stiffness. Hyperglycaemic conditions can lead to increased 
arterial stiffness by increased collagen cross linking due to non-enzymatic 
glycation.35-37 As BMI is known to be strongly related to insulin38 this may be 
the mechanism underlying our observation of an association between BMI 
and carotid distensibility. However, no relation was found of PWV with BMI, 
measured concurrently, while unexpected inverse associations were found 
with childhood BMI. We have no explanation for the difference in fi ndings 
of BMI with carotid distensibility and PWV. A possible explanation for the 
confl icting result is that in obese persons PWV is structurally underestimated 
as a proper recording of the pulse wave at the femoral artery is more diffi cult 
in obese persons. Finally, we found a positive relation between PWV and 
total cholesterol, measured concurrently, but no signifi cant association was 
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found of PWV or carotid distensibility with total cholesterol, measured in 
childhood.
There is evidence that cardiovascular disease may partly have its origins in 
the fetal phase.39-42 Birth size has been found to be inversely associated 
with cardiovascular risk factors such as blood pressure, insulin resistance 
and obesity in adult life.43-45 Longitudinal data on the relation between birth 
size and blood lipid levels in later life are limited in the young and to some 
extent inconsistent.46-52 Within the EPOZ study, size at birth was related to 
the natural history of lipids from childhood to young adulthood. Children 
born with low birth weight or length obtained higher levels of adverse lipids 
particularly when they reached young adulthood. Associations of birth 
weight with total cholesterol changed from positive in childhood to inverse 
in young adulthood. Both in males and females, birth length was inversely 
associated with total cholesterol levels from childhood to adulthood. The 
mechanism by which birth size could be related to cholesterol levels is largely 
unknown. Intra-uterine growth retardation, particularly when occurring 
during late gestation, results in a disproportionate effect on liver growth, 
which may lead to altered lipoprotein cholesterol metabolism.50 
Another factor that infl uences one’s cardiovascular risk is alcohol 
consumption. The relation between alcohol intake and risk of CVD has been 
shown to be U-shaped, suggesting a higher risk of cardiovascular disease 
in non-drinkers and heavy alcohol consumers compared to those with 
moderate alcohol intake.53 Mechanisms proposed to explain a positive health 
effect of moderate alcohol consumption include benefi cial effects of alcohol 
consumption on lipoprotein metabolism,54 hemostasis55 and infl ammatory 
processes56 and insulin sensitivity.57 While cardiovascular protection has been 
demonstrated in middle-aged and older subjects, it is less clear whether 
benefi cial effects of alcohol intake on the cardiovascular system express well 
before the occurrence of symptomatic cardiovascular disease. We found 
that moderate intake of alcohol affected vascular elasticity at an early age, 
notably in women. In young women, an alcohol intake of 1 to 2 glasses per 
day decreased arterial stiffness, measured by the PWV by approximately 
7% compared to non-drinkers. In young men, the relation between alcohol 
and PWV was less pronounced. The mechanism by which moderate alcohol 
intake may reduce arterial stiffness is unknown. Alcohol consumption 
increases HDL-cholesterol,54 with associated increases in paraoxonase 
activity54 and cholesterol effl ux.58 These changes might decrease the amount 
of cholesterol within peripheral vascular cells and thus increase the fl exibility 
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of the vascular wall. However, the relation between alcohol intake and PWV 
remained when HDL-cholesterol was taken into account, suggesting that our 
fi nding could not be fully explained by an increase in HDL-cholesterol. With 
increasing age, the arteries become stiffer due to a decrease in elastin and 
an increase in collagen and connective tissues in the arterial wall.59 Alcohol 
intake might delay or change this process, possibly by an effect on gene 
expression. Furthermore, epidemiological studies have shown that moderate 
alcohol consumption reduces the risk of diabetes mellitus type 2 60 and 
increase insulin sensitivity.57 Therefore, alcohol consumption might decrease 
the formation and cross-linking of glycated collagen in the vascular wall, 
which is accelerated in hyperglycaemic milieu,61 and thereby increase arterial 
elasticity.
The potential role of insulin-like growth factor (IGF)-1 in cardiovascular 
pathophysiology has raised considerable interest over the past years. IGF-
1 is an essential regulator of developmental growth as IGF-1 levels are 
strongly associated with both fetal and postnatal growth.62-65 Recently, a 
polymorphism in the promoter region of IGF-1 on chromosome 12q21 has 
been identifi ed, which may infl uence IGF-1 production and body height.66-68 
Our fi ndings show a clear association between the IGF-1 gene polymorphism 
and body height growth from childhood into adulthood. Already at birth 
the carriers of the wild-type allele of this polymorphism were 0.3 cm taller 
compared to the variant carriers. Like Frayling et al.,69-71 we could neither 
confi rm the results of Vaessen et al.,72 who found that non-carriers of the 
192-bp allele had a low birth weight, nor the results of Arends et al.,73 who 
showed an association between birth size and an intronic repeat in the 
promoter region of the IGF-1 gene in a cohort of 124 short children with a 
mean age of 7 years and born small for gestational age. Our data showed 
no relation between the IGF-1 gene polymorphism and cardiovascular risk 
profi le at a young age nor between the polymorphism and parameters of 
vascular damage. 
METHODOLOGICAL CONSIDERATIONS
The EPOZ study is a population-based cohort study in healthy children. 
At baseline between 1975 and 1978, 596 children, aged 5-19 years, were 
randomly included in the study. The long annual follow-up creates on 
the one hand the advantage of using repeated measurements but on 
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the other hand causes problems concerning loss-to-follow-up while the 
correlation between the repeated measures need to be dealt with. Another 
methodological issue that will be discussed is the use of surrogate endpoints 
in the EPOZ study.
REPEATED MEASUREMENTS
Within the EPOZ study, many measurements of growth and of cardiovascular 
risk factors are repeated in each person during the 27-year follow-up period. 
These measurements have within-subject variability and measurement 
error. One of the advantages of the large number of measurements that 
was performed in each individual is the enhancement of a more accurate 
estimation of the person’s true underlying levels. Moreover, as a single 
research assistant performed the vast majority of the average of 15 
measurements per participant, measurement variation was reduced. One 
complication in the analysis of the data is that the repeated measures for 
the same subject are correlated. When this correlation is ignored and the 
responses in the same subject are treated as independent observations the 
effect estimates are usually still valid but the standard errors are usually 
incorrect (usually too small for between-subjects effects and usually too 
large for within-subject effects). Sometimes it is satisfactory to do separate 
analyses for each time point, but problems of multiple testing arise because 
many tests of the association are conducted within one person. Moreover, 
one may loose statistical power, as not all information is exhaustively used. 
Another diffi culty is the interpretation of the results: how to combine all time 
points? To overcome these problems, all measurements should be included 
in one model and the correlation between the measurements must be 
taken into account. This is possible with unbalanced repeated measurement 
analysis. We used the MIXED procedure within SAS (PROC MIXED). A 
mixed linear model is a generalization of the standard linear model, the 
generalization being that the data are permitted to exhibit correlation and 
nonconstant variability. In most repeated measurements analyses we used 
a model with intercept and age as random effects. This means that, besides 
an estimated fi xed intercept and fi xed age-effect for each subject a personal 
deviation from this mean intercept and mean age-effect is estimated. 
In summary, with the Proc Mixed model data can be used more exhaustively. 
Secondly, this model takes into account the correlation between the 
repeated measurements within each participant. Thirdly, the model is 
very fl exible as not only the means but also the variances and covariances 
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are modelled. Finally and very importantly, each subject with at least 1 
measurement can be used in the analysis.
NON-RESPONSE AND LOSS-TO-FOLLOW-UP
Selection bias can lead to either an under- or an overestimation of the 
studied relations, depending on the selection process and cannot be 
corrected for in the analysis. Non-response can cause selective losses 
leading to selection bias. The population selected for follow-up in the EPOZ 
study was a random sample from the youngsters who participated in the 
baseline study. The only selection criterion was an age between 5 and 19 
years. Theoretically, selection bias occurs only when the relation between 
the determinant and the outcome is different for those who participated 
and those who were eligible but did not participate. We do not consider 
selection bias by non-response to have occurred, as it is unlikely that the 
children or the parents based their participation in EPOZ on awareness of 
relations between early determinants and later disease. 
Another potential problem in our 27-year follow-up study is selective loss-to 
follow-up that may have biased our results in the sense that determinant-
outcome relations were different among those who pursued and those 
who terminated study participation. However, our data do not indicate such 
bias. BMI, blood pressure and total cholesterol values at previous visits were 
similar among those who were and those who were not lost to follow-up 
at a later stage. Moreover, loss-to-follow up only biases an association, for 
example between blood pressure and atherosclerosis, if particularly persons 
with high blood pressure and extensive atherosclerosis were lost. We think 
that this is unlikely, as the EPOZ cohort is a young population with a mean 
age of 37 years at the last visit. At this age, persons are usually not aware 
of the their extent of atherosclerosis, as this is usually non-symptomatic and 
seldom measured in practice. Thus, even though high risk factor levels, as 
measured during the EPOZ visits, were reported to the general practitioners 
and were known to the participants, possible loss to follow-up based solely 
on this information would not have affected our risk estimates. Finally, as the 
EPOZ study comprises a young population, not many persons are lost due to 
death or illnesses, causing selective loss-to-follow-up. 
 
SURROGATE ENDPOINTS
The mean age of the participants of the EPOZ 2002 study was 37 years. 
Therefore, we could not use clinically manifest coronary heart disease or 
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death as endpoints in our studies. Therefore, we chose surrogate endpoints 
that refl ect the risk for such clinical endpoints or end-organ damage properly 
and were positioned on the time axis in between the causal pathway.74-76 
Some main advantages of using these biomarkers are that suffi cient power 
can be attained, as they can be measured in all participants, and that the 
participants can be studied at a young age. To use a measure as surrogate 
endpoint, the measure must fi rst be valid and well reproducible. Secondly, 
the measure must be signifi cantly related to the disease of interest. A change 
in the surrogate measure should be refl ected in a change in risk of the 
disease of interest Thirdly, a biologically plausible mechanism should underlie 
the pathway between the measure and the disease of interest. We used the 
measurements of IMT of the carotid arteries, which is a validated surrogate 
marker for atherosclerosis and cardiovascular disease risk.77 Ultrasonographic 
measurement of carotid IMT correlates well with pathological measurements 
of atherosclerosis.78, 79 Prospective epidemiological studies have shown 
that an increase in IMT is associated with an increase in relative risk for 
myocardial infarction and stroke, and that a decrease in IMT due to drug 
treatment is associated with a decrease in the incidence of vascular events. 
80-84 The presence of carotid plaques is associated with cardiovascular and 
cerebrovascular disease as well, irrespective of the side and location of the 
plaques.83, 85, 86 Other measures that we used in our study were femoral-
carotid PWV as a measure of aortic stiffness and carotid distensibility. 
Aortic stiffness, measured through PWV is increased in the presence of 
a myocardial infarction with a strength of association comparable to that 
of atherosclerosis and myocardial infarction.87-89 Common carotid arterial 
distensibility is strongly associated with previous stroke and also, but less 
strongly with previous myocardial infarction.90 
CARDIOVASCULAR RISK PREDICTION IN THE YOUNG
EARLY ORIGINS OF ADULT DISEASE
Children’s health could infl uence their well being for the rest of their life. 
The public health interest in early life determinants of adult disease already 
emerged a long time ago.91 Studying adult mortality in Britain before 1920, 
Derrick had shown that each succeeding generation displayed a lower 
mortality at all ages from childhood to old age.92 He concluded that ‘each 
generation is endowed with a vitality peculiarly of its own, which persistently 
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manifests itself through the succeeding stages of its existence’. At the 
beginning of the twentieth century, the idea that early life conditions and 
experience affect adult health was an important component of the prevailing 
public health model. This idea went hand in hand with the expanding 
knowledge on nutrition in the 1930s with its emphasis on the importance 
of nutrition in childhood. One of the fi rst studies to suggest that adverse 
conditions in early life affect health in the adult was performed by Kermack 
and co-workers and includes data going back to as early as 1751.93, 94 The 
authors conclude that their data on relative adult mortality for various years 
of birth  ‘behave as if expectation of life was determined by conditions, 
which existed during the child’s earlier years’ and that maternal health 
during and around the time of pregnancy may be important in this respect. 
In 1964, Geoffrey Rose had reported that siblings of patients with coronary 
heart disease had stillbirth and infant mortality rates that were twice as high 
as those of controls.95 He concluded that ‘ischaemic heart disease tends to 
occur in individuals who come from a constitutionally weaker stock’.  During 
this period, McCance and Widdowson showed in animals that undernutrition 
before or shortly after birth profoundly and permanently modifi es the 
morphology and physiology of the body.96 McCance already in 1976 
pointed at the critical periods of growth.97 In 1973, Anders Forsdahl found 
a geographical link between past infant mortality and subsequent adult 
mortality from heart disease.98 He hypothesized that poor living conditions in 
early life, which are known to increase infant death rates, make babies that 
survive more vulnerable to heart disease. 
FETAL ORIGINS OF CARDIOVASCULAR DISEASE
In 1986, David Barker found that ischaemic heart disease was strongly 
correlated with both neonatal and postneonatal mortality and suggested 
that poor nutrition in early life increases susceptibility to the effects of an 
affl uent diet.99 Subsequently, in 1989, Barker fi rst showed that the strong 
correlation between ischaemic heart disease and past infant mortality 
originated in poor conditions in utero, rather than poor conditions in 
childhood, although the latter also contributed. He hypothesized that a 
baby’s nourishment before birth and during infancy ‘programmes’ the 
development of risk factors for CVD.100 Undernutrition of the fetus during 
critical periods of development would lead to adaptations in the structure 
and physiology of the fetal body, and these adaptations would increase 
the risk of coronary heart disease, hypertension, hypercholesterolaemia 
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and diabetes in later life. Barker’s fetal origins of adult disease hypothesis 
is supported by fi ndings from animal experiments that show that 
undernutrition during pregnancy has permanent adverse effects on 
the cardiovascular health of the offspring.101-103 Also, the effects of 
undernutrition during gestation on adult health are studied in humans, 
mostly using data from persons born during famines.104-112 One of the 
outcomes considered in Barker’s hypothesis is blood pressure. There 
are a number of possible mechanisms by which restricted intrauterine 
growth could either initiate or amplify raised blood pressure and lead 
to cardiovascular disease.113 First, there is evidence that the fetal renin-
angiotensin system is activated in intrauterine growth retardation.114 Fetal 
hypoxaemia stimulates the release of renin and the subsequent generation of 
angiotensin II induces vasoconstriction. Secondly, Brenner hypothesized that 
retarded fetal growth leads to reduced numbers of nephrons, which in turn 
leads to increased pressure in the glomerular capillaries and the development 
of glomerular sclerosis.115, 116 It has been empirically shown that the number 
of nephrons is reduced in hypertensives.117 Thirdly, fetal undernutrition could 
lead to lifelong changes in the fetal hypothalamic-pituitary-adrenal axis, 
which in turn resets homeostatic mechanisms controlling blood pressure. 
Treatment of pregnant rats with low dose dexamethasone led to persistently 
raised blood pressure in the offspring.118 Finally, fetal undernutrition may lead 
to a higher risk for childhood excess weight gain, which in turn may induce 
hypertension as weight is among the most important determinants of blood 
pressure.
In the past decade, this fetal origins of adult disease hypothesis has been 
subject to heated debate in the literature.119-128 An alternative explanation of 
the association of low birth weight with diabetes and vascular disease is the 
fetal insulin hypothesis.129 Hattersley and Tooke proposed that genetically 
determined insulin resistance results in impaired insulin-mediated growth in 
the fetus as well as insulin resistance in adult life. Low birth weight, measures 
of insulin resistance in life, and ultimately glucose intolerance, diabetes, and 
hypertension could all be phenotypes of the same insulin-resistant genotype. 
Concerning Barker’s hypothesis, the critics point at problems of selection 
bias and confounding by socio-economic status. Furthermore, within and 
across studies exploring the fetal origins of adult disease hypothesis, a 
range of different obstetric and perinatal measures as marker for intra-
uterine growth have been used as explanatory variables and this may have 
led to inconsistencies. Another issue comprises the rationale of additional 
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adjustment for attained body size in the analysis between birth weight and 
cardiovascular endpoints. On the one hand, adjustment for adult body size 
can distort the results since one assigns a higher rate of growth to smaller 
infants and a slower rate of growth to larger infants. On the other hand, 
at any point in time, body size is correlated with both earlier and later size. 
Therefore, even when birth size is correlated directly with CVD endpoints, 
the postnatal growth must be taken into account by adjusting for adult body 
size. If this adjustment attenuates the effect of early size, later size is likely 
to be more relevant than early size in the aetiology of CVD. Amplifi cation 
of the effect due to adjustment for adult body size indicates a dominant 
impact of catch-up growth on future CVD in the infants with lower birth 
weight. Finally, some facts remain confl icting with the fetal origins of adult 
disease hypothesis. CVD-mortality is higher in northern Europe than in 
southern Europe130 despite higher birth weights up north. But then again, 
adults also grow taller in the northern countries compared to the south.  
The independent contribution to the high CVD-mortality of restricted fetal 
growth has been shown to be very small. Also, a 1-kg difference in birth 
weight is huge and not achievable as public health target.
In this thesis, we examined the relation between birth size and blood lipids. 
Our data support the view that differences in levels of lipids may have their 
origins in early life. Low birth weight and low birth length were related to 
higher blood lipid levels of children and adolescents particularly when they 
reached young adulthood. Differences amounted to almost 0.5 mmol/l per 
kilogram difference in birth weight for LDL-cholesterol in adulthood and are 
as such important. These differences are graded and particularly pertain to 
children born at term. Further, as the relations between birth size and lipids 
in this study were obtained without any adjustment, unlike relations with 
blood pressure in these age groups,131 these fi ndings may have implications 
from a public health point of view.
THE OBESITY EPIDEMIC
The recent increase in the global prevalence of obesity qualifi es as an 
epidemic.5, 132 An increasing number of deaths worldwide is due to medical 
complications of obesity.133 Moreover, obesity claims 1.6% of the total 
costs in health care in the Netherlands annually and even 9.8% of the total 
health budget in the United States, amounting to 99 billion dollar.134 The 
obesity epidemic is recognized by the World Health Organisation (WHO) 
as one of the top 10 global health problems. According to the WHO it is 
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essential to develop new preventive public health strategies which affect 
the entire society and not only children and adults who have a high BMI.135 
It has been proposed that early life prevention is the only effective solution 
to the problem of adult obesity.136 Children are a vulnerable population, 
because they may not be prepared to make informed health-related choices 
on their own. Childhood obesity seems to be increasing at a disturbing rate 
and thereby obese children tend to become obese adults. Of children who 
were overweight at around 12 years of age some 80% were still obese at 
around 30 years.137 The results of the EPOZ study about familial clustering 
of body weight and its impact on the cardiovascular risk profi le underline 
the importance of parents in solving the problem. Having both parents in 
the highest tertile of BMI was associated with an average 3 kg/m² higher 
BMI in comparison with having both parents in the lowest tertile. Moreover, 
children with paternal BMI in the highest tertile had a signifi cantly higher 
IMT compared to offspring of fathers with a BMI in the lowest tertile 
(chapter 3.2). The impact of parental BMI was present over the whole 
range of parental BMI levels, meaning the lower the parental BMI the lower 
the child’s BMI. Unfortunately, we could not discriminate between effects 
of environment and biology in our study as we lack information on main 
environmental determinants of obesity, physical activity and nutrition. The 
rise in overweight, also in children, occurred very rapidly over the last 3 
decades. This suggests strong environmental determinants of childhood 
obesity, which may well explain our fi nding of familial aggregation. We must 
inspire parents to make behavioural changes that are suffi cient to resist the 
pressures of current environmental factors towards excessive weight gain 
of their offspring. Parents’ attention should be drawn to this huge medical 
problem and to their responsibility regarding the future health of their 
children. Apart from the impact of parents, demonstrated with our data, also 
other parts of the society should be more willing to carefully manage the 
food and physical activity environments of our children at home, in school, 
and in other places frequented by children.
STARTING EARLIER TO PREVENT HEART DISEASE
Research investigating the early origins of adult cardiovascular disease 
provides new insight into the aetiology of cardiovascular disease and the 
early phases of life may be an interesting starting-point in the prevention 
of cardiovascular disease. The EPOZ study stressed the importance of risk 
assessment in younger individuals by showing (1) evident relations between 
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childhood levels of cardiovascular risk factors blood pressure, body mass 
index and total cholesterol and vascular damage in adulthood, (2) evident 
relation between childhood lifestyle and vascular damage in adulthood and 
(3) the important parental impact in developing overweight and vascular 
damage. The importance of the study of cardiovascular risk assessment in 
the young has been underlined by several other observations as well. First, a 
considerable number of school-age children have risk factors which in adults 
are predictive of coronary heart disease.138 Thereby, clustering of risk factor 
variables occurs as early as childhood and adolescence and is associated with 
atherosclerosis in young adulthood and thus risk of later CVD.139, 140 Secondly, 
the process of atherosclerosis may start at a very early age4 and there is 
evidence that the relation between arterial wall changes and cardiovascular 
risk factors already exist in children and adolescents.140, 141 For example, the 
Bogalusa Heart Study showed that as the number of cardiovascular risk 
factors increased in young people, so does the severity of asymptomatic 
coronary and aortic atherosclerosis.140 Thirdly, longitudinal studies of children 
followed into adulthood showed that adverse life style, for example physical 
inactivity due to television watching, and cardiovascular risk factors tend 
to track throughout life.32, 142-151 In older children and adolescents, habitual 
tobacco use has been shown to contribute to raised blood pressure and 
the development of other risk factors in early life, most of which track into 
adulthood.152
Thus, the existing evidence indicates that in order to stop the atherosclerotic 
process one may have to start intervening early in life but the key questions 
are how early and in whom? The feasibility of the proposed guidelines 
as described in the American Heart Association Guidelines for primary 
prevention of atherosclerotic cardiovascular disease beginning in childhood153 
is questionable. In this report, Kavey et al. recommend that from the age 
of 3 years, blood pressure should be measured at each doctor’s visit, for 
whatever reason the child’s examined. Like growth, blood pressure should 
be entered on a chart for age/sex/height. Furthermore, targeted screening 
of fasting lipids is recommended in children >2 years of age with a family 
history of dyslipidemia or premature CVD. For children in whom the family 
history is unknown and other risk factors are present, lipids and lipoproteins 
should be assessed. If averaged results of 3 fasting lipid profi les are above 
cut points, fi rst additional therapeutic lifestyle changes should be initiated 
including diet. However, these guidelines are not yet evidence based. 
When starting pharmacological treatment in young children according 
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to the proposed guidelines, it is particularly relevant to know what is the 
potentially longstanding preventive effect of several intervention strategies. 
Also, issues of medicalization of children, the cost-effectiveness of shifting 
the clinical implementation towards the young age group, and the possible 
stigmatization should be considered. To know whether treatment or a 
preventive measure succeeds in improving the cardiovascular risk profi le and 
delaying the development of vascular damage, a randomized controlled trial 
that prospectively evaluates the amount of atherosclerosis at different time-
points is needed. The effects of intervention strategies could be monitored 
using new promising tools as surrogate endpoints. The newest generation 
multidetector CT (MDCT) has the ability to non-invasively quantify the 
amount of coronary-, carotid- and aortic calcifi cation very accurately as well 
as plaque composition.154, 155 A major drawback using MDCT in the young is 
radiation. MRI is another promising tool for measuring atherosclerotic plaque 
composition in extracoronary arteries.156 In view of primary prevention, MRI 
has the big advantage of absence of radiation. 
These considerations will put medical treatment of blood pressure and 
cholesterol or even dietary advises on a longer track. An exception should be 
made here for obesity. As far as overweight is concerned, primary prevention 
is non-pharmacological, involving mainly lifestyle changes both in parents 
and children. Moreover, as discussed in the previous paragraph, obesity 
is a highly frequent, increasing and therefore urgent problem. Therefore, 
considering the current obesity epidemic, action to overcome the problem 
of overweight must and could start early in life. In the previous paragraph, 
different strategies to attack the obesity epidemic are discussed.
Summarizing, our results emphasized the importance of childhood factors 
and parental infl uence on developing overweight and vascular damage in 
adulthood. The proper strategy for tackling the obesity epidemic and the 
worldwide number-one killer, CVD, should probably target children and 
young adults. The time for serious considerations about primary prevention 
beginning in childhood has come, although the consequences in clinical 
practice can only be realized when early treatment and prevention have 
proven effective and when the issues of costs, medicalization, stigmatisation 
have been considered. 
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Summary
Despite recent advances in treatment, leading to a considerable reduction 
in cardiovascular mortality, cardiovascular morbidity is still a huge health 
problem in the industrialized countries and rapidly increasing in the rest 
of the world. Aging of the population and improved survival after non-
fatal cardiovascular disease (CVD) events bear heavily on medical costs. 
For stopping the cardiovascular epidemic it is essential to improve primary 
prevention of CVD in order to delay the development of atherosclerosis 
and hence the incidence of CVD. Already in the seventies, much attention 
was paid to risk-indicators of CVD. The Framingham Heart Study showed 
strong associations of blood pressure, levels of total cholesterol and smoking 
cigarettes with the occurrence of CVD. Overweight appears to infl uence the 
cardiovascular risk profi le already at young ages. This thesis aims at exploring 
the early determinants of overweight and cardiovascular disease risk. Most 
studies presented in this thesis are based on data from the Epidemiological 
Preventive Study of Zoetermeer (EPOZ study), a prospective population-
based cohort study in the Netherlands that was started in 1975 among 5 to 
19 years old children. CHAPTER 2 describes the rationale and the design of 
this longitudinal study.
CHAPTER 3 focuses on the impact of parents’ risk factor status on the 
cardiovascular risk in the offspring. Prospective studies have shown that 
cardiovascular disease aggregates in families. This is probably partly due to 
familial aggregation of cardiovascular risk factors such as blood pressure 
and plasma cholesterol, which was shown to be detectable in children at 
a very young age. In longitudinal studies, children with a family history 
of hypertension were shown to have persistently higher blood pressure 
levels than children without such a history over follow-up periods of up 
to 10 years. Still the usefulness of recording a positive family history in the 
prediction of hypertension in the individual is considered to be limited. It 
is of particular interest to know whether parental blood pressure levels 
are predictors of their offspring’s subsequent blood pressure development 
into young adulthood and whether this holds for the whole distribution 
of parental blood pressure. In our 27-year follow-up study, actual parental 
blood pressure showed to be an important predictor of blood pressure 
development from childhood into young adulthood (CHAPTER 3.1). Our 
fi ndings add to the current knowledge in several ways. The impact of 
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parental blood pressure was present over the whole distribution of parental 
blood pressure levels, meaning the lower the parental blood pressure the 
lower the blood pressure levels of the offspring. Furthermore, our data 
suggest that the impact of parental blood pressure starts at an early age and 
is strong and long lasting.
Already at young ages, family dynamics also play an important role in 
the development of obesity. Contrary to earlier studies, we used actual 
measurements of parental body mass index (BMI) and repeatedly measured 
BMI in offspring from childhood into adulthood. We showed that the impact 
of parental BMI was present over the whole range of parental BMI levels, 
meaning the lower the parental BMI the lower the child’s BMI (CHAPTER 
3.2). Furthermore, our data suggest that the impact of parental BMI starts at 
an early age, is strong and long lasting and is also associated with increased 
cardiovascular risk. Our results showed that parental and children’s BMI do 
not only affect the current health status but are also predictors of future 
vascular damage and thereby the risk of manifest cardiovascular disease 
in later life. These results underline the importance of early prevention of 
excessive weight gain and the necessity of involving the parents in fi ghting 
the obesity epidemic.
Thus, parental risk status is important for one’s cardiovascular risk profi le. 
In CHAPTER 4, the associations between several childhood risk factors and 
vascular damage at young adulthood are presented. When knowing more 
about the predictability of early levels of cardiovascular risk factors, such as 
BMI, systolic blood pressure and total cholesterol, for atherosclerosis and 
arterial stiffness in young adulthood, identifi cation of those at highest risk 
would be possible at a younger age. And early detection can lead to early 
treatment. We found that BMI, systolic blood pressure and total cholesterol 
measured during childhood were strongly related to both carotid intima-
media thickness (IMT) and presence of plaques in the carotid arteries 
(CHAPTER 4.1). For example, IMT increased with 0.025 mm per 1 kg/m² 
increase in BMI during childhood, 20 years before assessment of IMT. The 
risk of having plaques in the carotid arteries increased with 60% per 1 
mmol/l increase in total cholesterol level measured in childhood. Notably, 
we found an association between childhood systolic blood pressure and 
both pulse wave velocity (PWV) and carotid distensibility in adult offspring 
indicating an increase in arterial stiffness with increasing blood pressure. 
No relation was found between childhood total cholesterol and vascular 
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stiffness.
The relation between alcohol intake and the occurrence of CVD has found 
to be U-shaped, suggesting a higher risk of CVD in non-drinkers and 
heavy alcohol consumers compared to those with moderate alcohol intake. 
Mechanisms proposed to explain a positive health effect of moderate 
alcohol consumption include benefi cial effects of alcohol on lipoprotein 
metabolism, hemostasis and infl ammatory processes and insulin sensitivity. 
While cardiovascular protection has been demonstrated in middle-aged and 
older subjects, it is less clear whether benefi cial effects of alcohol intake on 
the cardiovascular system express well before the occurrence of symptomatic 
cardiovascular disease. We found that moderate intake of alcohol affected 
vascular elasticity at an early age, notably in women (CHAPTER 4.2). In 
young women, an alcohol intake of 1 to 2 glasses per day decreased the 
PWV by approximately 7% compared to non-drinkers. In young men, the 
relation between alcohol and vascular elasticity was less pronounced. 
There is evidence that cardiovascular disease has its origins in the fetal phase 
and early childhood. Birth size has been found to be inversely associated 
with cardiovascular risk factors such as blood pressure, insulin resistance and 
obesity in adult life. Longitudinal data on the relation between birth size and 
blood lipid levels in later life are limited in the young and to some extent 
inconsistent. Within our 27-year follow-up study, size at birth was related to 
the natural history of lipids from childhood to young adulthood (CHAPTER 
5.1). Children born with low birth weight or length obtain higher lipid levels 
particularly when they reach young adulthood. Associations of birth weight 
with total cholesterol changed from positive in childhood to inverse at young 
adulthood. Both in males and females, birth length was inversely associated 
with cholesterol levels from childhood to adulthood. These fi ndings were 
consistent with results of analyses of birth size in relation to individual 
change of lipids over time. The mechanism by which birth size could be 
related to cholesterol levels is largely unknown. Possibly, intra-uterine 
growth retardation, particularly when occurring during late gestation, results 
in a disproportionate effect on liver growth, which may lead to altered 
lipoprotein cholesterol metabolism. 
Next to intra-uterine growth, also genes could play a role in the early 
origins of CVD. The potential role of insulin-like growth factor (IGF)-1 in 
cardiovascular pathophysiology has raised considerable interest over the past 
years. IGF-1 is an essential regulator of developmental growth as IGF-1 levels 
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are strongly associated with both fetal and postnatal growth. Recently, a 
polymorphism in the promoter region of IGF-1 on chromosome 12q21 has 
been identifi ed, which may infl uence IGF-1 production and body height. 
The fetal insulin hypothesis by Hattersley suggests that genes involved in 
insulin resistance cause low birth size, type 2 diabetes mellitus and in later 
life CVD through adverse vascular development and body-fat distribution. 
This hypothesis provides an alternative explanation of the association 
of low birth weight with vascular disease as proposed by Barker’s fetal 
programming hypothesis. Our fi ndings show a clear association between the 
IGF-1 polymorphism and body height growth from childhood into adulthood 
(CHAPTER 5.2). Already at birth, carriers of this polymorphism were 0.3 cm 
taller compared to the variant carriers. Like Frayling et al., we could confi rm 
neither the results of Vaessen et al., who found that non-carriers of the 
192-bp allele had a low birth weight, nor the results of Arends et al., who 
showed an association between birth size and an intronic repeat in the 
promoter region of the IGF-1 gene in a cohort of 124 short children with a 
mean age of 7 years and born small for gestational age. Our data showed 
no relation between the IGF-1 gene polymorphism and cardiovascular risk 
profi le at a young age nor between the polymorphism and parameters of 
vascular damage.
In the general discussion in CHAPTER 6, the main fi ndings of this thesis 
are considered in the context of current scientifi c knowledge and ongoing 
research in the fi eld of early origins of adult disease. In addition, relevant 
methodological aspects are discussed together with implications for public 
health and future research.
CHAPTER 7
182
 Samenvatting
Ondanks verbeterde behandelmethoden van hart- en vaatziekten, die 
de laatste jaren geleid hebben tot een daling van de cardiovasculaire 
mortaliteit, blijven hart- en vaatziekten het grootste gezondheidsprobleem 
in de geïndustrialiseerde landen. Daarnaast is er in de rest van de wereld 
een alarmerende toename van hart- en vaatziekten. De vergrijzing van de 
bevolking en de verbeterde overleving na hart- en vaatziekten eisen een 
groot deel van de totale medische kosten op. Het is daarom essentieel 
primaire preventie van hart- en vaatziekten te verbeteren waardoor de 
ontwikkeling van atherosclerose wordt vertraagd en daarmee de incidentie 
van hart- en vaatziekten. Al in de jaren zeventig is veel aandacht besteed 
aan de risicofactoren voor hart- en vaatziekten. De Framingham Heart 
Study liet sterke associaties zien tussen bloeddruk, cholesterol, het roken 
van sigaretten en het voorkomen van hart- en vaatziekten. Overgewicht 
lijkt het cardiovasculaire risicoprofi el al op jonge leeftijd te beïnvloeden. 
Dit proefschrift heeft als doel de vroege voorspellers van overgewicht 
en risico op hart- en vaatziekten te onderzoeken. Veel van de studies die 
in dit proefschrift beschreven zijn, zijn gebaseerd op gegevens van het 
Epidemiologisch Preventief Onderzoek Zoetermeer (EPOZ), een prospectieve 
vervolgstudie in Nederland die in 1975 van start is gegaan in een groep van 5 
tot 19 jaar oude kinderen. HOOFDSTUK 2 beschrijft de achtergronden en het 
ontwerp van deze longitudinale studie.
HOOFDSTUK 3 richt zich op de invloed van de ouders op het cardiovasculaire 
risico van hun kinderen. Prospectieve studies hebben laten zien dat hart- 
en vaatziekten clusteren in families. Dit komt waarschijnlijk door clustering 
van cardiovasculaire risicofactoren als bloeddruk en cholesterol, zoals 
al op heel jonge leeftijd bij kinderen is aangetoond. Kinderen met een 
familiegeschiedenis van hoge bloeddruk hadden een bij herhaling hogere 
bloeddruk dan kinderen zonder zo’n familiegeschiedenis, zoals bleek uit 
een aantal longitudinale studies met een follow-up oplopend tot 10 jaar. 
Voor het voorspellen van de kans op hoge bloeddruk bij een individu blijft 
de familiegeschiedenis van beperkte waarde. Het is met name interessant te 
weten of ouderlijke bloeddrukwaarden de ontwikkeling van de bloeddruk 
bij hun kinderen voorspellen en of dit geldt voor de hele verdeling van 
ouderlijke bloeddruk, van hoog tot laag. In onze 27-jarige vervolgstudie 
hebben we laten zien dat ouderlijke bloeddruk een belangrijke voorspeller is 
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van de bloeddruk ontwikkeling vanaf de kindertijd tot in jong volwassenheid 
(HOOFDSTUK 3.1). Wat is nieuw aan onze bevindingen?  De invloed van 
ouderlijke bloeddruk was aanwezig over de hele verdeling van bloeddruk. 
Dit betekent dat hoe lager de ouderlijke bloeddruk hoe lager de bloeddruk 
bij hun kinderen. Daarnaast lieten onze data zien dat de invloed van 
ouderlijke bloeddruk sterk is, al op jonge leeftijd begint en voortduurt tot in 
volwassenheid. 
Al op jonge leeftijd, speelt de familie ook een belangrijke rol bij de 
ontwikkeling van obesitas. In tegenstelling tot eerdere studies, hebben wij 
metingen van ouderlijke body mass index (BMI) gebruikt en BMI metingen 
van de kinderen vanaf de kindertijd tot in volwassenheid. We hebben 
laten zien dat de invloed van de ouderlijke BMI aanwezig was over de hele 
verdeling van ouderlijke BMI: hoe lager de ouderlijke BMI, hoe lager de 
BMI van het kind (HOOFDSTUK 3.2). Daarnaast blijkt de sterke invloed van 
ouderlijke BMI al vanaf jonge leeftijd aanwezig te zijn en voort te duren tot in 
volwassenheid. Ook is de ouderlijke BMI geassocieerd met een toegenomen 
risico op hart- en vaatziekten. De BMI van zowel de ouders als de kinderen 
beïnvloeden niet alleen de huidige gezondheidsstatus maar zijn ook 
voorspellers voor toekomstige vaatschade en daarmee voor het optreden van 
hart- en vaatziekten. Deze resultaten onderstrepen het belang van vroege 
preventie van excessieve gewichtstoename en de noodzaak de ouders hierin 
te betrekken teneinde de obesitas epidemie te bestrijden. 
Het risicoprofi el van ouders blijkt dus belangrijk voor het cardiovasculaire 
risicoprofi el van hun kinderen. In HOOFDSTUK 4 worden de associaties tussen 
verschillende risicofactoren gemeten in de kindertijd en vasculaire schade, 
gemeten in jong volwassenheid, gepresenteerd. Vroege identifi catie van 
personen met een hoog risico op hart- en vaatziekten is alleen mogelijk 
wanneer meer bekend is over de mate waarin cardiovasculaire risicofactoren, 
die al op jonge leeftijd gemeten zijn, atherosclerose en vaatwandstijfheid 
bepalen. Vroege detectie kan leiden tot vroege behandeling. In onze studie 
bleken BMI, systolische bloeddruk en totaal cholesterol, gemeten tijdens 
de kindertijd, sterk gerelateerd te zijn aan zowel intima-media dikte van de 
halsslagaders als aanwezigheid van plaques in de halsslagaders (HOOFDSTUK 
4.1). Bijvoorbeeld, de intima-media dikte nam toe met 0.025 mm per 1 kg/m² 
toename van de BMI, gemeten tijdens de kindertijd. De kans op plaques in de 
halsslagaderen nam toe met 60% per 1 mmol/l toename in totaal cholesterol 
gemeten in de kindertijd. Een duidelijke relatie vonden we ook tussen 
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systolische bloeddruk op de kinderleeftijd en zowel de polsgolfsnelheid 
(PWV) als de distensibiliteit van de halsslagaderen op de volwassen leeftijd: 
de vaatwandstijfheid neemt toe met toename van bloeddruk. Geen relatie is 
gevonden tussen totaal cholesterol en vasculaire stijfheid.
De relatie tussen alcoholinname en het optreden van hart-en vaatziekten 
is U-vormig. Dit betekent dat er een hoger risico op hart- en vaatziekten 
bestaat bij geheelonthouders en zware alcoholgebruikers vergeleken met 
hen die matig alcohol gebruiken. Een aantal mechanismen is geopperd 
om het gunstige effect van matig alcoholgebruik te verklaren, te weten 
gunstige effecten van alcohol op het lipoproteine metabolisme, hemostasis 
en ontstekingsprocessen en insuline gevoeligheid. Aangezien cardiovasculaire 
bescherming aangetoond is bij mensen van middelbare- en bejaarde leeftijd, 
is het minder duidelijk of de gunstige effecten van alcoholgebruik op het 
cardiovasculaire systeem al ver voor het optreden van symptomatische 
hart- en vaatziekten zichtbaar zijn. Onze studies lieten zien dat matig 
alcoholgebruik al een gunstig effect had op de vaatwandelasticiteit op jonge 
leeftijd, met name in vrouwen (HOOFDSTUK 4.2). Jonge vrouwen die per 
week 1-2 glazen alcohol nuttigden, hadden een ongeveer 7% lagere PWV 
vergeleken met geheelonthoudende vrouwen. De relatie tussen alcohol en 
vaatwandelasticiteit was minder duidelijk bij jonge mannen.
Er zijn aanwijzingen dat hart- en vaatziekten hun oorsprong hebben tijdens 
de foetale fase en vroege kindertijd. Eerdere studies lieten een inverse 
relatie zien tussen geboortegewicht en geboortelengte en cardiovasculaire 
risicofactoren, zoals bloeddruk, insuline resistentie en obesitas in het 
volwassen leven. Longitudinale data met betrekking tot de relatie tussen 
geboortegewicht/-lengte en lipidenconcentraties in het bloed op latere 
leeftijd zijn beperkt en ook inconsistent. Binnen onze 27-jarige vervolgstudie 
was geboortegewicht/-lengte gerelateerd aan de cholesterolwaarden vanaf 
de kindertijd tot in jong volwassenheid (HOOFDSTUK 5.1). Kinderen die 
geboren worden met een laag geboortegewicht of klein zijn bij de geboorte 
hebben hogere cholesterolwaarden, met name wanneer ze volwassen zijn. 
De associaties tussen geboortegewicht en totaal cholesterol veranderden van 
positief tijdens de kindertijd naar invers tijdens jong volwassenheid. Zowel 
bij mannen als bij vrouwen was geboortelengte invers geassocieerd met 
cholesterolwaarden van de kindertijd tot in volwassenheid. Het mechanisme 
die deze relatie tussen geboorteproporties en cholesterol zou kunnen 
verklaren is onbekend. Mogelijk resulteert intra-uteriene groeivertraging, 
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met name wanneer deze optreedt tijdens het laatste trimester van de 
zwangerschap, in een disproportioneel effect op de groei van de lever, 
waardoor een veranderd cholesterol metabolisme ontstaat. 
Naast intra-uteriene groei, zouden ook de genen een rol kunnen spelen bij de 
vroege oorsprong van hart- en vaatziekten. De laatste jaren is er toenemende 
interesse voor een potentiële rol van de insuline-achtige groeifactor-1 (IGF-1) 
in de cardiovasculaire pathosfysiologie. IGF-1 is een essentiële regulator van 
ontwikkelingsgroei aangezien IGF-1 concentraties sterk geassocieerd zijn met 
zowel foetale als postnatale groei. Recent is een polymorfi sme in de promotor 
regio van IGF-1 op chromosoom 12q21 geïdentifi ceerd, welke mogelijk de 
IGF-1 productie en lichaamslengte beïnvloedt. De foetale insuline hypothese 
van Hattersley suggereert dat genen die betrokken zijn bij insuline resistentie 
een laag geboortegewicht, type 2 diabetes mellitus en op latere leeftijd 
hart- en vaatziekten veroorzaken door ongunstige vasculaire ontwikkeling 
en lichaamsvetdistributie. Deze hypothese verschaft een alternatieve 
verklaring voor de associatie tussen laag geboortegewicht en vasculaire 
ziekte zoals voorgesteld door Barker’s foetale programmeringshypothese. 
Onze bevindingen laten een duidelijke associatie zien tussen het IGF-1 
polymorfi sme en lichaamslengte van de kindertijd naar volwassenheid 
(HOOFDSTUK 5.2). Al bij de geboorte waren de dragers van dit polymorfi sme 
0.3 cm groter vergeleken met de variabele dragers. Zoals Frayling et al., 
konden we noch de gegevens van Vaessen bevestigen, die vond dat de 
niet dragers van het 192-bp allel een lager geboortegewicht hebben, 
noch de gegevens van Arends et al., die een associatie aantoonde tussen 
geboortegewicht en een intron repeat in de promotor regio van het IGF-1 
gen in een cohort  van 124 kinderen van gemiddeld 7 jaar die bij geboorte te 
klein waren voor de zwangerschapsduur. Onze data lieten geen relatie zien 
tussen het IGF-1 gen polymorfi sme en het cardiovasculaire risicoprofi el op 
jonge leeftijd en ook geen relatie tussen het polymorfi sme en parameters van 
vasculaire schade.
In de algemene discussie in HOOFDSTUK 6 worden de belangrijkste 
bevindingen van dit proefschrift geplaatst in een breder kader van huidige 
wetenschappelijke kennis en lopend onderzoek naar de vroege oorsprong 
van volwassen ziekte. Daarnaast worden relevante methodologische aspecten 
van de studie besproken en ook de gevolgen voor de maatschappelijke 
gezondheidszorg en voor toekomstig onderzoek.
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Dankwoord
Een follow-up studie van 27 jaar kan je niet in je eentje doen. Allereerst 
bedank ik alle enthousiaste EPOZ deelnemers voor hun trouwe komst al de 
jaren naar het onderzoekscentrum in Zoetermeer.
Daarnaast wil ik 2 van de initiatoren van dit fantastische EPOZ onderzoek 
bedanken voor hun moed in de jaren zeventig, om voor het eerst in 
Nederland zo’n langlopend en groot project op te zetten: Prof.dr. H.A. 
Valkenburg en prof.dr. A. Hofman. Beste Bert, ik wil je tevens bedanken 
voor de mogelijkheid die je me hebt gegeven data van dit EPOZ onderzoek 
te gebruiken en daarnaast klinisch epidemiologische kennis over te brengen 
naar de kindergeneeskunde.
De EPOZ data heb ik kunnen verzamelen dankzij een fantastisch EPOZ team: 
Pauli van Eldik, Inge Haumersen, Joke Jansen en Toos Stehmann. Bedankt 
voor jullie geweldige inzet, zowel in Rotterdam Ommoord als in Zoetermeer 
Schoutenhoek! Tijdens mijn verlof heeft Ingrid van Vuuren de administratie 
perfect op orde gehouden, dankjewel! Anneke Korving wil ik bedanken voor 
haar gastvrijheid en prettige gezelschap op het ERGO centrum.
Toos Stehmann vormde de spil voor deze EPOZ ronde. Lieve Toos, zonder 
jou was dit allemaal niet gelukt. Het was een voorrecht jou aan mijn zijde te 
hebben gehad de afgelopen jaren. Bedankt voor je fi jne hulp op alle fronten, 
je luisterende oor en je vriendschap. Ik zal je missen in de kliniek!
Beste Jacqueline, de klus is geklaard met name dankzij jou. De eerste fase 
was de dataverzameling, waarbij je heel gericht oplossingen bedacht voor 
de problemen en altijd optimistisch bleef. Bij de tweede fase, het analyseren 
van de data en het schrijven, waardeerde ik je snelle inzicht in alle materie, 
je weloverwogen kritiek en je gestructureerdheid bij het schrijven. Bedankt 
voor het vertrouwen dat je in me hebt gehad en gehouden al deze jaren, ik 
heb ontzettend veel van je geleerd.
Beste Cuno, met veel plezier reed ik altijd naar Utrecht voor overleg met 
jou. Jouw mede-enthousiasme voor EPOZ werkte altijd heel opbouwend. 
Bedankt voor al je goede ideeën waarmee je me altijd scherp hield, de 
leerzame, constructieve discussies en je heldere blik. ‘Hypothesis testing’ 
blijft het leukste dat er is!
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Ook Michiel Bots wil ik hier noemen vanwege de zeer prettige 
samenwerking: ‘Het is allemaal leuk, leuk, leuk!’ 
Dankzij Ben Semmekrot en Henri Marres ontdekte ik hoe leuk het is om 
onderzoek te doen. Zoals jullie zien hebben de Pierre Robin’s heel wat 
aangewakkerd, bedankt voor jullie wetenschappelijke enthousiasme.
Voor alle laboratoriumbepalingen en vragen kon ik terecht bij Jeannette 
Vergeer en Ruud Oskamp. Dick Slof stond altijd klaar voor vervoer van het 
echo-apparaat en stikstofvat naar Zoetermeer, bedankt voor jullie geweldige 
hulp!
Zonder Marcel Vonk en Nano Suwarno was het computertechnisch gezien 
een zootje geworden. Dataset toevoegingen en veranderingen werden zeer 
precies gedaan door Frank van Rooij. De invoerschermen voor alle EPOZ data 
werden gemaakt door René Vermeeren. Allen hartelijk dank voor jullie hulp!
Altijd kon ik binnenlopen bij het secretariaat, Petra, Marti en Marjolijn, 
voor een vraag. Speciaal wil ik jou, Petra, bedanken voor je hulp en je 
gezelligheid. Geweldig hoe jij het reilen en zeilen van de HVZ groep 
ondersteunt!
Maria, fantastisch zo’n lange follow-up van EPOZ maar met zoveel metingen 
per individu wordt het er statistisch gezien niet gemakkelijker op. Gelukkig 
kon ik altijd terugvallen op jou! Bedankt voor je deskundige SAS hulp en de 
plezierige samenwerking. Daarnaast stond ook bij Bettina, Lidia en Maarten 
de deur altijd open, wat ik altijd zeer gewaardeerd heb.
Aafje, na jouw prachtige proefschrift ben ik aan de beurt. Tijdens een pauze 
van een n i h e s cursus, raakten we aan de praat over ‘onze’ studies en ook 
al bleek het poolen van de data uiteindelijk moeilijker dan we dachten, het 
was erg leuk om dit samen met je te doen!
Arlette, bedankt voor je heerlijke directheid, je humor en je gezelschap 
onderweg. Nog een keer eten in Le:en (Utrecht blijft toch leuker….)?
Annemarieke, bedankt voor je gezelligheid, voor al je hulp bij de CRP 
bepalingen, voor je nuchtere meedenken met de papers en het doorlezen 
van het manuscript. Succes in het Zuider!
Beter een goede buuv dan een verre vriend! Gysèle, de laatste maanden was 
het erg stil achter de muur zonder jouw gelach….. Mariëtte, gelukkig was 
jij er de laatste maanden nog wel om even een appeltje ‘te doen’. Succes in 
Delft! Sabine, je wijze visie op werk en gezin heb ik altijd zeer gewaardeerd. 
Veel succes met de laatste loodjes, het gaat je zeker lukken!
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Vincent, met z’n tweetjes begonnen op een ‘kindercohort’, naast het grote 
ERGO was dat niet altijd makkelijk! Maar gelukkig kan ik met jou uitgebreid 
over Barker discussieren en delen we bovendien het enthousiasme voor de 
kindergeneeskunde.
Loes, tegelijkertijd moeder worden en promoveren, dat schept een 
bijzondere band. Het relaxen kan beginnen, alhoewel….. 
Sacha, ‘Dikkie Dik’, erg leuk dat we naaste collega’s geworden zijn! We 
houden het (natte) lunchen erin!
Anna, Bas, Cornelis, Dominiek, Ewoud, Fakhredin, Francesco, Ingrid, Isabella, 
Jan, Kamran, Karen, Kristel, Lonneke, Majanka, Marie Josee, Marieke, 
Marjolein, Mark, Monica, Niels, Rogier, Sarah, Sharmila, Simone, Stephanie, 
Tom en Ylian: even een praatje tussen alle analyses en schrijverij door werkte 
erg ontspannend. Succes met jullie carrières en wellicht tot ziens in de 
kliniek.
Met een gerust hart kan ik Jens en Ties altijd achterlaten bij jou, Chantal, 
ook nu weer tijdens de verdediging van mijn proefschrift. Geweldig dat je 
altijd voor ons klaarstaat!
Trots ben ik op mijn Brabantse roots, familie van den Elzen en familie 
Leenders! Heel speciaal voor mij blijven ome Jan, tante Mia, die dit helaas 
niet meer kan meemaken, tante Annie en ome Piet.
Zonder vrienden zou het leven naast het werk erg saai zijn. Een aantal wil ik 
in het bijzonder noemen. 
In Woerden voel ik me intussen thuis dankzij 3 geweldige meiden: 
Yvonne (heerlijk dat je om de hoek woont en dat ik altijd even bij je kan 
binnenwaaien), Els (jouw en Frank’s Limburgse gastvrijheid waardeer ik 
enorm) en Christine (lange telefoontjes, veel lachen, veel delen, lekker eten 
(Roland!!): een bijzondere klik).
Lieve Lene, onze tijd samen in Tanzania heeft een band voor het leven 
gesmeed! Naast de tropen, de vakanties en het moederschap ook nog 
beiden in opleiding tot kinderarts, nu dat trouwen nog……
Marion, vanaf het 1e jaar geneeskunde kennen we elkaar al en hebben we 
veel beleefd. Je oprechtheid en je enorme gastvrijheid waardeer ik zeer. 
Sweet memories heb ik aan de enerverende jaren op de boerderij dankzij 
jullie, Dennenstreetgirls: lieve Suus, Siep en Carlino!
ME CHICA’s, sinds het CAS zijn we verbonden en dat vind ik heel bijzonder! 
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Tot het volgende weekend!
Een speciaal woord voor mijn beste vriendinnen: Ellen, hartsvriendin van 
het eerste uur, het voelt zo heerlijk dat je weer hier in Nederland woont! 
Bedankt voor je luisterende oor, je humor, je gezelligheid en enthousiasme, 
en bovenal je vriendschap. Wendy, op jou kan ik altijd terugvallen, ook 
al is dat helemaal in Maastricht (anders zou ik wel vaker even bij je 
binnenwippen!). Bedankt voor je onvoorwaardelijke vriendschap.
Mama, jij en papa hebben mij en Jet altijd enorm gestimuleerd. Het was 
papa die voorstelde i.p.v. diergeneeskunde geneeskunde te gaan doen, hij 
had geen betere suggestie kunnen doen. Zonder jullie nooit afl atende steun 
had ik dit uiteindelijk nooit kunnen bereiken. Mama, bedankt voor alles! 
Dit boekje draag ik op aan papa. Henriëtte, twinsissie, wat moest ik zonder 
jou??? Alle Bremers, heit en mem, het voelt elke keer heerlijk thuiskomen in 
Friesland, tige tank!
Liesbeth en Hok-Hay, heel trots ben ik dat jullie mijn paranymphen zijn. 
Liesbeth, bij aankomst op de Epi zat jij daar en het klikte. Ik waardeer je 
trouwe vriendschap enorm. Hok-Hay, kamergenoot in hart en nieren! Het 
laatste ‘half jaar min 1 dag’ was het dan wel netjes op K2132 maar het 
voelde erg leeg zonder jou. Bedankt voor je fi jne gezelschap al die jaren en je 
vriendschap.
Jens en Ties, wat ben ik trots op jullie! Jouw heerlijke armpjes om me heen, 
Jens en jouw hartveroverende lach, Ties, maken het thuiskomen van werk 
elke dag weer tot een feest.
En naast het werk geniet ik met jou, Paul, van het leven. Bedankt dat je 
er voor me bent, overal en altijd. Nu kunnen we weer op vakantie met z’n 
allen!
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